FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Russo, FB
   Brito, A
   de Freitas, AM
   Castanha, A
   de Freitas, BC
   Beltrao-Braga, PCB
AF Russo, Fabiele Baldino
   Brito, Anita
   de Freitas, Ariane Miranda
   Castanha, Andrelissa
   de Freitas, Beatriz C.
   Baleeiro Beltrao-Braga, Patricia Cristina
TI The use of iPSC technology for modeling Autism Spectrum Disorders
SO NEUROBIOLOGY OF DISEASE
LA English
DT Review
DE Autism Spectrum Disorders; Stem cells; iPSC; Disease modeling; Brain
   cells; Brain organoid
ID PLURIPOTENT STEM-CELLS; RETT-SYNDROME; CEREBRAL ORGANOIDS; MOUSE MODEL;
   MICROGLIAL ACTIVATION; ENVIRONMENTAL-FACTORS; INTERLEUKIN-6 IL-6; NEURAL
   DEVELOPMENT; ANGELMAN-SYNDROME; PROGENITOR CELLS
AB Autism Spectrum Disorders (ASDs) are a group of neurodevelopmental disorders that influence social skills, involving communication, interaction, and behavior, usually with repetitive and restrictive manners. Due to the variety of genes involved in ASDs and several possible environmental factors influence, there is still no answer to what really causes syndromic and non-syndromic types of ASDs, usually affecting each individual in a unique way. However, we know that the mechanism underlying ASDs involves brain functioning. The human brain is a complex structure composed of close to 100 billion cells, which is a big challenge to study counting just with post mortem tissue investigation or genetic approaches. Therefore, human induced pluripotent stem cells (iPSC) technology has been used as a tool to produce viable cells for understanding a working brain. Taking advantage of patient-derived stem cells, researchers are now able to generate neurons, glial cells and brain organoids in vitro to model ASDs. In this review we report data from different studies showing how iPSCs have been a critical tool to study the different phenotypes of ASDs.
C1 [Russo, Fabiele Baldino; Brito, Anita; de Freitas, Ariane Miranda; Castanha, Andrelissa; de Freitas, Beatriz C.; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, SP, Brazil.
   [Baleeiro Beltrao-Braga, Patricia Cristina] Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.
RP Beltrao-Braga, PCB (corresponding author), 2nd Floor,Room 227b,Av Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, SP, Brazil.
EM patriciacbbbraga@usp.br
RI Brito, Anita/AAG-2283-2020; Beltrao-Braga, Patricia C B/D-6450-2013
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091
FU agency FAPESP [2011/20683-0, 09/51180-03, 2016/02978-6]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX We would like to thank the support of the agency FAPESP (2011/20683-0,
   09/51180-03, 2016/02978-6), CNPq for PhD fellowship and to the ASDs and
   control individuals and their families for donation of their teeth to
   "the tooth fairy project". We also thank Thomas McGilvray for manuscript
   revision.
CR Amenduni M, 2011, EUR J HUM GENET, V19, P1246, DOI 10.1038/ejhg.2011.131
   Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810
   Archer HL, 2006, J MED GENET, V43, P729, DOI 10.1136/jmg.2006.041467
   Ariani F, 2008, AM J HUM GENET, V83, P89, DOI 10.1016/j.ajhg.2008.05.015
   Armstrong DD, 1998, J NEUROPATH EXP NEUR, V57, P1013, DOI 10.1097/00005072-199811000-00003
   Ashwood P, 2008, J NEUROIMMUNOL, V204, P149, DOI 10.1016/j.jneuroim.2008.07.006
   Baio J, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6706a1
   Baltussen LL, 2018, EMBO J, V37, DOI 10.15252/embj.201899763
   BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0
   Basuodan R, 2018, J ANAT, V233, P155, DOI 10.1111/joa.12827
   Bauman ML, 2010, NEUROTHERAPEUTICS, V7, P320, DOI 10.1016/j.nurt.2010.06.001
   Belichenko PV, 1997, ACTA NEUROPATHOL, V93, P50, DOI 10.1007/s004010050582
   Ben-Itzchak E, 2013, AUTISM RES, V6, P596, DOI 10.1002/aur.1319
   Bett Glenna Cl, 2012, N Am J Med Sci (Boston), V5, P135
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Brito A, 2018, CELL TISSUE RES, V371, P153, DOI 10.1007/s00441-017-2685-x
   Casanova MF, 2003, NEUROSCIENTIST, V9, P496, DOI 10.1177/1073858403253552
   Cawthorpe David, 2017, Perm J, V21, P16, DOI 10.7812/TPP/16-088
   Centeno EGZ, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0258-4
   Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107
   Cheli VT, 2018, GLIA, V66, P2324, DOI 10.1002/glia.23468
   Clarke TK, 2016, MOL PSYCHIATR, V21, P419, DOI 10.1038/mp.2015.12
   Corrigan NM, 2013, JAMA PSYCHIAT, V70, P964, DOI 10.1001/jamapsychiatry.2013.1388
   Darville H, 2016, EBIOMEDICINE, V9, P293, DOI 10.1016/j.ebiom.2016.05.032
   de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071
   De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772
   Derecki NC, 2013, TRENDS IMMUNOL, V34, P144, DOI 10.1016/j.it.2012.10.002
   Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907
   Doers ME, 2014, STEM CELLS DEV, V23, P1777, DOI 10.1089/scd.2014.0030
   Douvaras P, 2017, STEM CELL REP, V8, P1516, DOI 10.1016/j.stemcr.2017.04.023
   Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007
   Dykens EM, 2007, OBESITY, V15, P1816, DOI 10.1038/oby.2007.216
   Edmonson C, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-3
   Elena G, 2012, J OBES, V2012, DOI 10.1155/2012/473941
   Emanuele E, 2010, NEUROSCI LETT, V471, P162, DOI 10.1016/j.neulet.2010.01.033
   Enstrom AM, 2010, BRAIN BEHAV IMMUN, V24, P64, DOI 10.1016/j.bbi.2009.08.001
   Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612
   Fernandez BA, 2017, DIALOGUES CLIN NEURO, V19, P353
   Fink JJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15038
   Fombonne Eric, 2009, Mcgill J Med, V12, P73
   Freitas BC, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00394
   Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X
   GESCHWIND DH, 2015, LANCET NEUROL, V4422, P1
   Gipson Tanjala T, 2013, World J Clin Pediatr, V2, P16, DOI 10.5409/wjcp.v2.i3.16
   Goines PE, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-13
   Gouder L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36993-x
   Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141
   Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787
   Hernandez RN, 2009, AM J MED GENET A, V149A, P1125, DOI 10.1002/ajmg.a.32848
   Hoang N, 2018, PATIENT EDUC COUNS, V101, P352, DOI 10.1016/j.pec.2017.07.029
   Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908
   Jeon IH, 2014, MOLECULES, V19, P6941, DOI 10.3390/molecules19066941
   Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007
   Juttler E, 2002, NEUROSCIENTIST, V8, P268, DOI 10.1177/1073858402008003012
   Karimi P, 2017, J RES MED SCI, V22, DOI 10.4103/1735-1995.200272
   Kettenmann H, 2008, TRENDS NEUROSCI, V31, P653, DOI 10.1016/j.tins.2008.09.003
   Khwaja OS, 2014, P NATL ACAD SCI USA, V111, P4596, DOI 10.1073/pnas.1311141111
   Kleinhans NM, 2007, BRAIN RES, V1162, P85, DOI 10.1016/j.brainres.2007.04.081
   Kolevzon A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-54
   Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002
   Li YQ, 2017, STEM CELL REP, V8, P883, DOI 10.1016/j.stemcr.2017.02.020
   Liu C, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156166
   Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207
   Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834
   Malik M, 2011, IMMUNOBIOLOGY, V216, P80, DOI 10.1016/j.imbio.2010.03.001
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Marchetto MC, 2017, MOL PSYCHIATR, V22, P820, DOI 10.1038/mp.2016.95
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Modabbernia A, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0121-4
   Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024
   Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544
   Muskens JB, 2017, EUR CHILD ADOLES PSY, V26, P1093, DOI 10.1007/s00787-017-1020-0
   Nadadhur AG, 2019, STEM CELL REP, V12, P42, DOI 10.1016/j.stemcr.2018.11.019
   Nageshappa S, 2016, MOL PSYCHIATR, V21, P178, DOI 10.1038/mp.2015.128
   Neul Jeffrey Lorenz, 2012, Dialogues Clin Neurosci, V14, P253
   Ng M, 2017, HEALTH PROMOT CHRON, V37, P1, DOI 10.24095/hpcdp.37.1.01
   Pandya H, 2017, NAT NEUROSCI, V20, P753, DOI 10.1038/nn.4534
   Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576
   Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071
   Peters SU, 2004, CLIN GENET, V66, P530, DOI 10.1111/j.1399-0004.2004.00362.x
   Quaak I, 2013, INT J ENV RES PUB HE, V10, P3384, DOI 10.3390/ijerph10083384
   Quadrato G, 2016, NAT MED, V22, P1220, DOI 10.1038/nm.4214
   Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566
   Romito A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9451492
   Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x
   Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13
   Russo Fabiele B, 2015, World J Transplant, V5, P209, DOI 10.5500/wjt.v5.i4.209
   Russo FB, 2018, BIOL PSYCHIAT, V83, P569, DOI 10.1016/j.biopsych.2017.09.021
   Sajdel-Sulkowska EM, 2011, CEREBELLUM, V10, P43, DOI 10.1007/s12311-010-0223-4
   Sanchez-Sanchez SM, 2018, HUM MUTAT, V39, P1372, DOI 10.1002/humu.23584
   Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144
   Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009
   Schlegelmilch T, 2011, CURR OPIN NEUROBIOL, V21, P5, DOI 10.1016/j.conb.2010.08.004
   Sealey LA, 2016, ENVIRON INT, V88, P288, DOI 10.1016/j.envint.2015.12.021
   Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618
   Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203
   Soorya L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-18
   Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011
   Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002
   Stanurova J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30792
   Suzuki K, 2013, JAMA PSYCHIAT, V70, P49, DOI 10.1001/jamapsychiatry.2013.272
   Sweeten TL, 2003, AM J PSYCHIAT, V160, P1691, DOI 10.1176/appi.ajp.160.9.1691
   Tian Y, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0075-5
   Trazzi S, 2018, HUM MOL GENET, V27, P1572, DOI 10.1093/hmg/ddy064
   Trillingsgaard A, 2004, AUTISM, V8, P163, DOI 10.1177/1362361304042720
   Tsai SJ, 2012, MED SCI MONITOR, V18, pHY33, DOI 10.12659/MSM.883251
   Tsilioni I, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.142
   U.S. National Library of Medicine, 2018, GENET HOME REF, V16, P1
   U.S. National Library of Medicine, 2018, FRAG 10 SYND GEN HOM, P1
   Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082
   van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a
   Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315
   Vicidomini C, 2017, MOL PSYCHIATR, V22, P689, DOI [10.1038/mp.2016.30, 10.1038/mp.2017.82]
   Vignoli A, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0371-1
   Vorstman JAS, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.4
   Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1
   Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002
   Wasilewska J, 2015, PEDIATR HEALTH MED T, V6, P153, DOI 10.2147/PHMT.S85717
   Wei HG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-52
   Williams EC, 2014, HUM MOL GENET, V23, P2968, DOI 10.1093/hmg/ddu008
   Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243
   Ye F, 2017, NEURON, V96, P1204, DOI 10.1016/j.neuron.2017.11.034
   Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005
   Zhang SC, 2001, NAT REV NEUROSCI, V2, P840, DOI 10.1038/35097593
   Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005
   Zheng W, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00239
   Zucco AJ, 2018, MOL CELL NEUROSCI, V92, P149, DOI 10.1016/j.mcn.2018.08.004
   Zuiki M, 2017, NEUROSCI LETT, V653, P296, DOI 10.1016/j.neulet.2017.06.004
NR 132
TC 7
Z9 7
U1 0
U2 25
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD OCT
PY 2019
VL 130
AR 104483
DI 10.1016/j.nbd.2019.104483
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA IR6QY
UT WOS:000481565000045
PM 31129084
DA 2020-12-01
ER

PT J
AU Lovato, DV
   Herai, RR
   Pignatari, GC
   Beltrao-Braga, PCB
AF Lovato, Diogo V.
   Herai, Roberto R.
   Pignatari, Graciela C.
   Beltrao-Braga, Patricia C. B.
TI The Relevance of Variants With Unknown Significance for Autism Spectrum
   Disorder Considering the Genotype-Phenotype Interrelationship
SO FRONTIERS IN PSYCHIATRY
LA English
DT Review
DE autism spectrum disorders; variants of unknown significance;
   next-generation sequencing; de novo mutation; rare variants
ID DE-NOVO MUTATION; DATA OPPORTUNITIES; MOSAIC MUTATIONS; RISK; GENETICS;
   CHILDREN; ARCHITECTURE; DIAGNOSIS; PATHWAYS; DATABASE
AB Several efforts in basic and clinical research have been contributing to unveiling the genetics behind autism spectrum disorders (ASD). However, despite these advancements, many individuals diagnosed with ASD and related neuropsychiatric conditions have been genetically investigated without elucidative results. The enormous genetic complexity of ASD-related conditions makes it a significant challenge to achieve, with a growing number of genes (close to a thousand) involved, belonging to different molecular pathways and presenting distinct genetic variations. Next-generation sequencing (NGS) is the approach most used in genetic research related to ASD, identifying de novo mutation, which is closely related to more severe clinical phenotypes, especially when they affect constrained and loss-of-function intolerant genes. On the other hand, de novo mutation findings contribute to a small percentage of the ASD population, since most of the cases and genetic variants associated with neuropsychiatric conditions are inherited and phenotypes are results of additive polygenic models, which makes statistical efforts more difficult. As a result, NGS investigation can sound vainly or unsuccessful, and new mutations on genes already related with ASD are classified as variants of unknown significance (VUS), hampering their endorsement to a clinical phenotype. This review is focused on currently available strategies to clarify the impact of VUS and to describe the efforts to identify more pieces of evidence throughout clinical interpretation and genetic curation process.
C1 [Lovato, Diogo V.; Pignatari, Graciela C.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Lab Dis Modeling, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil.
   [Herai, Roberto R.] Pontificia Univ Catolica Parana, Expt Multiuser Lab, Grad Program Hlth Sci, Sch Med, Curitiba, Parana, Brazil.
   [Herai, Roberto R.] ILK, Curitiba, Parana, Brazil.
   [Beltrao-Braga, Patricia C. B.] Sci Platform Pasteur USP, Lab Dis Modeling, Sao Paulo, Brazil.
RP Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Lab Dis Modeling, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil.; Beltrao-Braga, PCB (corresponding author), Sci Platform Pasteur USP, Lab Dis Modeling, Sao Paulo, Brazil.
EM patriciacbbbraga@usp.br
RI Beltrao-Braga, Patricia C B/D-6450-2013
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Ventura Lovato,
   Diogo/0000-0001-6631-238X
CR Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36
   Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76
   Alexeeff SE, 2017, J AUTISM DEV DISORD, V47, P2067, DOI 10.1007/s10803-017-3130-4
   An JY, 2018, SCIENCE, V362, P1270, DOI 10.1126/science.aat6576
   Ancien F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22531-2
   Ballouz S, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0455-8
   Bertier G, 2017, CRIT REV CL LAB SCI, V54, P134, DOI 10.1080/10408363.2016.1275516
   Bourgeron T, 2016, CR BIOL, V339, P300, DOI 10.1016/j.crvi.2016.05.004
   Brandler WM, 2018, SCIENCE, V360, P327, DOI 10.1126/science.aan2261
   Carter H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S3
   Chen SW, 2018, NAT GENET, V50, P1032, DOI 10.1038/s41588-018-0130-z
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Crawford S, 2015, MED HYPOTHESES, V85, P798, DOI 10.1016/j.mehy.2015.10.006
   Daghsni M, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.978
   David MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157937
   De Rubeis S., 2014, NATURE, V515, P209, DOI DOI 10.1038/NATURE13772
   Du XJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00594
   Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036
   Forrest CB, 2014, HEALTH AFFAIR, V33, P1171, DOI 10.1377/hlthaff.2014.0127
   Freed D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006245
   Gandal MJ, 2016, NAT NEUROSCI, V19, P1397, DOI 10.1038/nn.4409
   Ganna A, 2018, AM J HUM GENET, V102, P1204, DOI 10.1016/j.ajhg.2018.05.002
   Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039
   Havrilla JM, 2019, NAT GENET, V51, P88, DOI 10.1038/s41588-018-0294-6
   Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016
   Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908
   Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224
   Krupp DR, 2017, AM J HUM GENET, V101, P369, DOI 10.1016/j.ajhg.2017.07.016
   Kuhlthau KA, 2018, J DEV BEHAV PEDIATR, V39, P168, DOI 10.1097/DBP.0000000000000534
   Lecavalier L, 2019, COMPR PSYCHIAT, V88, P57, DOI 10.1016/j.comppsych.2018.10.012
   Lee H, 2010, AM J MED GENET B, V153B, P1119, DOI 10.1002/ajmg.b.31103
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Li JC, 2018, NUCLEIC ACIDS RES, V46, P7793, DOI 10.1093/nar/gky678
   Li JC, 2019, MOL PSYCHIATR, V24, P1720, DOI 10.1038/s41380-018-0081-x
   Li JC, 2016, MOL PSYCHIATR, V21, P290, DOI 10.1038/mp.2015.40
   Lim ET, 2017, NAT NEUROSCI, V20, P1217, DOI 10.1038/nn.4598
   Lionel AC, 2018, GENET MED, V20, P435, DOI 10.1038/gim.2017.119
   Murray DS, 2016, PEDIATRICS, V137, pS72, DOI 10.1542/peds.2015-2851E
   Ng M, 2017, HEALTH PROMOT CHRON, V37, P1, DOI 10.24095/hpcdp.37.1.01
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031
   Payakachat N, 2016, PHARMACOECONOMICS, V34, P127, DOI 10.1007/s40273-015-0331-6
   Pereanu W, 2018, NUCLEIC ACIDS RES, V46, pD1049, DOI 10.1093/nar/gkx1093
   Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709
   Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018
   Pizzo L, 2019, GENET MED, V21, P816, DOI 10.1038/s41436-018-0266-3
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529
   Rossi M, 2017, PEDIATR NEUROL, V70, P34, DOI 10.1016/j.pediatrneurol.2017.01.033
   Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050
   Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016
   Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   Son JH, 2018, AM J HUM GENET, V103, P58, DOI 10.1016/j.ajhg.2018.05.010
   Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6
   Tammimies K, 2015, JAMA-J AM MED ASSOC, V314, P895, DOI 10.1001/jama.2015.10078
   Tordjman S, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00053
   Turner TN, 2017, CELL, V171, P710, DOI 10.1016/j.cell.2017.08.047
   Valencia CA, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00067
   Vears DF, 2018, EUR J HUM GENET, V26, P1743, DOI 10.1038/s41431-018-0239-7
   Vrijenhoek T, 2018, EUR J HUM GENET, V26, P1566, DOI 10.1038/s41431-018-0203-6
   Weiner DJ, 2017, NAT GENET, V49, P978, DOI 10.1038/ng.3863
   Wetterstrand K A, DNA SEQUENCING COSTS
   Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020
   Yang CH, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay106
   Yuen T, 2018, APPL HEALTH ECON HEA, V16, P481, DOI 10.1007/s40258-018-0390-x
   Zhang SY, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1915-2
   Zhao ZQ, 2018, 2018 9TH INTERNATIONAL CONFERENCE ON CIVIL ENGINEERING, MATERIALS AND MACHINERY (ICCEMM 2018), P1
NR 69
TC 4
Z9 4
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-0640
J9 FRONT PSYCHIATRY
JI Front. Psychiatry
PD JUN 7
PY 2019
VL 10
AR 409
DI 10.3389/fpsyt.2019.00409
PG 6
WC Psychiatry
SC Psychiatry
GA IC7SG
UT WOS:000471176700001
PM 31231258
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Pinheiro, LL
   de Lima, AR
   Martins, DM
   de Oliveira, EHC
   Souza, MPC
   Miranda, CMFD
   Beltrao-Braga, PCB
   Russo, FB
   Pignatari, GC
   Filho, ED
   Branco, E
AF Pinheiro, Luane Lopes
   de Lima, Ana Rita
   Martins, Danielli Martinelli
   de Oliveira, Edivaldo Herculano C.
   Souza, Michel Platini C.
   Figueiredo de Carvalho Miranda, Carla Maria
   Baleeiro Beltrao-Braga, Patricia Cristina
   Russo, Fabiele Baldino
   Pignatari, Graciela Conceicao
   Filho, Ednaldo da Silva
   Branco, Erika
TI Mesenchymal stem cells in dogs with demyelinating leukoencephalitis as
   an experimental model of multiple sclerosis
SO HELIYON
LA English
DT Article
DE Cell biology; Neuroscience; Mesenchymal stem cells; Canine distemper;
   Multiple sclerosis; Demyelination
ID STROMAL CELLS; CELLULAR-THERAPY; TRANSPLANTATION; PATHOGENESIS; REPAIR;
   TISSUE; GENE
AB Researchers have used dogs with neurological sequelae caused by distemper as an experimental model for multiple sclerosis, owing to the similarities of the neuropathological changes between distemper virus-induced demyelinating leukoencephalitis and multiple sclerosis in humans. However, little is known about the role of mesenchymal stem cells in treating such clinical conditions. Therefore, we investigated the use of mesenchymal stem cells in four dogs with neurological lesions caused by the distemper virus. During the first year after cellular therapy, the animals did not demonstrate significant changes in their locomotive abilities. However, the intense (Grade V) myoclonus in three animals was reduced to a moderate (Grade IV) level. At one year after the mesenchymal stem cell infusions, three animals regained functional ambulation (Grade I), and all four dogs started to move independently (Grades I and II). In two animals, the myoclonic severity had become mild (Grade III). It was concluded that the use of mesenchymal stem cells could improve the quality of life of dogs with neurological sequelae caused by canine distemper, thus presenting hope for similar positive results in human patients with multiple sclerosis.
C1 [Pinheiro, Luane Lopes; de Lima, Ana Rita; Martins, Danielli Martinelli; Filho, Ednaldo da Silva; Branco, Erika] Fed Rural Univ Amazonia, Fac Vet Med, Inst Anim Hlth & Prod, Belem, Para, Brazil.
   [de Oliveira, Edivaldo Herculano C.; Souza, Michel Platini C.] Inst Evandro Chagas, Environm Sect, Tissue Culture & Cytogenet Lab, Ananindeua, PA, Brazil.
   [Figueiredo de Carvalho Miranda, Carla Maria] Univ Sao Paulo, Fac Vet Med & Anim Sci, Dept Surg, Sao Paulo, SP, Brazil.
   [Baleeiro Beltrao-Braga, Patricia Cristina; Russo, Fabiele Baldino; Pignatari, Graciela Conceicao] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, SP, Brazil.
RP Pinheiro, LL (corresponding author), Fed Rural Univ Amazonia, Fac Vet Med, Inst Anim Hlth & Prod, Belem, Para, Brazil.
EM luanelopespinheiro@gmail.com
RI Beltrao-Braga, Patricia C B/D-6450-2013; de Oliveira, Edivaldo H.
   C./C-3368-2013
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; de Oliveira, Edivaldo
   H. C./0000-0001-6315-3352
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   BrasilCAPES [001]
FX This work was supported by the Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES), Brasil (Finance Code 001).
CR Auletta JJ, 2012, IMMUNOTHERAPY-UK, V4, P529, DOI [10.2217/imt.12.41, 10.2217/IMT.12.41]
   Baumgaertner Wolfgang, 2005, P871, DOI 10.1007/0-387-25518-4_51
   Bearden RN, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0639-6
   Beineke A, 2009, VET IMMUNOL IMMUNOP, V127, P1, DOI 10.1016/j.vetimm.2008.09.023
   Bogers SH, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00070
   Bonab MM, 2012, CURR STEM CELL RES T, V7, P407
   Brito H. F. V., 2015, THESIS, P79
   Cruz-Martinez P, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.130
   de Bakker E, 2013, VET QUART, V33, P225, DOI 10.1080/01652176.2013.873963
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dulamea A, 2015, J Med Life, V8, P24
   FDA. (2015). Food and Drug Administration, 2015, GUID IND CELL BAS PR
   Freedman MS, 2010, MULT SCLER J, V16, P503, DOI 10.1177/1352458509359727
   Gebara CMS, 2004, ARQ BRAS MED VET ZOO, V56, P480, DOI 10.1590/S0102-09352004000400009
   Goncalves D. S. V, 2018, GENET MOL RES, V17
   Jadasz JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071814
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248
   Kean TJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/732742
   Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015
   KOESTNER A, 1975, AM J PATHOL, V78, P361
   Kokai LE, 2014, TRANSL RES, V163, P399, DOI 10.1016/j.trsl.2013.11.009
   Lempp C, 2014, VIRUSES-BASEL, V6, P2571, DOI 10.3390/v6072571
   Llufriu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113936
   Mangia SH, 2008, VET ZOOTEC, V15, P416
   Marin-Banasco C, 2017, BRIT J PHARMACOL, V174, P238, DOI 10.1111/bph.13674
   Marx C, 2015, STEM CELLS DEV, V24, P803, DOI 10.1089/scd.2014.0407
   Monteiro B. A., 2017, THESIS, P68
   Nelson R. W., 2008, SMALL ANIMAL INTERNA
   Patricio LFL, 2013, ARQ BRAS MED VET ZOO, V65, P946, DOI 10.1590/S0102-09352013000400002
   Pinheiro AO, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15028310
   Rivera FJ, 2012, BIOL RES, V45, P257, DOI 10.4067/S0716-97602012000300007
   Santos B. P. C. R., 2013, THESIS, P90
   Silva MC, 2007, PESQUISA VET BRASIL, V27, P215, DOI 10.1590/S0100-736X2007000500006
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Ulrich R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095917
   Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764
   Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047
   Yamout B, 2010, J NEUROIMMUNOL, V227, P185, DOI 10.1016/j.jneuroim.2010.07.013
   Zhao W, 2012, WORLD J GASTROENTERO, V18, P1048, DOI 10.3748/wjg.v18.i10.1048
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 41
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD JUN
PY 2019
VL 5
IS 6
AR e01857
DI 10.1016/j.heliyon.2019.e01857
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IG5BK
UT WOS:000473818300123
PM 31198874
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Ohki, CMY
   Benazzato, C
   Russo, FB
   Beltrao-Braga, PCB
AF Yde Ohki, Cristine Marie
   Benazzato, Cecilia
   Russo, Fabiele Baldino
   Baleeiro Beltrao-Braga, Patricia Cristina
TI Developing animal models of Zika virus infection for novel drug
   discovery
SO EXPERT OPINION ON DRUG DISCOVERY
LA English
DT Review
DE Animal model; azithromycin; chloroquine; congenital Zika syndrome; drug
   discovery; galidesivir; niclosamide; novobiocin; sofosbuvir; ZIKV
AB Introduction: Just before the Brazilian outbreak, Zika virus was related to a mild infection, causing fever and skin rash. Congenital Zika Syndrome was first described in Brazil, causing microcephaly and malformations in newborns. Three years after the outbreak, the mechanisms of Zika pathogenesis are still not completely elucidated. Moreover, as of today, there is still no approved vaccine that can be administered to the susceptible population. Considering the unmet clinical need, animal models represent an unprecedented opportunity to study Zika pathophysiology and test drugs for the treatment and prevention of vertical transmission. Areas covered: The authors explore the current knowledge about Zika through animal models and advancements in drug discovery by highlighting drugs with the greatest potential to treat ZIKV infection and block vertical transmission. Expert opinion: Some drugs used to treat other infections have been repurposed to treat Zika infection, reducing the cost and time for clinical application. One promising example is Sofosbuvir, which protected mice models against Zika pathogenesis by preventing vertical transmission. Importantly, there is a lack on exploration on the long-term effects of Zika Congenital Syndrome, as well as the possible ways to treat its sequelae.
C1 [Yde Ohki, Cristine Marie; Benazzato, Cecilia; Russo, Fabiele Baldino; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.
   [Benazzato, Cecilia] Univ Sao Paulo, Sch Vet Med, Dept Surg, Sao Paulo, Brazil.
RP Beltrao-Braga, PCB (corresponding author), Av Prof Lineu Prestes 1374,2nd Floor,Room 227, BR-05508900 Sao Paulo, SP, Brazil.
EM patriciacbbbraga@usp.br
RI Benazzato, Cecilia/AAB-8869-2019; Beltrao-Braga, Patricia C
   B/D-6450-2013; Ohki, Cristine/U-6296-2017; Benazzato,
   Cecilia/U-5873-2017
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Ohki,
   Cristine/0000-0002-7414-2250; Benazzato, Cecilia/0000-0002-8656-0871
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [18/16748-8,
   16/02978-6]; Brazilian NGO 'the tooth fairy project'; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)CAPES [001];
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX This work was sponsored by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) (18/16748-8; 16/02978-6), the Brazilian NGO 'the
   tooth fairy project' and in part by the Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior-Brasil (CAPES)-Finance Code 001; and the
   CNPq.
CR ABBINK P, 2018, INTERNET, V353, P1129, DOI DOI 10.1126/SCIENCE.AAH6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, P1
   ALVARADO MG, 2018, INTERNET, V141, P26, DOI DOI 10.5858/ARPA.2016-0382-RA
   [Anonymous], 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   AOKI K, 2018, INTERNET, V11, P105, DOI DOI 10.1186/1743-422X-11-105
   Azar SR, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110661
   AZAR SR, 2018, AM J TROP MED HYG, V6, P1362, DOI DOI 10.4269/AJTMH.16-0111
   BARROWS NJ, 2018, INTERNET, V20, P259, DOI DOI 10.1016/J.CHOM.2016.07.004
   BERECZKY S, 2018, INTERNET, V91, P1473, DOI DOI 10.1099/VIR.0.019034-0
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Bidokhti MRM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006811
   Bierle CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187720
   Bradley MP, 2017, COMPARATIVE MED, V67, P242
   Broek MF, 1995, IMMUNOL REV, V148, P5
   Browning DJ, 2014, HYDROXYCHLOROQUINE C, DOI [10.1007/978-1-4939-0597-3, DOI 10.1007/978-1-4939-0597-3]
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   BULLARDFEIBELMA.KM, 2018, INTERNET, V137, P134, DOI DOI 10.1016/J.ANTIVIRAL.2016.11.023
   Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807
   CAOLORMEAU V, 2018, INTERNET, V387, P1531, DOI DOI 10.1016/S0140-6736(16)00562-6
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   CARTEAUX G, 2018, INTERNET, V374, P1595, DOI DOI 10.1056/NEJMC1602964
   CHAN J, 2018, INTERNET, V14, P112, DOI DOI 10.1016/J.EBIOM.2016.11.017
   Chang C., 2018, ROBOTICA, V05, P1
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DARBELLAY J, 2018, INTERNET, V25, P73, DOI DOI 10.1016/J.EBIOM.2017.09.021
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   DENG Y, 2018, INTERNET, V8, P1648, DOI DOI 10.1038/S41467-017-01923-4
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DOWALL SD, 2018, INTERNET, V93, P560, DOI DOI 10.1099/VIR.0.038455-0
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   DOWD KA, 2018, INTERNET, V354, P237, DOI DOI 10.1126/SCIENCE.AAI9137
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   FOY BD, 2018, INTERNET, V17, P880, DOI DOI 10.3201/EID1705.101939
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   GOVERO J, 2018, INTERNET, V540, P438, DOI DOI 10.1038/NATURE20556
   Gurung S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007507
   HADDOW AD, 2018, INTERNET, V23, P1274, DOI DOI 10.3201/EID2308.170036
   HAZIN AN, 2018, INTERNET, V374, P2193, DOI DOI 10.1056/NEJMC1603617
   HUANG S, 2018, INTERNET, V259, P1742
   IMPERATO PJ, 2018, INTERNET, V41, P674, DOI DOI 10.1007/S10900-016-0177-7
   Jackman JA, 2018, NAT MATER, V17, P971, DOI 10.1038/s41563-018-0194-2
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   LAMONICA BE, 2018, INTERNET, V22, P747, DOI DOI 10.1016/J.CONB.2012.03.006
   LAROCCA RA, 2018, INTERNET, V536, P474, DOI DOI 10.1038/NATURE18952
   LAZEAR HM, 2018, INTERNET, V19, P720, DOI DOI 10.1016/J.CHOM.2016.03.010
   LI C, 2018, INTERNET, V19, P120
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Lim S-Y, 2016, OPEN FORUM INFECT DI, V3
   Lim SY, 2017, OPEN FORUM INFECT DI, DOI [DOI 10.1093/ofid/ofx162.129, 10.1093/ofid/ofx162.129]
   Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005
   LIZARRAGA SB, 2018, INTERNET, V137, P1907, DOI DOI 10.1242/DEV.040410
   MA W, 2005, INTERNET, V167, P1511, DOI DOI 10.1016/J.CELL.2016.11.016
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   MAGNANI DM, 2018, INTERNET, V9, P1, DOI DOI 10.1038/S41467-018-04056-4
   MEIER KC, 2018, INTERNET, V5
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Miller LJ, 2018, AM J TROP MED HYG, V98, P864, DOI 10.4269/ajtmh.17-0686
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MULLER U, 2018, INTERNET, V264, P1918
   Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802
   MUSSO D, 2018, INTERNET, V21, P359, DOI DOI 10.3201/EID2102.141363
   MUSSO D, 2018, INTERNET, V29, P487, DOI DOI 10.1128/CMR.00072-15
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Oliveira-Melo AS, 2016, INTERNET, V47, P6
   OROZCO S, 2018, INTERNET, V93, P2152, DOI DOI 10.1099/VIR.0.045088-0
   OSUNA CE, 2010, INTERNET, V216, pS928, DOI DOI 10.1093/INFDIS/JIX540
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   PARTIDOS CD, 2018, INTERNET, V30, P4638, DOI DOI 10.1016/J.VACCINE.2012.04.099
   Pessoa A, 2016, INTERNET, V65, P1343
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   PRESTWOOD TR, 2018, INTERNET, V86, P12561, DOI DOI 10.1128/JVI.06743-11
   PULVERS JN, 2018, INTERNET, V107, P16595, DOI DOI 10.1073/PNAS.1010494107
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Schmitt K, 2018, VIROLOGY, V515, P235, DOI 10.1016/j.virol.2017.12.026
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Schuler-Faccini L, 2016, INTERNET, V65, P59
   SEYMOUR RL, 2018, INTERNET, V88, P1170, DOI DOI 10.4269/AJTMH.12-0674
   SHAN C, 2018, INTERNET, V19, P891, DOI DOI 10.1016/J.CHOM.2016.05.004
   SHRESTA S, 2018, INTERNET, V78, P2701, DOI DOI 10.1128/JVI.78.6.2701-2710.2004
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x
   Sun YQ, 2018, INORG CHEM FRONT, V5, P145, DOI 10.1039/c7qi00491e
   TANG WW, 2018, INTERNET, V17, P3091, DOI DOI 10.1016/J.CELREP.2016.11.070
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Viranaicken W, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010038
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   WANG S, 2018, INTERNET, V27, P158, DOI DOI 10.1038/CR.2016.144
   WARREN TK, 2018, INTERNET, V508, P402, DOI DOI 10.1038/NATURE13027
   WIKAN N, 2018, INTERNET, V16, pE119, DOI DOI 10.1016/S1473-3099(16)30010-X
   WU K, 2018, INTERNET, V26, P645, DOI DOI 10.1038/CR.2016.58
   WU Y, 2018, INTERNET, V12
   YAUCH LE, 2018, INTERNET, V182, P4865, DOI DOI 10.4049/JIMMUNOL.0801974
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   YOCKEY LJ, 2005, INTERNET, V166, P1247, DOI DOI 10.1016/J.CELL.2016.08.004
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 106
TC 3
Z9 3
U1 1
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1746-0441
EI 1746-045X
J9 EXPERT OPIN DRUG DIS
JI Expert. Opin. Drug Discov.
PD JUN 3
PY 2019
VL 14
IS 6
BP 577
EP 589
DI 10.1080/17460441.2019.1597050
EA APR 2019
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HY1MA
UT WOS:000466002200001
PM 30991850
DA 2020-12-01
ER

PT J
AU Rosa-Fernandes, L
   Cugola, FR
   Russo, FB
   Kawahara, R
   Freire, CCD
   Leite, PEC
   Stern, ACB
   Angeli, CB
   de Oliveira, DBL
   Melo, SR
   Zanotto, PMD
   Durigon, EL
   Larsen, MR
   Beltrao-Braga, PCB
   Palmisano, G
AF Rosa-Fernandes, Livia
   Cugola, Fernanda Rodrigues
   Russo, Fabiele Baldino
   Kawahara, Rebeca
   de Melo Freire, Caio Cesar
   Correa Leite, Paulo Emlio
   Bassi Stern, Ana Carolina
   Angeli, Claudia Blanes
   Leal de Oliveira, Danielle Bruna
   Melo, Stella Rezende
   de Andrade Zanotto, Paolo Marinho
   Durigon, Edison Luiz
   Larsen, Martin Rossel
   Baleeiro Beltrao-Braga, Patricia Cristina
   Palmisano, Giuseppe
TI Zika Virus Impairs Neurogenesis and Synaptogenesis Pathways in Human
   Neural Stem Cells and Neurons
SO FRONTIERS IN CELLULAR NEUROSCIENCE
LA English
DT Article
DE Zika virus; microcephaly; congenital Zika syndrome; neurogenesis;
   synaptogenesis
ID TISSUE GROWTH-FACTOR; MICROTUBULE-ASSOCIATED PROTEIN; SEXUAL
   TRANSMISSION; DIFFERENTIATION; DOUBLECORTIN; BETA; ENRICHMENT;
   TGF-BETA-1; MOLECULES; CORTEX
AB Growing evidences have associated Zika virus (ZIKV) infection with congenital malformations, including microcephaly. Nonetheless, signaling mechanisms that promote the disease outcome are far from being understood, affecting the development of suitable therapeutics. In this study, we applied shotgun mass spectrometry (MS)based proteomics combined with cell biology approaches to characterize altered molecular pathways on human neuroprogenitor cells (NPC) and neurons derived from induced pluripotent stem cells infected by ZIKV-BR strain, obtained from the 2015 Brazilian outbreak. Furthermore, ZIKV-BR infected NPCs showed unique alteration of pathways involved in neurological diseases, cell death, survival and embryonic development compared to ZIKV-AF, showing a human adaptation of the Brazilian viral strain. Besides, infected neurons differentiated from NPC presented an impairment of neurogenesis and synaptogenesis processes. Taken together, these data explain that CNS developmental arrest observed in Congenital Zika Syndrome is beyond neuronal cell death.
C1 [Rosa-Fernandes, Livia; Larsen, Martin Rossel] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.
   [Cugola, Fernanda Rodrigues; Russo, Fabiele Baldino; Leal de Oliveira, Danielle Bruna; Melo, Stella Rezende; de Andrade Zanotto, Paolo Marinho; Durigon, Edison Luiz; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil.
   [Kawahara, Rebeca; Bassi Stern, Ana Carolina; Angeli, Claudia Blanes; Palmisano, Giuseppe] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.
   [de Melo Freire, Caio Cesar] Univ Fed Sao Carlos, Dept Genet & Evolut, Sao Carlos, SP, Brazil.
   [Correa Leite, Paulo Emlio] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil.
RP Larsen, MR (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil.; Palmisano, G (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil.
EM mrl@bmb.sdu.dk; patriciacbbbraga@usp.br; palmisano.gp@usp.com
RI de A. Zanotto, Paolo M./B-9286-2019; Oliveira, Danielle BL/H-8030-2015;
   Leite, Paulo Emilio C/N-3443-2013; Rosa-Fernandes, Livia/AAH-3734-2019;
   Palmisano, Giuseppe/N-3602-2013; Beltrao-Braga, Patricia C
   B/D-6450-2013; Angeli, Claudia Blanes/M-1282-2016
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; Oliveira, Danielle
   BL/0000-0002-3452-1336; Leite, Paulo Emilio C/0000-0002-1783-1228;
   Rosa-Fernandes, Livia/0000-0003-1612-1950; Palmisano,
   Giuseppe/0000-0003-1336-6151; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; Oliveira, Danielle/0000-0002-0534-0886; Angeli,
   Claudia Blanes/0000-0002-3906-1973
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [202077/2015-2, 441105/2016-5, 441878/2014-8]; FAPESPFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/02866-0, 2011/20683-0,
   2013/08844-3, 2016/02978-6, 2018/16748-8, 2014/06863-3]; NGO "The Tooth
   Fairy Project"; Ministero della SaluteMinistry of Health, Italy
   [172/GR-2011-02350301]; VILLUM Center for Bioanalytical Sciences at the
   University of Southern Denmark; CAPESCAPES
FX LR-F was supported by CNPq (202077/2015-2). RK was supported by FAPESP
   (2015/02866-0). PZ was supported by CNPq (441105/2016-5). PB-B was
   supported by FAPESP (2011/20683-0, 2013/08844-3, 2016/02978-6, and
   2018/16748-8), the NGO "The Tooth Fairy Project" and CAPES for Ph.D.
   fellowship. GP was supported by FAPESP (2014/06863-3), CNPq
   (441878/2014-8) and Ricerca Finalizzata (Convenzione
   n.172/GR-2011-02350301) from the Ministero della Salute. This work was
   also supported by the VILLUM Center for Bioanalytical Sciences at the
   University of Southern Denmark.
CR Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235
   Benitez MJ, 2014, BBA-MOL CELL RES, V1843, P245, DOI 10.1016/j.bbamcr.2013.11.013
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9
   Burkarth N, 2007, MOL CELL NEUROSCI, V36, P59, DOI 10.1016/j.mcn.2007.06.001
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Cheng YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30314
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3
   Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5
   Jiang X, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01067
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248
   Lambi AG, 2012, DEV DYNAM, V241, P1944, DOI 10.1002/dvdy.23888
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee M, 2017, DEV BIOL, V424, P62, DOI 10.1016/j.ydbio.2017.02.010
   Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Miller MW, 2003, J COMP NEUROL, V460, P410, DOI 10.1002/cne.10658
   Mishima T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090004
   Palmisano G, 2012, MOL CELL PROTEOMICS, V11, P1191, DOI 10.1074/mcp.M112.017509
   Palmisano G, 2010, NAT PROTOC, V5, P1974, DOI 10.1038/nprot.2010.167
   Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012
   Quinn DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42920
   Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057
   ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167
   Rodriguez-Martinez G, 2012, CNS NEUROL DISORD-DR, V11, P844, DOI 10.2174/1871527311201070844
   Russo FB, 2018, BIOL PSYCHIAT, V83, P569, DOI 10.1016/j.biopsych.2017.09.021
   Russo FB, 2017, BIOCHEM BIOPH RES CO, V492, P603, DOI 10.1016/j.bbrc.2017.01.074
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Sanchez-San Martin C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32400-7
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tarr J., 2015, FASEB J S, V29, P63, DOI [10.3390/jdb6030018, DOI 10.3390/JDB6030018]
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Trimbuch T, 2016, NAT REV NEUROSCI, V17, P118, DOI 10.1038/nrn.2015.16
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Waites CL, 2013, EMBO J, V32, P954, DOI 10.1038/emboj.2013.27
   Williams KL, 2006, J NEUROSCI RES, V84, P716, DOI 10.1002/jnr.20983
   Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 55
TC 6
Z9 6
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1662-5102
J9 FRONT CELL NEUROSCI
JI Front. Cell. Neurosci.
PD MAR 15
PY 2019
VL 13
AR 64
DI 10.3389/fncel.2019.00064
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA HP6HT
UT WOS:000461785600001
PM 30949028
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Weissman, I
   Rawlins, E
   Jensen, K
   Barker, R
   Beltrao-Braga, P
   Dekel, B
   Frisen, J
   Surani, A
   Fehlings, M
AF Weissman, Irving
   Rawlins, Emma
   Jensen, Kim
   Barker, Roger
   Beltrao-Braga, Patricia
   Dekel, Benjamin
   Frisen, Jonas
   Surani, Azim
   Fehlings, Michael
TI Voices: The Importance of Fetal Tissue Research
SO CELL STEM CELL
LA English
DT Editorial Material
AB The value of fetal tissue research cannot be understated and has led to remarkable advances in understanding human development, therapeutic discovery, and stem cell research across many organ systems. We asked 9 researchers to reflect on the impact and key contributions of fetal tissue in their field of expertise.
C1 [Weissman, Irving] Stanford Univ, Stanford, CA 94305 USA.
   [Rawlins, Emma; Barker, Roger; Surani, Azim] Univ Cambridge, Cambridge, England.
   [Jensen, Kim] Univ Copenhagen, Copenhagen, Denmark.
   [Beltrao-Braga, Patricia] Univ Sao Paulo, Sao Paulo, Brazil.
   [Dekel, Benjamin] Tel Aviv Univ, Tel Aviv, Israel.
   [Frisen, Jonas] Karolinska Inst, Stockholm, Sweden.
   [Fehlings, Michael] Univ Toronto, Toronto, ON, Canada.
RP Weissman, I (corresponding author), Stanford Univ, Stanford, CA 94305 USA.
RI Beltrao-Braga, Patricia C B/D-6450-2013
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD MAR 7
PY 2019
VL 24
IS 3
BP 357
EP 359
DI 10.1016/j.stem.2019.01.012
PG 3
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA HO1NB
UT WOS:000460672700008
PM 30770301
OA Bronze
DA 2020-12-01
ER

PT J
AU Freitas, BC
   Mei, A
   Mendes, APD
   Beltrao-Braga, PCB
   Marchetto, MC
AF Freitas, Beatriz C.
   Mei, Arianna
   Mendes, Ana Paula D.
   Beltrao-Braga, Patricia C. B.
   Marchetto, Maria Carolina
TI Modeling Inflammation in Autism Spectrum Disorders Using Stem Cells
SO FRONTIERS IN PEDIATRICS
LA English
DT Review
DE autism spectrum disorder (ASD); disease modeling; neuroinflammation;
   neurodevelopmental disorders; induced pluripotent stem (iPS) cells
ID MATERNAL IMMUNE ACTIVATION; FRAGILE-X-SYNDROME;
   RECEPTOR-TYROSINE-KINASE; WILD-TYPE MICROGLIA; RETT-SYNDROME;
   BRAIN-DEVELOPMENT; TRANSCRIPTOMIC ANALYSIS; AUTOIMMUNE-DISEASES; NEURAL
   DEVELOPMENT; GUT MICROBIOTA
AB Recent reports show an increase in the incidence of Autism Spectrum Disorders (ASD) to 1 in every 59 children up to 8 years old in 11 states in North America. Induced pluripotent stem cell (iPSC) technology offers a groundbreaking platform for the study of polygenic neurodevelopmental disorders in live cells. Robust inflammation states and immune system dysfunctions are associated with ASD and several cell types participate on triggering and sustaining these processes. In this review, we will examine the contribution of neuroinflammation to the development of autistic features and discuss potential therapeutic approaches. We will review the available tools, emphasizing stem cell modeling as a technology to investigate the various molecular pathways and different cell types involved in the process of neuroinflammation in ASD.
C1 [Freitas, Beatriz C.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Dis Modeling, Sao Paulo, Brazil.
   [Mei, Arianna; Mendes, Ana Paula D.; Marchetto, Maria Carolina] Salk Inst Biol Studies, Lab Genet, La Jolla, CA 92037 USA.
   [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil.
RP Marchetto, MC (corresponding author), Salk Inst Biol Studies, Lab Genet, La Jolla, CA 92037 USA.
EM marchetto@salk.edu
RI Beltrao-Braga, Patricia C B/D-6450-2013
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R03
   MH115426-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [R03MH115426]
   Funding Source: NIH RePORTER
FX The authors would like to acknowledge the support from the National
   Institutes of Health (NIH) grant number R03 MH115426-01A1 (MM).
CR Acab A, 2015, NEUROTHERAPEUTICS, V12, P534, DOI 10.1007/s13311-015-0354-x
   Amenduni M, 2011, EUR J HUM GENET, V19, P1246, DOI 10.1038/ejhg.2011.131
   Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810
   Ansel A, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00601
   Atladottir HO, 2009, PEDIATRICS, V124, P687, DOI 10.1542/peds.2008-2445
   Baio J, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6706a1
   Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004
   Boland MJ, 2017, BRAIN, V140, P582, DOI 10.1093/brain/aww357
   Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180
   Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103
   Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252
   Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001
   Chen QA, 2010, J NEUROSCI, V30, P12777, DOI 10.1523/JNEUROSCI.1102-10.2010
   Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093
   Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314
   Croen LA, 2019, AUTISM RES, V12, P123, DOI 10.1002/aur.1979
   Cronk JC, 2015, IMMUNITY, V42, P679, DOI 10.1016/j.immuni.2015.03.013
   de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071
   Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907
   Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002
   Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002
   Doenyas C, 2018, NEUROSCIENCE, V374, P271, DOI 10.1016/j.neuroscience.2018.01.060
   Efteltharian MM, 2018, CYTOKINE, V108, P120, DOI 10.1016/j.cyto.2018.03.034
   Estes ML, 2015, NAT REV NEUROSCI, V16, P469, DOI 10.1038/nrn3978
   Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013
   Geschwind DH, 2015, LANCET NEUROL, V14, P1109, DOI 10.1016/S1474-4422(15)00044-7
   Goines P, 2010, CURR OPIN NEUROL, V23, P111, DOI 10.1097/WCO.0b013e3283373514
   Gorelik A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15096
   Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141
   Gupta S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6748
   Habela CW, 2016, MOL CELL NEUROSCI, V73, P52, DOI 10.1016/j.mcn.2015.12.002
   Horiuchi M, 2017, BRAIN BEHAV IMMUN, V60, P106, DOI 10.1016/j.bbi.2016.02.014
   Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024
   Hsiao EY, 2012, DEV NEUROBIOL, V72, P1317, DOI 10.1002/dneu.22045
   Imamura R, 2017, CYTOKINE, V98, P97, DOI 10.1016/j.cyto.2016.12.025
   Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009
   Jeon IH, 2014, MOLECULES, V19, P6941, DOI 10.3390/molecules19066941
   Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x
   Keil A, 2010, EPIDEMIOLOGY, V21, P805, DOI 10.1097/EDE.0b013e3181f26e3f
   Khwaja OS, 2014, P NATL ACAD SCI USA, V111, P4596, DOI 10.1073/pnas.1311141111
   Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187
   Kolevzon A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-54
   Krasovska V, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00272
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanz TA, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-45
   Lee S, 2014, J NEUROSCI, V34, P12538, DOI 10.1523/JNEUROSCI.0853-14.2014
   Leoncini S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/421624
   Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002
   Liao WL, 2012, NEUROBIOL DIS, V46, P88, DOI 10.1016/j.nbd.2011.12.048
   Limatola C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00229
   Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214
   Maezawa I, 2011, NEURON GLIA BIOL, V7, P85, DOI 10.1017/S1740925X1200004X
   Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010
   Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011
   Marchetto MC, 2017, MOL PSYCHIATR, V22, P820, DOI 10.1038/mp.2016.95
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mazur-Kolecka B, 2014, BRAIN DEV-JPN, V36, P322, DOI 10.1016/j.braindev.2013.04.015
   Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731
   Nageshappa S, 2016, MOL PSYCHIATR, V21, P178, DOI 10.1038/mp.2015.128
   Nance E, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1004-5
   O'Connor RM, 2017, J CELL BIOL, V216, P595, DOI 10.1083/jcb.201607093
   Odell D, 2005, HUM IMMUNOL, V66, P140, DOI 10.1016/j.humimm.2004.11.002
   Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007
   Pacey LKK, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.400
   Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576
   Peng Y, 2013, INT REV NEUROBIOL, V113, P135, DOI 10.1016/B978-0-12-418700-9.00005-8
   Piven J, 2018, MOL PSYCHIATR, V23, P165, DOI 10.1038/mp.2017.212
   Rakela B, 2018, ELIFE, V7, DOI 10.7554/eLife.31629
   Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566
   Ross CA, 2014, HUM MOL GENET, V23, pR17, DOI 10.1093/hmg/ddu204
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Russo FB, 2018, BIOL PSYCHIAT, V83, P569, DOI 10.1016/j.biopsych.2017.09.021
   Schafer DP, 2016, ELIFE, V5, DOI 10.7554/eLife.15224
   Schanen C, 1998, AM J HUM GENET, V63, P267, DOI 10.1086/301932
   Scott O, 2017, DEV MED CHILD NEUROL, V59, P947, DOI 10.1111/dmcn.13432
   Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659
   Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027
   Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618
   Shen XT, 2019, DEV NEUROBIOL, V79, P20, DOI 10.1002/dneu.22644
   Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203
   Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491
   Sunamura N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30025-4
   Theoharides TC, 2015, J NEUROIMMUNOL, V279, P33, DOI 10.1016/j.jneuroim.2014.12.003
   Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106
   Tsilioni I, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.142
   Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005
   Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188
   Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110
   Volk HE, 2014, EPIDEMIOLOGY, V25, P44, DOI 10.1097/EDE.0000000000000030
   Wang JQ, 2015, NATURE, V521, pE1, DOI 10.1038/nature14444
   WARREN RP, 1994, ARCH PEDIAT ADOL MED, V148, P180, DOI 10.1001/archpedi.1994.02170020066011
   Williams EC, 2014, HUM MOL GENET, V23, P2968, DOI 10.1093/hmg/ddu008
   Wu WL, 2017, BRAIN BEHAV IMMUN, V62, P11, DOI 10.1016/j.bbi.2016.11.007
   Zuiki M, 2017, NEUROSCI LETT, V653, P296, DOI 10.1016/j.neulet.2017.06.004
NR 95
TC 3
Z9 3
U1 1
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2360
J9 FRONT PEDIATR
JI Front. Pediatr.
PD DEC 12
PY 2018
VL 6
AR 394
DI 10.3389/fped.2018.00394
PG 8
WC Pediatrics
SC Pediatrics
GA HE2KG
UT WOS:000453105000001
PM 30619789
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Mesci, P
   Macia, A
   Moore, SM
   Shiryaev, SA
   Pinto, A
   Huang, CT
   Tejwani, L
   Fernandes, IR
   Suarez, NA
   Kolar, MJ
   Montefusco, S
   Rosenberg, SC
   Herai, RH
   Cugola, FR
   Russo, FB
   Sheets, N
   Saghatelian, A
   Shresta, S
   Momper, JD
   Siqueira-Neto, JL
   Corbett, KD
   Beltrao-Braga, PCB
   Terskikh, AV
   Muotri, AR
AF Mesci, Pinar
   Macia, Angela
   Moore, Spencer M.
   Shiryaev, Sergey A.
   Pinto, Antonella
   Huang, Chun-Teng
   Tejwani, Leon
   Fernandes, Isabella R.
   Suarez, Nicole A.
   Kolar, Matthew J.
   Montefusco, Sandro
   Rosenberg, Scott C.
   Herai, Roberto H.
   Cugola, Fernanda R.
   Russo, Fabiele B.
   Sheets, Nicholas
   Saghatelian, Alan
   Shresta, Sujan
   Momper, Jeremiah D.
   Siqueira-Neto, Jair L.
   Corbett, Kevin D.
   Beltrao-Braga, Patricia C. B.
   Terskikh, Alexey V.
   Muotri, Alysson R.
TI Blocking Zika virus vertical transmission (vol 8, pg 1218, 2018)
SO SCIENTIFIC REPORTS
LA English
DT Correction
C1 [Mesci, Pinar; Macia, Angela; Moore, Spencer M.; Tejwani, Leon; Fernandes, Isabella R.; Suarez, Nicole A.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego Dept Cellular & Mol, Rady Childrens Hosp San Diego,Stem Cell Program, La Jolla, CA 92037 USA.
   [Shiryaev, Sergey A.; Pinto, Antonella; Huang, Chun-Teng; Terskikh, Alexey V.] Sanford Burnham Prebys Med Discovery Inst, 10901N Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Kolar, Matthew J.; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Montefusco, Sandro; Siqueira-Neto, Jair L.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Ctr Discovery & Innovat Parasit Dis, 9500 Gilman Dr,MC 0755, La Jolla, CA 92093 USA.
   [Rosenberg, Scott C.; Corbett, Kevin D.] Ludwig Inst Canc Res, San Diego Branch, 9500 Gilman Dr,MC 2385, La Jolla, CA 92093 USA.
   [Rosenberg, Scott C.] Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr,MC 2385, La Jolla, CA 92093 USA.
   [Herai, Roberto H.] Pontificia Univ Catolica Parana PUCPR, Sch Med, Grad Program Hlth Sci, Curitiba, Parana, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Stem Cell & Dis Modeling, BR-05508000 Sao Paulo, SP, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, BR-01246903 Sao Paulo, SP, Brazil.
   [Sheets, Nicholas; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Momper, Jeremiah D.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
RP Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego Dept Cellular & Mol, Rady Childrens Hosp San Diego,Stem Cell Program, La Jolla, CA 92037 USA.; Terskikh, AV (corresponding author), Sanford Burnham Prebys Med Discovery Inst, 10901N Torrey Pines Rd, La Jolla, CA 92037 USA.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Stem Cell & Dis Modeling, BR-05508000 Sao Paulo, SP, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, BR-01246903 Sao Paulo, SP, Brazil.
EM patriciacbbbraga@usp.br; terskikh@sbpdiscovery.org; muotri@ucsd.edu
RI Beltrao-Braga, Patricia C B/D-6450-2013; Siqueira-Neto, Jair
   L/D-6040-2012
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Siqueira-Neto, Jair
   L/0000-0001-9574-8174; Huang, Chun-Teng/0000-0003-3737-7875; Mesci,
   Pinar/0000-0003-3402-5671; herai, roberto/0000-0001-9885-2735; Kolar,
   Matthew/0000-0001-8054-9121
FU NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [F30DK112604, F30DK112604] Funding Source: NIH
   RePORTER; NIDDK NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [F30 DK112604] Funding
   Source: Medline
CR Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
NR 1
TC 1
Z9 1
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 5
PY 2018
VL 8
AR 8794
DI 10.1038/s41598-018-26959-4
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GI1IH
UT WOS:000434123400001
PM 29867187
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Russo, FB
   Freitas, BC
   Pignatari, GC
   Fernandes, IR
   Sebat, J
   Muotri, AR
   Beltrao-Braga, PCB
AF Russo, Fabiele Baldino
   Freitas, Beatriz Camille
   Pignatari, Graciela Conceicao
   Fernandes, Isabella Rodrigues
   Sebat, Jonathan
   Muotri, Alysson Renato
   Baleeiro Beltrao-Braga, Patricia Cristina
TI Modeling the Interplay Between Neurons and Astrocytes in Autism Using
   Human Induced Pluripotent Stem Cells
SO BIOLOGICAL PSYCHIATRY
LA English
DT Article
DE ASD; Astrocytes; Autism; Co-culture model; iPSCs; Neurons
ID CAUSE INTELLECTUAL DISABILITY; DNA-SEQUENCING DATA; SPECTRUM DISORDERS;
   DE-NOVO; NEURAL DEVELOPMENT; CRITICAL REGION; BRAIN; MUTATIONS; SETD5;
   SYNAPTOGENESIS
AB BACKGROUND: Autism spectrum disorder (ASD) is a neurodevelopmental disorder with unclear etiology and imprecise genetic causes. The main goal of this work was to investigate neuronal connectivity and the interplay between neurons and astrocytes from individuals with nonsyndromic ASD using induced pluripotent stem cells.
   METHODS: Induced pluripotent stem cells were derived from a clinically well-characterized cohort of three individuals with nonsyndromic ASD sharing common behaviors and three control subjects, two clones each. We generated mixed neural cultures analyzing synaptogenesis and neuronal activity using a multielectrode array platform. Furthermore, using an enriched astrocyte population, we investigated their role in neuronal maintenance.
   RESULTS: ASD-derived neurons had a significant decrease in synaptic gene expression and protein levels, glutamate neurotransmitter release, and, consequently, reduced spontaneous firing rate. Based on co-culture experiments, we observed that ASD-derived astrocytes interfered with proper neuronal development. In contrast, control-derived astrocytes rescued the morphological neuronal phenotype and synaptogenesis defects from ASD neuronal co-cultures. Furthermore, after identifying interleukin-6 secretion from astrocytes in individuals with ASD as a possible culprit for neural defects, we were able to increase synaptogenesis by blocking interleukin-6 levels.
   CONCLUSIONS: Our findings reveal the contribution of astrocytes to neuronal phenotype and confirm previous studies linking interleukin-6 and autism, suggesting potential novel therapeutic pathways for a subtype of individuals with ASD. This is the first report demonstrating that glial dysfunctions could contribute to nonsyndromic autism pathophysiology using induced pluripotent stem cells modeling disease technology.
C1 [Russo, Fabiele Baldino; Pignatari, Graciela Conceicao; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, SP, Brazil.
   [Russo, Fabiele Baldino; Fernandes, Isabella Rodrigues; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Surg, Sch Vet Med, Sao Paulo, SP, Brazil.
   [Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Obstet, Sch Arts Sci & Humanities, Sao Paulo, SP, Brazil.
   [Freitas, Beatriz Camille; Fernandes, Isabella Rodrigues; Muotri, Alysson Renato] Rady Childrens Hosp San Diego, Dept Pediat, San Diego, CA USA.
   [Freitas, Beatriz Camille; Fernandes, Isabella Rodrigues; Muotri, Alysson Renato] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Stem Cell Program,Sanford Consortium Regenerat Me, La Jolla, CA 92093 USA.
   [Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat Cellular & Mol Med, La Jolla, CA 92093 USA.
RP Beltrao-Braga, PCB (corresponding author), Av Prof Lineu Prestes 1374,Room 227, BR-05508900 Sao Paulo, SP, Brazil.
EM patriciacbbbraga@usp.br
RI Beltrao-Braga, Patricia C B/D-6450-2013
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091
FU Sao Paulo Research Foundation-FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); University of Sao Paulo [2011/20683-0,
   2014/27013-8, 2016/02978-6]; NGO the Tooth Fairy Project from Brazil;
   California Institute for Regenerative MedicineCalifornia Institute for
   Regenerative Medicine [DISC1-08825]; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01MH108528, R01MH094753, R01MH109885, R01MH100175,
   R21MH107771, R56MH109587, U19MH107367]; Simons Foundation Autism
   Research Initiative [345469]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Mental Health (NIMH)
   [U19MH107367, R01MH109885, R56MH109587, U19MH107367, U19MH107367,
   R01MH100175, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, R01MH100175, R01MH108528, R01MH100175, U19MH107367,
   U19MH107367, U19MH107367, R01MH108528, R01MH100175, R01MH108528,
   R01MH109885, U19MH107367, R01MH108528, U19MH107367, R01MH108528,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, R01MH100175,
   R01MH109885, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   R21MH107771, U19MH107367, U19MH107367, U19MH107367, U19MH107367] Funding
   Source: NIH RePORTER
FX This work was supported by the Sao Paulo Research Foundation-FAPESP and
   University of Sao Paulo (Grant Nos. 2011/20683-0, 2014/27013-8,
   2016/02978-6 to PCBBB), by the NGO the Tooth Fairy Project from Brazil
   (to PCBBB), California Institute for Regenerative Medicine (Grant No.
   DISC1-08825 to ARM), National Institutes of Health (Grant Nos.
   R01MH108528, R01MH094753, R01MH109885, R01MH100175, R21MH107771,
   R56MH109587, and U19MH107367 to ARM), and Simons Foundation Autism
   Research Initiative (Grant No. 345469 to ARM).
CR Ashwood P, 2008, J NEUROIMMUNOL, V204, P149, DOI 10.1016/j.jneuroim.2008.07.006
   Beauchemin P, 2016, MULT SCLER J, V22, P254, DOI 10.1177/1352458515623862
   Beltrao-Braga PCB, 2013, CYTOM PART A, V83A, P11, DOI 10.1002/cyto.a.22231
   Beltrao-Braga PCB, 2017, BRAIN RES, V1656, P49, DOI 10.1016/j.brainres.2016.01.057
   Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235
   Bemben MA, 2015, P NATL ACAD SCI USA, V112, P2551, DOI 10.1073/pnas.1500501112
   Blumberg Stephen J, 2013, Natl Health Stat Report, P1
   Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915
   Chailangkarn T, 2016, NATURE, V536, P338, DOI 10.1038/nature19067
   Chauhan Abha, 2006, Pathophysiology, V13, P171, DOI 10.1016/j.pathophys.2006.05.007
   Chen JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062082
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Colangelo AM, 2014, NEUROSCI LETT, V565, P59, DOI 10.1016/j.neulet.2014.01.014
   De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   DeRosa BA, 2012, NEUROSCI LETT, V516, P9, DOI 10.1016/j.neulet.2012.02.086
   Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002
   Edmonson C, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-3
   Emanuele E, 2010, NEUROSCI LETT, V471, P162, DOI 10.1016/j.neulet.2010.01.033
   Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612
   Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141
   Grozeva D, 2014, AM J HUM GENET, V94, P618, DOI 10.1016/j.ajhg.2014.03.006
   Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007
   Kellogg G, 2013, AM J MED GENET A, V161A, P1405, DOI 10.1002/ajmg.a.35876
   Kuechler A, 2015, EUR J HUM GENET, V23, P753, DOI 10.1038/ejhg.2014.165
   Lehtimaki KA, 2011, EPILEPSY RES, V95, P184, DOI 10.1016/j.eplepsyres.2011.03.004
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013
   Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002
   Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010
   Malik M, 2011, IMMUNOBIOLOGY, V216, P80, DOI 10.1016/j.imbio.2010.03.001
   Marchetto MC, 2017, MOL PSYCHIATR, V22, P820, DOI 10.1038/mp.2016.95
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194
   Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019
   Narzisi G, 2014, NAT METHODS, V11, P1033, DOI [10.1038/NMETH.3069, 10.1038/nmeth.3069]
   Parenti I, 2017, HUM GENET, V136, P307, DOI 10.1007/s00439-017-1758-y
   Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071
   Phillips M, 2015, NEUROSCI LETT, V601, P30, DOI 10.1016/j.neulet.2015.01.011
   Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018
   Quaak I, 2013, INT J ENV RES PUB HE, V10, P3384, DOI 10.3390/ijerph10083384
   Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036
   Russo Fabiele B, 2015, World J Transplant, V5, P209, DOI 10.5500/wjt.v5.i4.209
   Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124
   Sajdel-Sulkowska EM, 2011, CEREBELLUM, V10, P43, DOI 10.1007/s12311-010-0223-4
   Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945
   Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618
   Spooren W, 2012, TRENDS PHARMACOL SCI, V33, P669, DOI 10.1016/j.tips.2012.09.004
   Szczaluba K, 2016, AM J MED GENET A, V170, P2322, DOI 10.1002/ajmg.a.37832
   Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082
   Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315
   Wei H, 2013, NEUROSCIENCE, V252, P320, DOI 10.1016/j.neuroscience.2013.08.025
   Wei HG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-52
   Williams EC, 2014, HUM MOL GENET, V23, P2968, DOI 10.1093/hmg/ddu008
   WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288
   Yang CJ, 2015, NEUROSCIENCE, V284, P290, DOI 10.1016/j.neuroscience.2014.10.011
   Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005
NR 60
TC 41
Z9 41
U1 4
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0006-3223
EI 1873-2402
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD APR 1
PY 2018
VL 83
IS 7
BP 569
EP 578
DI 10.1016/j.biopsych.2017.09.021
PG 10
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FY1JT
UT WOS:000426569000006
PM 29129319
DA 2020-12-01
ER

PT J
AU Mesci, P
   Macia, A
   Moore, SM
   Shiryaev, SA
   Pinto, A
   Huang, CT
   Tejwani, L
   Fernandes, IR
   Suarez, NA
   Kolar, MJ
   Montefusco, S
   Rosenberg, SC
   Herai, RH
   Cugola, FR
   Russo, FB
   Sheets, N
   Saghatelian, A
   Shresta, S
   Momper, JD
   Neto, JLS
   Corbett, KD
   Beltrao-Braga, PCB
   Terskikh, AV
   Muotri, AR
AF Mesci, Pinar
   Macia, Angela
   Moore, Spencer M.
   Shiryaev, Sergey A.
   Pinto, Antonella
   Huang, Chun-Teng
   Tejwani, Leon
   Fernandes, Isabella R.
   Suarez, Nicole A.
   Kolar, Matthew J.
   Montefusco, Sandro
   Rosenberg, Scott C.
   Herai, Roberto H.
   Cugola, Fernanda R.
   Russo, Fabiele B.
   Sheets, Nicholas
   Saghatelian, Alan
   Shresta, Sujan
   Momper, Jeremiah D.
   Siqueira-Neto, Jair L.
   Corbett, Kevin D.
   Beltrao-Braga, Patricia C. B.
   Terskikh, Alexey V.
   Muotri, Alysson R.
TI Blocking Zika virus vertical transmission
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HEPATITIS-C-VIRUS; MULTIPLE SEQUENCE ALIGNMENT; SOFOSBUVIR; MODEL;
   BIRTH; RISK; INHIBITORS; INFECTION; PREGNANCY; INFANTS
AB The outbreak of the Zika virus (ZIKV) has been associated with increased incidence of congenital malformations. Although recent efforts have focused on vaccine development, treatments for infected individuals are needed urgently. Sofosbuvir (SOF), an FDA-approved nucleotide analog inhibitor of the Hepatitis C (HCV) RNA-dependent RNA polymerase (RdRp) was recently shown to be protective against ZIKV both in vitro and in vivo. Here, we show that SOF protected human neural progenitor cells (NPC) and 3D neurospheres from ZIKV infection-mediated cell death and importantly restored the antiviral immune response in NPCs. In vivo, SOF treatment post-infection (p.i.) decreased viral burden in an immunodeficient mouse model. Finally, we show for the first time that acute SOF treatment of pregnant dams p.i. was well-tolerated and prevented vertical transmission of the virus to the fetus. Taken together, our data confirmed SOF-mediated sparing of human neural cell types from ZIKV-mediated cell death in vitro and reduced viral burden in vivo in animal models of chronic infection and vertical transmission, strengthening the growing body of evidence for SOF anti-ZIKV activity.
C1 [Mesci, Pinar; Macia, Angela; Moore, Spencer M.; Tejwani, Leon; Fernandes, Isabella R.; Suarez, Nicole A.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego, Dept Cellular & Mol Med,Dept Pediat,Stem Cell Pro, La Jolla, CA 92037 USA.
   [Shiryaev, Sergey A.; Pinto, Antonella; Huang, Chun-Teng; Terskikh, Alexey V.] Sanford Burnham Prebys Med Discovery Inst, 10901N Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Kolar, Matthew J.; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Montefusco, Sandro; Siqueira-Neto, Jair L.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Ctr Discovery & Innovat Parasit Dis, 9500 Gilman Dr,MC 0755, La Jolla, CA 92093 USA.
   [Rosenberg, Scott C.; Corbett, Kevin D.] Ludwig Inst Canc Res, San Diego Branch, 9500 Gilman Dr,MC 2385, La Jolla, CA 92093 USA.
   [Rosenberg, Scott C.] Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr,MC 2385, La Jolla, CA 92093 USA.
   [Herai, Roberto H.] Pontificia Univ Catolica Parana PUCPR, Sch Med, Grad Program Hlth Sci, Curitiba, Parana, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Stem Cell & Dis Modeling, BR-05508000 Sao Paulo, SP, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, BR-01246903 Sao Paulo, SP, Brazil.
   [Sheets, Nicholas; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Momper, Jeremiah D.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
RP Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego, Dept Cellular & Mol Med,Dept Pediat,Stem Cell Pro, La Jolla, CA 92037 USA.; Terskikh, AV (corresponding author), Sanford Burnham Prebys Med Discovery Inst, 10901N Torrey Pines Rd, La Jolla, CA 92037 USA.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Stem Cell & Dis Modeling, BR-05508000 Sao Paulo, SP, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, BR-01246903 Sao Paulo, SP, Brazil.
EM patriciacbbbraga@usp.br; terskikh@sbpdiscovery.org; muotri@ucsd.edu
RI Siqueira-Neto, Jair L/D-6040-2012; Terskikh, Alexey/U-8407-2019;
   Beltrao-Braga, Patricia C B/D-6450-2013
OI Siqueira-Neto, Jair L/0000-0001-9574-8174; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; Kolar, Matthew/0000-0001-8054-9121; Macia Ortega,
   Angela/0000-0001-8735-0916; Mesci, Pinar/0000-0003-3402-5671; herai,
   roberto/0000-0001-9885-2735; Corbett, Kevin/0000-0001-5854-2388; Moore,
   Spencer/0000-0001-9811-9007
FU California Institute for Regenerative MedicineCalifornia Institute for
   Regenerative Medicine [DISC2-09649]; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [U19MH107367]; NGO "The tooth fairy project"; NARSAD
   Independent Investigator GrantNARSAD; International Rett syndrome
   foundation (IRSF) mentored training fellowship; NARSAD Young
   Investigator GrantNARSAD; Autism Science Foundation; Rett Syndrome
   Research Trust (RSRT); Ludwig Institute for Cancer Research;  [F30
   DK112604]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [F30DK112604, F30DK112604] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [T32GM007198, T32GM007198, T32GM007198,
   T32GM007198, T32GM007198, T32GM007198, T32GM007198, T32GM007198,
   T32GM007198, T32GM007198, T32GM007198, T32GM007198, T32GM007198,
   T32GM007198, T32GM007198, T32GM007198, T32GM007198, T32GM007198,
   T32GM007198, T32GM007198, T32GM007198, T32GM007198, T32GM007198,
   T32GM007198, T32GM007198, T32GM007198, T32GM007198, T32GM007198,
   T32GM007198, T32GM007198, T32GM007198, T32GM007198, T32GM007198,
   T32GM007198, T32GM007198, T32GM007198, T32GM007198, T32GM007198,
   T32GM007198, T32GM007198, T32GM007198, T32GM007198, T32GM007198] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [R21NS100477,
   R21NS100477] Funding Source: NIH RePORTER
FX This work was supported by grants from the California Institute for
   Regenerative Medicine (DISC2-09649), the National Institutes of Health
   through the U19MH107367, the NGO "The tooth fairy project", and an
   NARSAD Independent Investigator Grant to A.R.M. M.J.K. is funded by F30
   DK112604 grant. Dr. Mesci has an International Rett syndrome foundation
   (IRSF) mentored training fellowship. Dr. Macia has an NARSAD Young
   Investigator Grant and Spencer M. Moore is supported by a grant from the
   Autism Science Foundation and Rett Syndrome Research Trust (RSRT).
   K.D.C. acknowledges support from the Ludwig Institute for Cancer
   Research. We thank Mary Braxtan, Buddy Charbono, Francisco Beltran,
   Hilda Clarke and the SBP Animal Facility Core for their help with animal
   experiments. We also like to thank E. Durigon and his group for the
   ZKV2015 aliquots, and P. Vasconcelos for providing a lyophilized ZKV2015
   seed. Dr. Mesci and Dr. Macia drew the mouse schematics in the
   manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   [Anonymous], 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Balakrishnan A., 2013, GENOME ANNOUNC, V1, P4
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bhatia HK, 2014, J PHARMACOL PHARMACO, V5, P278, DOI 10.4103/0976-500X.142464
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G., 2016, LANCET INFE IN PRESS, V3099
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Chailangkarn T, 2016, NATURE, V536, P338, DOI 10.1038/nature19067
   Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439
   Cugola FR, 2016, NATURE, P1
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Elfiky AA, 2013, PROTEIN J, V32, P75, DOI 10.1007/s10930-013-9462-9
   Ellis C., 2013, PHARM REV S
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gentile I, 2015, EXPERT OPIN DRUG DIS, V10, P1363, DOI 10.1517/17460441.2015.1094051
   Gilead Sciences I., 2013, HIGHL PRESCR INF
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Jackowiak P, 2014, INFECT GENET EVOL, V21, P67, DOI 10.1016/j.meegid.2013.10.021
   KATAOKA S, 1983, DIABETES, V32, P247, DOI 10.2337/diabetes.32.3.247
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lindenbach B, 2007, FIELDS VIROLOGY
   Lu L, 2007, J GEN VIROL, V88, P1519, DOI 10.1099/vir.0.82820-0
   Mandelbrot L, 2015, CLIN INFECT DIS, V61, P1715, DOI 10.1093/cid/civ578
   Marchetto M.C, 2016, MOL PSYCHIAT
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mesci P., 2017, HUM MOL GENET
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703
   Naveca FG, 2012, J VIROL, V86, P1897, DOI 10.1128/JVI.06731-11
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pasternak B, 2010, JAMA-J AM MED ASSOC, V304, P859, DOI 10.1001/jama.2010.1206
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Potisopon S, 2017, ANTIVIR RES, V140, P25, DOI 10.1016/j.antiviral.2016.12.021
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Retallack H., 2016, P NATL ACAD SCI USA, V113
   Rezk MR, 2015, J PHARMACEUT BIOMED, V114, P97, DOI 10.1016/j.jpba.2015.05.006
   Reznik S. E., 2016, J INFECT DIS, V55
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Singha H, 2013, ARCH VIROL, V158, P113, DOI 10.1007/s00705-012-1474-9
   Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Toussaint-Miller KA, 2015, ANN PHARMACOTHER, V49, P1015, DOI 10.1177/1060028015592015
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu D, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001628
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zmurko J., 2016, ANTIVIRAL R IN PRESS, V55
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 73
TC 20
Z9 22
U1 1
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 19
PY 2018
VL 8
AR 1218
DI 10.1038/s41598-018-19526-4
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT1JJ
UT WOS:000422891000048
PM 29352135
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Mesci, P
   Macia, A
   LaRock, CN
   Tejwani, L
   Fernandes, IR
   Suarez, NA
   Zanotto, PMD
   Beltrao-Braga, PCB
   Nizet, V
   Muotri, AR
AF Mesci, Pinar
   Macia, Angela
   LaRock, Christopher N.
   Tejwani, Leon
   Fernandes, Isabella R.
   Suarez, Nicole A.
   Zanotto, Paolo M. de A.
   Beltrao-Braga, Patricia C. B.
   Nizet, Victor
   Muotri, Alysson R.
TI Modeling neuro-immune interactions during Zika virus infection
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID CEREBRAL ORGANOIDS; BLOOD MONOCYTES; STEM-CELLS; MICROGLIA;
   DIFFERENTIATION; ENHANCEMENT; MACROPHAGES; ACTIVATION; MORPHOLOGY;
   ZYMOSAN
AB Although Zika virus (ZIKV) infection is often asymptomatic, in some cases, it can lead to birth defects in newborns or serious neurologic complications in adults. However, little is known about the interplay between immune and neural cells that could contribute to the ZIKV pathology. To understand the mechanisms at play during infection and the antiviral immune response, we focused on neural precursor cells (NPCs)-microglia interactions. Our data indicate that human microglia infected with the current circulating Brazilian ZIKV induces a similar pro-inflammatory response found in ZIKV-infected human tissues. Importantly, using our model, we show that microglia interact with ZIKV-infected NPCs and further spread the virus. Finally, we show that Sofosbuvir, an FDA-approved drug for Hepatitis C, blocked viral infection in NPCs and therefore the transmission of the virus from microglia to NPCs. Thus, our model provides a new tool for studying neuro-immune interactions and a platform to test new therapeutic drugs.
C1 [Mesci, Pinar; Macia, Angela; Tejwani, Leon; Fernandes, Isabella R.; Suarez, Nicole A.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Pediat, Rady Childrens Hosp San Diego, La Jolla, CA 92093 USA.
   [Mesci, Pinar; Macia, Angela; Tejwani, Leon; Fernandes, Isabella R.; Suarez, Nicole A.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Stem Cell Program, La Jolla, CA 92093 USA.
   [LaRock, Christopher N.; Nizet, Victor] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.
   [LaRock, Christopher N.; Nizet, Victor] Univ Calif San Diego, Sch Med, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
   [Zanotto, Paolo M. de A.] Univ Sao Paulo, Inst Microbiol Sci, Dept Microbiol, Lab Mol Evolut & Bioinformat, BR-05508000 Sao Paulo, SP, Brazil.
   [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Stem Cell & Dis Modeling, BR-05508000 Sao Paulo, SP, Brazil.
   [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.
   [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, BR-01246903 Sao Paulo, SP, Brazil.
RP Muotri, AR (corresponding author), 2880 Torrey Pines Scen Dr, La Jolla, CA 92093 USA.
EM muotri@ucsd.edu
RI Beltrao-Braga, Patricia C B/D-6450-2013; de A. Zanotto, Paolo
   M./B-9286-2019; Nizet, Victor/AAF-3190-2019; LaRock,
   Christopher/E-1554-2013
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; de A. Zanotto, Paolo
   M./0000-0002-8167-0625; LaRock, Christopher/0000-0003-3035-5331; Macia
   Ortega, Angela/0000-0001-8735-0916; Mesci, Pinar/0000-0003-3402-5671
FU California Institute for Regenerative MedicineCalifornia Institute for
   Regenerative Medicine [DISC2-09649]; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [U19MH107367]; Zika Network FAPESP projects
   [2011/18703-2, 2014/17766-9]; NGO "the tooth fairy project"; A.P.
   Giannini Foundation; NARSAD Independent Investigator GrantNARSAD;
   NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) [U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367] Funding Source: NIH RePORTER
FX This work was supported by grants from the California Institute for
   Regenerative Medicine (DISC2-09649), the National Institutes of Health
   through the U19MH107367, Zika Network FAPESP projects 2011/18703-2 and
   2014/17766-9, the NGO "the tooth fairy project", a fellowship from the
   A.P. Giannini Foundation to C.N.L., and an NARSAD Independent
   Investigator Grant to A.R.M. Dr. Mesci has an International Rett
   syndrome foundation (IRSF) mentored training fellowship. Dr. Macia has a
   NARSAD Young Investigator grant.
CR Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Biacchesi S, 2004, J VIROL, V78, P12877, DOI 10.1128/JVI.78.23.12877-12887.2004
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Delatorre E, 2017, MEM I OSWALDO CRUZ, V112, P793, DOI 10.1590/0074-02760170299
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Douvaras P, 2017, STEM CELL REP, V8, P1516, DOI 10.1016/j.stemcr.2017.04.023
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141
   Grozdanov V, 2014, ACTA NEUROPATHOL, V128, P651, DOI 10.1007/s00401-014-1345-4
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nageshappa S, 2016, MOL PSYCHIATR, V21, P178, DOI 10.1038/mp.2015.128
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ohradanova-Repic A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2015.39
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rezaie P, 1999, DEV BRAIN RES, V115, P71, DOI 10.1016/S0165-3806(99)00043-7
   Rosenberger CM, 2014, J GEN VIROL, V95, P350, DOI 10.1099/vir.0.058438-0
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   SPEERT DP, 1985, J LEUKOCYTE BIOL, V38, P655
   Tan MC, 2007, VIROLOGY, V357, P1, DOI 10.1016/j.virol.2006.08.004
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 59
TC 22
Z9 22
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 1
PY 2018
VL 27
IS 1
BP 41
EP 52
DI 10.1093/hmg/ddx382
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA FS1YV
UT WOS:000419575800004
PM 29048558
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Brito, A
   Russo, FB
   Muotri, AR
   Beltrao-Braga, PCB
AF Brito, Anita
   Russo, Fabiele Baldino
   Muotri, Alysson Renato
   Baleeiro Beltrao-Braga, Patricia Cristina
TI Autism spectrum disorders and disease modeling using stem cells
SO CELL AND TISSUE RESEARCH
LA English
DT Review
DE Autism spectrum disorders; ASD; iPSC; Stem cells; Disease modeling
ID FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; IPSC-DERIVED NEURONS;
   ANGELMAN-SYNDROME; RETT-SYNDROME; IDENTIFY COMPOUNDS; SYNDROME PATIENT;
   NEURAL STEM; EXPRESSION; MUTATIONS
AB Autism spectrum disorders (ASD) represent a variety of disorders characterized as complex lifelong neurodevelopment disabilities, which may affect the ability of communication and socialization, including typical comportments like repetitive and stereotyped behavior. Other comorbidities are usually present, such as echolalia, hypotonia, intellectual disability and difficulties in processing figured speech. Furthermore, some ASD individuals may present certain abilities, such as eidetic memory, outstanding musical or painting talents and special mathematical skills, among others. Considering the variability of the clinical symptoms, one autistic individual can be severely affected in communication while others can speak perfectly, sometimes having a vocabulary above average in early childhood. The same variability can be seen in other clinical symptoms, thus the "spectrum" can vary from severe to mild. Induced pluripotent stem cell technology has been used to model several neurological diseases, including syndromic and non-syndromic autism. We discuss how modeling the central nervous system cells in a dish may help to reach a better understanding of ASD pathology and variability, as well as personalize their treatment.
C1 [Brito, Anita; Russo, Fabiele Baldino; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, Brazil.
   [Brito, Anita; Russo, Fabiele Baldino; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.
   [Muotri, Alysson Renato] Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego, Dept Pediat,Dept Cellular & Mol Med,Stem Cell Pro, La Jolla, CA 92037 USA.
   [Baleeiro Beltrao-Braga, Patricia Cristina] Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.
RP Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.; Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego, Dept Pediat,Dept Cellular & Mol Med,Stem Cell Pro, La Jolla, CA 92037 USA.; Beltrao-Braga, PCB (corresponding author), Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.
EM muotri@ucsd.edu; patriciacbbbraga@yahoo.com.br
RI Beltrao-Braga, Patricia C B/D-6450-2013; Brito, Anita/AAG-2283-2020
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; 
FU agency FAPESP [2011/20683-0, 09/51180-03]; NGO "the tooth fairy project,
   Brazil"; National Institutes of HealthUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [R01MH108528,
   R01MH094753, R01MH109885, R01MH100175, R56MH109587, U19MH107367];
   "Autour des Williams" Association; NARSAD Independent Investigator
   GrantNARSAD; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Mental Health (NIMH) [U19MH107367, R01MH100175,
   U19MH107367, R01MH100175, U19MH107367, R01MH100175, R01MH109885,
   U19MH107367, R01MH109885, R01MH108528, U19MH107367, R01MH109885,
   U19MH107367, U19MH107367, U19MH107367, R01MH094753, R01MH100175,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   R01MH109885, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   R56MH109587, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, R01MH094753, U19MH107367, U19MH107367,
   U19MH107367, R01MH108528, R01MH100175, R01MH108528, U19MH107367,
   U19MH107367, U19MH107367, R01MH108528, U19MH107367, U19MH107367,
   U19MH107367, R01MH094753, U19MH107367, U19MH107367, R01MH100175,
   U19MH107367, U19MH107367, R01MH094753, R01MH109885, U19MH107367,
   R01MH094753, U19MH107367, U19MH107367, U19MH107367] Funding Source: NIH
   RePORTER
FX We would like to thank the support of the agency FAPESP (2011/20683-0,
   09/51180-03), the NGO "the tooth fairy project, Brazil", the National
   Institutes of Health (R01MH108528, R01MH094753, R01MH109885,
   R01MH100175, R56MH109587, U19MH107367), the "Autour des Williams"
   Association, a NARSAD Independent Investigator Grant (to A.R.M.) and to
   the ASD and control individuals and their families for donation of their
   teeth to "the tooth fairy project".
CR Acab A, 2015, NEUROTHERAPEUTICS, V12, P534, DOI 10.1007/s13311-015-0354-x
   Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810
   Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531
   Baudouin SJ, 2013, M S-MED SCI, V29, P121, DOI 10.1051/medsci/2013292002
   Boland MJ, 2017, BRAIN, V140, P582, DOI 10.1093/brain/aww357
   Callan MA, 2011, GENESIS, V49, P424, DOI 10.1002/dvg.20745
   Cassidy SB, 2000, AM J MED GENET, V97, P136, DOI 10.1002/1096-8628(200022)97:2<136::AID-AJMG5>3.0.CO;2-V
   Catterall WA, 2013, J BIOL CHEM, V288, P10742, DOI 10.1074/jbc.R112.411645
   CESARONI L, 1991, J AUTISM DEV DISORD, V21, P303, DOI 10.1007/BF02207327
   Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001
   Chailangkarn T, 2016, NATURE, V536, P338, DOI 10.1038/nature19067
   Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107
   Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6503a1
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013
   De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772
   Doers ME, 2014, STEM CELLS DEV, V23, P1777, DOI 10.1089/scd.2014.0030
   Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933
   Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860
   Fink JJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15038
   Germain ND, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-44
   Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003
   Gomathi Mohan, 2017, Stem Cell Investig, V4, P20, DOI 10.21037/sci.2017.02.11
   Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141
   Grzadzinski R, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-12
   Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X
   Halevy T, 2015, STEM CELL REP, V4, P37, DOI 10.1016/j.stemcr.2014.10.015
   Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699
   Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908
   Kaufmann M, 2015, J BIOMOL SCREEN, V20, P1101, DOI 10.1177/1087057115588287
   Khwaja OS, 2014, P NATL ACAD SCI USA, V111, P4596, DOI 10.1073/pnas.1311141111
   KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235
   Kolevzon A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-54
   Kover ST, 2013, J AUTISM DEV DISORD, V43, P2696, DOI 10.1007/s10803-013-1823-x
   Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307
   Kumari D, 2015, STEM CELL TRANSL MED, V4, P800, DOI 10.5966/sctm.2014-0278
   Leonard H, 2017, NAT REV NEUROL, V13, P37, DOI 10.1038/nrneurol.2016.186
   Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834
   Lu P, 2016, SCI CHINA LIFE SCI, V59, P1093, DOI 10.1007/s11427-016-0194-6
   Marchetto M.C, 2016, MOL PSYCHIAT
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Martins-Taylor K, 2014, HUM MOL GENET, V23, P2364, DOI 10.1093/hmg/ddt628
   McLennan Y, 2011, CURR GENOMICS, V12, P216, DOI 10.2174/138920211795677886
   Meng LY, 2015, NATURE, V518, P409, DOI 10.1038/nature13975
   Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0
   Nygren G, 2012, J AUTISM DEV DISORD, V42, P1491, DOI 10.1007/s10803-011-1391-x
   Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576
   Phelan K, 2011, MOL SYNDROMOL, V2, P186, DOI 10.1159/000334260
   Pierce K, 2011, J PEDIATR-US, V159, P458, DOI 10.1016/j.jpeds.2011.02.036
   Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018
   Quaak I, 2013, INT J ENV RES PUB HE, V10, P3384, DOI 10.3390/ijerph10083384
   Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14
   Samaco RC, 2004, HUM MOL GENET, V13, P629, DOI 10.1093/hmg/ddh063
   Sarasua SM, 2014, GENET MED, V16, P318, DOI 10.1038/gim.2013.144
   Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618
   Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203
   Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011
   Stanurova J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30792
   State MWLP, 2014, NAT NEUROSCI, V14, P1499
   Tian Y, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0075-5
   Tonelli A, 2006, J NEUROL SCI, V241, P13, DOI 10.1016/j.jns.2005.10.007
   Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399
   Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005
   Vicidomini C, 2017, MOL PSYCHIATR, V22, P689, DOI [10.1038/mp.2016.30, 10.1038/mp.2017.82]
   Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999
   Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212
   Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074
   Williams EC, 2014, HUM MOL GENET, V23, P2968, DOI 10.1093/hmg/ddu008
   Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575
   WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288
   Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855
NR 72
TC 6
Z9 6
U1 2
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD JAN
PY 2018
VL 371
IS 1
BP 153
EP 160
DI 10.1007/s00441-017-2685-x
PG 8
WC Cell Biology
SC Cell Biology
GA FR5ZW
UT WOS:000419146100013
PM 28918504
DA 2020-12-01
ER

PT J
AU Russo, FB
   Beltrao-Braga, PCB
AF Russo, Fabiele Baldino
   Baleeiro Beltrao-Braga, Patricia Cristina
TI The impact of Zika virus in the brain
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Zika; ZIKV; Microcephaly; Brain damage; Flavivirus; Neuroprogenitor
   cells
ID TOLL-LIKE RECEPTOR-3; NEURAL PROGENITORS; STEM-CELLS; SEXUAL
   TRANSMISSION; NEGATIVE REGULATOR; CEREBRAL ORGANOIDS; INFECTION;
   NEUROGENESIS; ACTIVATION; INHIBITORS
AB The recent outbreak of ZIKV in Brazil called the attention of the world because the effects of viral infection in the brain under development in fetuses. Consequences of vertical infection comprise brain malformation, especially microcephaly, eye and musculoskeletal abnormalities, among others. In adults, outcomes of infection include meningoencephalitis and Guillain-Barre Syndrome. Recent data specific suggest that neural progenitor cells are the main targets of ZIKV infection, causing massive cellular death and impairment in the neurogenesis process. Here we review the fetal and adult brain damage after ZIKV exposure, exploring models to study the mechanisms underlying the pathways related to microcephaly and cell death. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Russo, Fabiele Baldino; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, Brazil.
   [Baleeiro Beltrao-Braga, Patricia Cristina] Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.
RP Beltrao-Braga, PCB (corresponding author), Av Prof Dr Orlando Marques de Paiva, BR-05508270 Sao Paulo, SP, Brazil.
EM patriciacbbbraga@usp.br
RI Beltrao-Braga, Patricia C B/D-6450-2013; Russo, Fabiele/N-4340-2017
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Russo,
   Fabiele/0000-0002-4076-1846
FU Zika Network FAPESP [2011/18703-2, 2014/17766-9]; NGO
FX We would like to thank Anita J. Brito for the writing review. This work
   was supported by grants from the Zika Network FAPESP projects
   2011/18703-2 and 2014/17766-9 and the NGO "The Tooth Fairy Project".
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Ashwal S., 2009, PRACTICE PARAMETER E
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Bell T.M., 1971, ZIKA VIRUS INFECT CE, V193
   Besnard M., 2013, EVIDENCE PERINATAL T, P8
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007
   Cao-Lormeau V.M., 2014, EMERG INFECT DIS, V20, P5
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   De Fatima M., 2015, CLIN FEATURES NEUROI
   Di Guardo G, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.103
   Dick G.W.A., 1952, T R SOC, V46
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall S.D., 2016, SUSCEPTIBLE MOUSE MO, P1
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gotz H.W., 2005, NAT REV MOL CELL BIO, V6, P777
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Johnson K, 2015, NEURAL REGEN RES, V10, P344, DOI 10.4103/1673-5374.153671
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008
   Lee DY, 2015, EXP NEUROBIOL, V24, P177, DOI 10.5607/en.2015.24.3.177
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Marton RM, 2016, CELL STEM CELL, V19, P145, DOI 10.1016/j.stem.2016.07.017
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Namba T, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.256
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen S.A., 2016, SPECIAL REPORT ZIKA
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Schwartz D.A., 2016, ARCH PATHOL LAB MED
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Velho T., 2016, ASS ZIKA VIRUS INFEC, V3099, P1
   Wahane SD, 2014, J NEUROCHEM, V130, P255, DOI 10.1111/jnc.12718
   Wang J, 2011, STEM CELLS, V29, P1589, DOI 10.1002/stem.699
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 62
TC 10
Z9 10
U1 0
U2 23
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 28
PY 2017
VL 492
IS 4
SI SI
BP 603
EP 607
DI 10.1016/j.bbrc.2017.01.074
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FK3OB
UT WOS:000413393300011
PM 28108286
DA 2020-12-01
ER

PT J
AU Feitosa, MLT
   Sarmento, CAP
   Bocabello, RZ
   Beltrao-Braga, PCB
   Pignatari, GC
   Giglio, RF
   Miglino, MA
   Orlandin, JR
   Ambrosio, CE
AF Tajra Feitosa, Matheus Levi
   Palmeira Sarmento, Carlos Alberto
   Bocabello, Renato Zonzini
   Baleeiro Beltrao-Braga, Patricia Cristina
   Pignatari, Graciela Conceicao
   Giglio, Robson Fortes
   Miglino, Maria Angelica
   Orlandin, Jessica Rodrigues
   Ambrosio, Carlos Eduardo
TI Transplantation of human immature dental pulp stem cell in dogs with
   chronic spinal cord injury
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE Cell- and Tissue-Based Therapy; Spinal Cord Injuries; Dental Pulp; Dogs
ID PROMOTES FUNCTIONAL RECOVERY; MARROW STROMAL CELLS; HUMAN BONE-MARROW
AB Purpose: To investigate the therapeutic potential of human immature dental pulp stem cells in the treatment of chronic spinal cord injury in dogs.
   Methods: Three dogs of different breeds with chronic SCI were presented as animal clinical cases. Human immature dental pulp stem cells were injected at three points into the spinal cord, and the animals were evaluated by limb function and magnetic resonance imaging (MRI) pre and post-operative.
   Results: There was significant improvement from the limb function evaluated by Olby Scale, though it was not supported by the imaging data provided by MRI and clinical sign and evaluation.
   Conclusion: Human dental pulp stem cell therapy presents promising clinical results in dogs with chronic spinal cord injuries, if used in association with physical therapy.
C1 [Tajra Feitosa, Matheus Levi; Palmeira Sarmento, Carlos Alberto] Univ Sao Paulo, Dept Surg, Fac Vet Med & Anim Sci, Postgrad Program Anat Domest & Wild Anim, Sao Paulo, SP, Brazil.
   [Bocabello, Renato Zonzini; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Surg, Stem Cell Lab, Sao Paulo, SP, Brazil.
   [Pignatari, Graciela Conceicao] Univ Sao Paulo, Dept Surg, Fac Vet Med & Anim Sci, Sao Paulo, SP, Brazil.
   [Giglio, Robson Fortes] Univ Florida, Coll Vet Med, Dept Clin Sci, Gainesville, FL USA.
   [Miglino, Maria Angelica; Ambrosio, Carlos Eduardo] CNPq Grant Level 1A CA VT, Pirassunung, SP, Brazil.
   [Miglino, Maria Angelica] Univ Sao Paulo, Dept Vet Med, Fac Anim Sci & Food Engn, Pirassunung, SP, Brazil.
   [Orlandin, Jessica Rodrigues; Ambrosio, Carlos Eduardo] Univ Sao Paulo, Postgrad Program Anim Biosci, Lab Stem Cell & Gene Therapy, Vet Med Dept,Fac Anim Sci & Food Engn, Pirassunung, SP, Brazil.
   [Tajra Feitosa, Matheus Levi; Palmeira Sarmento, Carlos Alberto; Bocabello, Renato Zonzini; Baleeiro Beltrao-Braga, Patricia Cristina; Pignatari, Graciela Conceicao; Giglio, Robson Fortes; Miglino, Maria Angelica; Orlandin, Jessica Rodrigues; Ambrosio, Carlos Eduardo] Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Surg, Stem Cell Lab, Pirassununga, SP, Brazil.
   [Tajra Feitosa, Matheus Levi; Palmeira Sarmento, Carlos Alberto; Bocabello, Renato Zonzini; Baleeiro Beltrao-Braga, Patricia Cristina; Pignatari, Graciela Conceicao; Giglio, Robson Fortes; Miglino, Maria Angelica; Orlandin, Jessica Rodrigues; Ambrosio, Carlos Eduardo] Univ Sao Paulo, Lab Stem Cell & Gene Therapy, Vet Med Dept, Fac Anim Sci & Food Engn, Pirassununga, SP, Brazil.
RP Ambrosio, CE (corresponding author), Univ Sao Paulo, Dept Med Vet, Fac Ciencias Anim & Engn Alimentos, Ave Duque Caxias 225, BR-13635900 Pirassununga, SP, Brazil.
EM ceambrosio@usp.br
RI Orlandin, Jessica R/D-5235-2016; Miglino, Maria Angelica/B-9519-2012;
   Ambrosio, Carlos Eduardo/F-3402-2010; Feitosa, Matheus/J-5528-2014;
   Beltrao-Braga, Patricia C B/D-6450-2013
OI Orlandin, Jessica R/0000-0002-8122-5986; Miglino, Maria
   Angelica/0000-0003-4979-115X; Ambrosio, Carlos
   Eduardo/0000-0002-8224-5022; Feitosa, Matheus/0000-0002-9247-8532;
   Beltrao-Braga, Patricia C B/0000-0003-0004-1091
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [09/51605-4]
FX FAPESP (Process Number: 09/51605-4)
CR Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908
   Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011
   CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2
   da Silva AJ, 2015, SEMIN-CIENC AGRAR, V35, P3205, DOI 10.5433/1679-0359.2014v35n6p3205
   Freund P, 2009, EUR J NEUROSCI, V29, P983, DOI 10.1111/j.1460-9568.2009.06642.x
   Frostell A, 2012, SPINAL CORD, V50, P315, DOI 10.1038/sc.2011.155
   Goldshmit Y, 2015, MOL CELL NEUROSCI, V68, P82, DOI 10.1016/j.mcn.2015.04.006
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299
   Kano F, 2014, J ORAL MAXILLOFAC SU, V72, pe121, DOI [10.1016/j.joms.2014.06.213, DOI 10.1016/J.JOMS.2014.06.213]
   Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617
   KNECHT CD, 1972, J SMALL ANIM PRACT, V13, P449, DOI 10.1111/j.1748-5827.1972.tb06872.x
   Lee KH, 2007, ACTA NEUROBIOL EXP, V67, P13
   Li K, 2015, EXP NEUROL, V271, P479, DOI 10.1016/j.expneurol.2015.07.020
   Lim JH, 2007, J VET SCI, V8, P275, DOI 10.4142/jvs.2007.8.3.275
   Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173
   Meng XT, 2008, CELL BIOL INT, V32, P1546, DOI 10.1016/j.cellbi.2008.09.001
   Mitsui T, 2003, J UROLOGY, V170, P1421, DOI 10.1097/01.ju.0000075501.05758.33
   Nosrat IV, 2001, DEV BIOL, V238, P120, DOI 10.1006/dbio.2001.0400
   Olby NJ, 2001, AM J VET RES, V62, P1624, DOI 10.2460/ajvr.2001.62.1624
   Orlandin JR, 2017, ACTA CIR BRAS, V32, P168, DOI 10.1590/s0102-865020170209
   Paul C, 2009, SPINE, V34, P328, DOI 10.1097/BRS.0b013e31819403ce
   Penha EM, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/437521
   Ramon Y, 1928, J NEUROL PSYCHOPATH, V9, P760
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   Ryu HH, 2009, J VET SCI, V10, P273, DOI 10.4142/jvs.2009.10.4.273
   Seim HB, 1996, SEMIN VET MED SURG, V11, P235
   Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381
   Yu PP, 2007, BRAIN RES, V1147, P66, DOI 10.1016/j.brainres.2007.02.013
   Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015
NR 30
TC 10
Z9 11
U1 1
U2 5
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
EI 1678-2674
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD JUL
PY 2017
VL 32
IS 7
BP 540
EP 549
DI 10.1590/s0102-865020170070000005
PG 10
WC Surgery
SC Surgery
GA FD2MF
UT WOS:000407368300005
PM 28793038
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Marchetto, MC
   Belinson, H
   Tian, Y
   Freitas, BC
   Fu, C
   Vadodaria, KC
   Beltrao-Braga, PC
   Trujillo, CA
   Mendes, APD
   Padmanabhan, K
   Nunez, Y
   Ou, J
   Ghosh, H
   Wright, R
   Brennand, KJ
   Pierce, K
   Eichenfield, L
   Pramparo, T
   Eyler, LT
   Barnes, CC
   Courchesne, E
   Geschwind, DH
   Gage, FH
   Wynshaw-Boris, A
   Muotri, AR
AF Marchetto, M. C.
   Belinson, H.
   Tian, Y.
   Freitas, B. C.
   Fu, C.
   Vadodaria, K. C.
   Beltrao-Braga, P. C.
   Trujillo, C. A.
   Mendes, A. P. D.
   Padmanabhan, K.
   Nunez, Y.
   Ou, J.
   Ghosh, H.
   Wright, R.
   Brennand, K. J.
   Pierce, K.
   Eichenfield, L.
   Pramparo, T.
   Eyler, L. T.
   Barnes, C. C.
   Courchesne, E.
   Geschwind, D. H.
   Gage, F. H.
   Wynshaw-Boris, A.
   Muotri, A. R.
TI Altered proliferation and networks in neural cells derived from
   idiopathic autistic individuals
SO MOLECULAR PSYCHIATRY
LA English
DT Article
ID PLURIPOTENT STEM-CELLS; TRANSCRIPTIONAL REGULATION; NEURONAL
   DIFFERENTIATION; BRAIN OVERGROWTH; CATENIN PATHWAY; SPECTRUM; INSULIN;
   ABNORMALITIES; PHENOTYPE; CHILDREN
AB Autism spectrum disorders (ASD) are common, complex and heterogeneous neurodevelopmental disorders. Cellular and molecular mechanisms responsible for ASD pathogenesis have been proposed based on genetic studies, brain pathology and imaging, but a major impediment to testing ASD hypotheses is the lack of human cell models. Here, we reprogrammed fibroblasts to generate induced pluripotent stem cells, neural progenitor cells (NPCs) and neurons from ASD individuals with early brain overgrowth and non-ASD controls with normal brain size. ASD-derived NPCs display increased cell proliferation because of dysregulation of a beta-catenin/BRN2 transcriptional cascade. ASD-derived neurons display abnormal neurogenesis and reduced synaptogenesis leading to functional defects in neuronal networks. Interestingly, defects in neuronal networks could be rescued by insulin growth factor 1 (IGF-1), a drug that is currently in clinical trials for ASD. This work demonstrates that selection of ASD subjects based on endophenotypes unraveled biologically relevant pathway disruption and revealed a potential cellular mechanism for the therapeutic effect of IGF-1.
C1 [Marchetto, M. C.; Vadodaria, K. C.; Mendes, A. P. D.; Nunez, Y.; Ghosh, H.; Wright, R.; Gage, F. H.] Salk Inst Biol Studies, Lab Genet, La Jolla, CA USA.
   [Belinson, H.; Wynshaw-Boris, A.] Univ Calif San Francisco, Inst Human Genet, Dept Pediat, San Francisco, CA 94143 USA.
   [Tian, Y.; Ou, J.; Geschwind, D. H.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Autism Res & Treatment, Semel Inst,Dept Neurol,Program Neurogenet, Los Angeles, CA 90095 USA.
   [Freitas, B. C.; Beltrao-Braga, P. C.; Trujillo, C. A.; Nunez, Y.; Muotri, A. R.] Univ Calif San Diego, Rady Childrens Hosp San Diego, Dept Cellular & Mol Med, Dept Pediat,Stem Cell Program, La Jolla, CA 92093 USA.
   [Fu, C.; Wynshaw-Boris, A.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.
   [Beltrao-Braga, P. C.] Univ Sao Paulo, Ctr Cellular & Mol Therapy, Dept Obstet & Surg, Sao Paulo, Brazil.
   [Padmanabhan, K.] Univ Rochester, Sch Med & Dent, Dept Neurosci, Rochester, NY USA.
   [Brennand, K. J.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.
   [Pierce, K.; Eichenfield, L.; Pramparo, T.; Eyler, L. T.; Barnes, C. C.; Courchesne, E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.
RP Muotri, AR (corresponding author), Univ Calif San Diego, Rady Childrens Hosp San Diego, Dept Cellular & Mol Med, Dept Pediat,Stem Cell Program, La Jolla, CA 92093 USA.; Wynshaw-Boris, A (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.
EM ajw168@case.edu; muotri@ucsd.edu
RI Vadodaria, Krishna C./H-1711-2017; Brennand, Kristen J/U-5470-2019;
   Brennand, Kristen/J-8704-2012; Beltrao-Braga, Patricia C B/D-6450-2013
OI Vadodaria, Krishna C./0000-0002-3455-0209; Brennand,
   Kristen/0000-0003-0993-5956; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091
FU California Institute for Regenerative Medicine (CIRM)California
   Institute for Regenerative Medicine [TR2-01814, TR4-06747]; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1-DP2-OD006495-01];
   NIMHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R01 MH100175-01, U19MH107367]; International Rett Syndrome
   Foundation (IRSF) [2915]; NARSADNARSAD; NIMH Autism Center of Excellence
   Program; Helmsley Trust; JPB Foundation; Engmann Foundation; CDMRP
   Autism Research Program; KL2 CTRI [KL2TR00099]; Autism Speaks; NATIONAL
   CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Advancing Translational Sciences (NCATS)
   [KL2TR000099, KL2TR000099, KL2TR000099] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Environmental Health Sciences (NIEHS)
   [T32ES007322, T32ES007322, T32ES007322, T32ES007322, T32ES007322]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Mental Health (NIMH)
   [R00MH101634, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, R00MH101634, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, R01MH100175, R01MH100175,
   R01MH094753, U19MH107367, U19MH107367, R01MH094753, R01MH094753,
   U19MH107367, R01MH100175, U19MH107367, R00MH101634, U19MH107367,
   R01MH113924, U19MH107367, R01MH094753, R01MH100175, U19MH107367,
   R01MH100175, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   R01MH094753, U19MH107367, U19MH107367, U19MH107367, R01MH113924,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, R01MH100175,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, R01MH100175,
   U19MH107367, U19MH107367] Funding Source: NIH RePORTER; OFFICE OF THE
   DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [DP2OD006495] Funding Source: NIH RePORTER
FX This work was supported by grants from the California Institute for
   Regenerative Medicine (CIRM) TR2-01814 and TR4-06747, the National
   Institutes of Health through the NIH Director's New Innovator Award
   Program (1-DP2-OD006495-01), an R01 MH100175-01 and U19MH107367 from
   NIMH, the International Rett Syndrome Foundation (IRSF Grant No. 2915);
   a NARSAD Independent Investigator Award to ARM, and NIMH Autism Center
   of Excellence Program Project grant (to EC, KP, AW-B and FHG); this work
   was also supported by the Helmsley Trust, the JPB Foundation, the
   Engmann Foundation, a grant from the CDMRP Autism Research Program (to
   AWB and FHG); a KL2 CTRI (KL2TR00099) to TP and Postdoctoral
   Translational Fellowship from Autism Speaks to HB.
CR Belinson H, 2016, MOL PSYCHIA IN PRESS
   Beltrao-Braga PCB, 2013, CYTOM PART A, V83A, P11, DOI 10.1002/cyto.a.22231
   Carper RA, 2002, NEUROIMAGE, V16, P1038, DOI 10.1006/nimg.2002.1099
   Chen YJ, 2015, J NEUROSCI, V35, P10252, DOI 10.1523/JNEUROSCI.5272-14.2015
   Cheng CM, 2000, P NATL ACAD SCI USA, V97, P10236, DOI 10.1073/pnas.170008497
   Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192
   Chow ML, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002592
   Ciucci F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000475
   Corvin AP, 2012, NEUROSCI LETT, V520, P51, DOI 10.1016/j.neulet.2012.05.029
   Courchesne E, 2005, DEV PSYCHOPATHOL, V17, P577, DOI 10.1017/S0954579405050285
   Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337
   Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245
   Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016
   Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638
   Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101
   Davis G, 2015, AUTISM, V19, P351, DOI 10.1177/1362361314552198
   Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064
   Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384
   Freitas B.C., 2012, EXP NEUROL, V260, P33
   Garber K, 2007, SCIENCE, V317, P190, DOI 10.1126/science.317.5835.190
   Garcia-Jimenez C, 2014, J MOL ENDOCRINOL, V52, pR51, DOI 10.1530/JME-13-0152
   Gmitrowicz A, 1994, Psychiatr Pol, V28, P509
   Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141
   Hahamy A, 2015, NAT NEUROSCI, V18, P302, DOI 10.1038/nn.3919
   Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366
   Hazlett HC, 2011, ARCH GEN PSYCHIAT, V68, P467, DOI 10.1001/archgenpsychiatry.2011.39
   Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165
   Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132
   Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011
   Niethammer M, 1996, J NEUROSCI, V16, P2157
   Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207
   Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789
   Palsgaard J, 2012, J BIOL CHEM, V287, P12016, DOI 10.1074/jbc.M111.337048
   Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031
   Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576
   Piven J, 1997, AM J PSYCHIAT, V154, P185
   Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d
   Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13
   Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945
   Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002
   Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618
   Shen MD, 2013, BRAIN, V136, P2825, DOI 10.1093/brain/awt166
   Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022
   Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184
   Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035
   Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491
   Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002
   Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070
   Voineagu I, 2012, NEUROBIOL DIS, V45, P69, DOI 10.1016/j.nbd.2011.07.017
   Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603
   Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020
   Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zikopoulos B, 2013, FRONT HUM NEUROSCI, V7, P1, DOI 10.3389/fnhum.2013.00609
NR 62
TC 118
Z9 120
U1 5
U2 73
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1359-4184
EI 1476-5578
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD JUN
PY 2017
VL 22
IS 6
BP 820
EP 835
DI 10.1038/mp.2016.95
PG 16
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA EV4BI
UT WOS:000401702800006
PM 27378147
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Russo, FB
   Jungmann, P
   Beltrao-Braga, PCB
AF Russo, Fabiele Baldino
   Jungmann, Patricia
   Baleeiro Beltrao-Braga, Patricia Cristina
TI Zika infection and the development of neurological defects
SO CELLULAR MICROBIOLOGY
LA English
DT Review
DE brain damage; congenital Zika syndrome; flaviviruses; microcephaly;
   Zika; ZIKV
ID GUILLAIN-BARRE-SYNDROME; VIRUS-INFECTION; NEURAL PROGENITORS; CEREBRAL
   ORGANOIDS; STEM-CELLS; BRAIN; TRANSMISSION; PREGNANCY; NEUROGENESIS;
   ACTIVATION
AB Starting with the outbreak in Brazil, Zika virus (ZIKV) infection has been correlated with severe syndromes such as congenital Zika syndrome and Guillain-Barre syndrome. Here, we review the status of Zika virus pathogenesis in the central nervous system (CNS). One of the main concerns about ZIKV exposure during pregnancy is abnormal brain development, which results in microcephaly in newborns. Recent advances in in vitro research show that ZIKV can infect and obliterate cells from the CNS, such as progenitors, neurons, and glial cells. Neural progenitor cells seem to be the main target of the virus, with infection leading to less cell migration, neurogenesis impairment, cell death and, consequently, microcephaly in newborns. The downsizing of the brain can be directly associated with defective development of the cortical layer. In addition, in vivo investigations in mice reveal that ZIKV can cross the placenta and migrate to fetuses, but with a significant neurotropism, which results in brain damage for the pups. Another finding shows that hydrocephaly is an additional consequence of ZIKV infection, being detected during embryonic and fetal development in mouse, as well as after birth in humans. In spite of the advances in ZIKV research in the last year, the mechanisms underlying ZIKV infection in the CNS require further investigation particularly as there are currently no treatments or vaccines against ZIKV infection.
C1 [Russo, Fabiele Baldino; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Surg, Sao Paulo, Brazil.
   [Russo, Fabiele Baldino; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Microbiol, Sao Paulo, Brazil.
   [Jungmann, Patricia] Univ Pernambuco, Dept Pathol, Recife, PE, Brazil.
   [Baleeiro Beltrao-Braga, Patricia Cristina] Sch Arts Sci & Human, Dept Obstet, Sao Paulo, Brazil.
RP Beltrao-Braga, PCB (corresponding author), Ave Prof Dr Orlando Marques Paiva,87 Cidade Univ, BR-05508270 Sao Paulo, SP, Brazil.
EM patriciacbbbraga@usp.br
RI Beltrao-Braga, Patricia C B/D-6450-2013; Russo, Fabiele/N-4340-2017
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Russo,
   Fabiele/0000-0002-4076-1846
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P., 2016, NEW ENGLAND J MED
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Gabriel E., 2017, CELL STEM CELL, P1
   Ghouzzi Vincent El, 2017, Cell Death Dis, V8, pe2567, DOI 10.1038/cddis.2016.446
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Johnson K, 2015, NEURAL REGEN RES, V10, P344, DOI 10.4103/1673-5374.153671
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lee DY, 2015, EXP NEUROBIOL, V24, P177, DOI 10.5607/en.2015.24.3.177
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Marton RM, 2016, CELL STEM CELL, V19, P145, DOI 10.1016/j.stem.2016.07.017
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Velho T., 2016, ASS ZIKA VIRUS INFEC, V3099, P1
   Wahane SD, 2014, J NEUROCHEM, V130, P255, DOI 10.1111/jnc.12718
   Wang J, 2011, STEM CELLS, V29, P1589, DOI 10.1002/stem.699
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 62
TC 44
Z9 44
U1 0
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD JUN
PY 2017
VL 19
IS 6
AR e12744
DI 10.1111/cmi.12744
PG 6
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA EU6YZ
UT WOS:000401183200002
PM 28370966
OA Bronze
DA 2020-12-01
ER

PT J
AU Beltrao-Braga, PCB
   Muotri, AR
AF Beltrao-Braga, Patricia C. B.
   Muotri, Alysson R.
TI Modeling autism spectrum disorders with human neurons
SO BRAIN RESEARCH
LA English
DT Review
DE Autism spectrum disorders; Disease modeling; Human induced pluripotent
   stem cells; Human neurons
ID PLURIPOTENT STEM-CELLS; FRAGILE-X-SYNDROME; RETT-SYNDROME; NEUROLOGICAL
   DISEASE; CONGENITAL VARIANT; TRPC6 CHANNELS; MUTATIONS; ANGELMAN;
   GENETICS; DELETION
AB Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders characterized by impaired social communication and interactions and by restricted and repetitive behaviors. Although ASD is suspected to have a heritable or sporadic genetic basis, its underlying etiology and pathogenesis are not well understood. Therefore, viable human neurons and glial cells produced using induced pluripotent stem cells (iPSC) to reprogram cells from individuals affected with ASD provide an unprecedented opportunity to elucidate the pathophysiology of these disorders, providing novel insights regarding ASD and a potential platform to develop and test therapeutic compounds. Herein, we discuss the state of art with regards to ASD modeling, including limitations of this technology, as well as potential future directions.
   This article is part of a Special Issue entitled SI: Exploiting human neurons. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, Sao Paulo, Brazil.
   [Beltrao-Braga, Patricia C. B.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Stem Cell Program,Rady Childrens Hosp San Diego, Dept Cellular & Mol Med,Dept Pediat, MC 0695, La Jolla, CA 92093 USA.
   [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Vet Med, Dept Surg, Stem Cell Lab, Sao Paulo, Brazil.
   [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Dept Obstet, Sch Arts Sci & Humanities, 1000 Arllindo Bettio Av, BR-03828000 Sao Paulo, Brazil.
RP Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Stem Cell Program,Rady Childrens Hosp San Diego, Dept Cellular & Mol Med,Dept Pediat, MC 0695, La Jolla, CA 92093 USA.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Dept Obstet, Sch Arts Sci & Humanities, 1000 Arllindo Bettio Av, BR-03828000 Sao Paulo, Brazil.
EM patriciacbbbraga@usp.br; muotri@ucsd.edu
RI Beltrao-Braga, Patricia C B/D-6450-2013
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP); NGO "The Tooth Fairy Project"; California Institute for
   Regenerative Medicine (CIRM)California Institute for Regenerative
   Medicine [TR4-06747]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01MH094753, R01MH103134, U19MH107367]; NARSAD Independent
   Investigator AwardNARSAD; NATIONAL INSTITUTE OF MENTAL HEALTHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Mental Health (NIMH)
   [R01MH103134, U19MH107367, U19MH107367, R21MH107771, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   R01MH094753, U19MH107367, R01MH094753, U19MH107367, U19MH107367,
   R01MH094753, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, R01MH094753, U19MH107367, U19MH107367, R01MH103134,
   U19MH107367, R01MH094753, R21MH107771, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, R01MH103134, R01MH103134, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367] Funding
   Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [DP2OD006495] Funding Source: NIH
   RePORTER
FX We thank Prof. Dr. John Kastelic, from the University of Calgary, for
   careful review of our text. The work in the Beltrao-Braga lab is
   supported by Grants from CNPq, FAPESP and the NGO "The Tooth Fairy
   Project". The work in the Muotri lab is supported by Grants from the
   California Institute for Regenerative Medicine (CIRM) TR4-06747, the
   National Institutes of Health (R01MH094753, R01MH103134, and
   U19MH107367) and a NARSAD Independent Investigator Award to A.R.M.
CR Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346
   Amenduni M, 2011, EUR J HUM GENET, V19, P1246, DOI 10.1038/ejhg.2011.131
   Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810
   Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255
   Ariani F, 2008, AM J HUM GENET, V83, P89, DOI 10.1016/j.ajhg.2008.05.015
   Bahi-Buisson N, 2010, NEUROGENETICS, V11, P241, DOI 10.1007/s10048-009-0220-2
   Beltrao-Braga PCB, 2013, CYTOM PART A, V83A, P11, DOI 10.1002/cyto.a.22231
   Bittel Douglas C., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009531
   Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252
   Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001
   Chailangkarn T, 2012, CURR OPIN NEUROBIOL, V22, P785, DOI 10.1016/j.conb.2012.04.004
   Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107
   Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093
   Courchesne V, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0006-3
   Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799
   Doers ME, 2014, STEM CELLS DEV, V23, P1777, DOI 10.1089/scd.2014.0030
   Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933
   Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677
   Freitag CM, 2010, EUR CHILD ADOLES PSY, V19, P169, DOI 10.1007/s00787-009-0076-x
   Geschwind D. H., 2013, GENETICS AUTISM SPEC, V15, P409
   Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016
   Griesi-Oliveira K., 2014, MOL PSYCHIAT
   Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X
   Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908
   Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012
   Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108
   KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235
   Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Leuner K, 2013, HIPPOCAMPUS, V23, P40, DOI 10.1002/hipo.22052
   Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477
   Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207
   Marchetto MC, 2011, HUM MOL GENET, V20, pR109, DOI 10.1093/hmg/ddr336
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Marchetto MCN, 2010, HUM MOL GENET, V19, pR71, DOI 10.1093/hmg/ddq159
   Mariani J., 2015, CELL, P1
   Mencarelli MA, 2010, J MED GENET, V47, P49, DOI 10.1136/jmg.2009.067884
   Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284
   Nageshappa S., 2015, MOL PSYCHIAT
   O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764
   Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576
   Percy AK, 2011, ARCH NEUROL-CHICAGO, V68, P985, DOI 10.1001/archneurol.2011.149
   Phelan K, 2011, MOL SYNDROMOL, V2, P186, DOI 10.1159/000334260
   Pierce K, 2011, J PEDIATR-US, V159, P458, DOI 10.1016/j.jpeds.2011.02.036
   Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008
   Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13
   Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618
   Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203
   Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030
   Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682
   Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011
   State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Thibert RL, 2013, PEDIATR NEUROL, V48, P271, DOI 10.1016/j.pediatrneurol.2012.09.015
   Tiscornia G, 2011, NAT MED, V17, P1570, DOI 10.1038/nm.2504
   Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005
   VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H
   Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188
   Warren Z, 2011, PEDIATRICS, V127, pE1303, DOI 10.1542/peds.2011-0426
   Whittington J, 2010, AM J MED GENET C, V154C, P438, DOI 10.1002/ajmg.c.30283
   Williams E. C., 2014, MUTANT ASTROCYTES DI
   Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020
   Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575
   Wingate M, 2014, MMWR SURVEILL SUMM, V63
   Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127
NR 69
TC 8
Z9 8
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-8993
EI 1872-6240
J9 BRAIN RES
JI Brain Res.
PD FEB 1
PY 2017
VL 1656
SI SI
BP 49
EP 54
DI 10.1016/j.brainres.2016.01.057
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA EK8RE
UT WOS:000394190500006
PM 26854137
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Russo, FB
   Pignatari, GC
   Fernandes, IR
   Dias, JLRM
   Beltrao-Braga, PCB
AF Russo, F. B.
   Pignatari, G. C.
   Fernandes, I. R.
   Dias, J. L. R. M.
   Beltrao-Braga, P. C. B.
TI Epithelial cells from oral mucosa: How to cultivate them?
SO CYTOTECHNOLOGY
LA English
DT Article
DE Oral mucosa; Epithelial cells; Epithelial cells from oral mucosa; Cell
   culture; Non-invasive method
ID OCULAR SURFACE RECONSTRUCTION; IN-VITRO; MOLECULAR CHARACTERIZATION;
   CULTURE; EXPRESSION; CHILDREN; CORNEAL
AB Epithelial cells from oral mucosa (EOM) are responsible for important functions, like the primary protection of oral mucosa against external aggressions building a mechanical barrier against microorganisms, mechanical damage, toxic material, thermal regulation and secretion of different classes of inflammatory mediators. EOM could be an interesting tool for cellular and molecular biology research. Usually, EOM are collected by a painful and invasive process. In this study, we propose an alternative method to cultivate EOM collected by non-invasive scraping method of oral mucosa. Papanicolaou staining showed mainly two kinds of epithelial cell population after EOM scraping. As result of the five culture methods tested here, our results revealed that the EOM were successfully cultured on a murine feeder layer. In addition, EOM could be frozen and thawed, without morphology changes and loss of viability. Our findings suggest that EOM can be considered as a good cell source for many purposes, such as genetic studies, diagnosis and cell therapy.
C1 [Russo, F. B.; Pignatari, G. C.; Fernandes, I. R.; Dias, J. L. R. M.; Beltrao-Braga, P. C. B.] Univ Sao Paulo, Sch Vet Med, Dept Surg, Stem Cell Lab, 87 Prof Dr Orlando Marques de Paiva Ave, BR-05508270 Sao Paulo, Brazil.
   [Pignatari, G. C.; Beltrao-Braga, P. C. B.] Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, 455 Dr Arnaldo Ave, BR-01246903 Sao Paulo, Brazil.
   [Beltrao-Braga, P. C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, 100 Arlindo Bettio Ave, BR-03828100 Sao Paulo, Brazil.
RP Russo, FB (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Surg, Stem Cell Lab, 87 Prof Dr Orlando Marques de Paiva Ave, BR-05508270 Sao Paulo, Brazil.
EM fabielerusso@gmail.com; patriciacbbbraga@usp.br
RI Beltrao-Braga, Patricia C B/D-6450-2013; Russo, Fabiele/N-4340-2017
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Russo,
   Fabiele/0000-0002-4076-1846
FU University of Sao Paulo (USP); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP)
FX We are thankful for University of Sao Paulo (USP) and FAPESP for the
   financial support provided for this research.
CR Aidar Marisi, 2007, Braz. Dent. J., V18, P148, DOI 10.1590/S0103-64402007000200012
   Amemiya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125391
   Ang LPK, 2006, ARCH OPHTHALMOL-CHIC, V124, P1543, DOI 10.1001/archopht.124.11.1543
   Bardag-Gorce F, 2015, OCUL SURF, V13, P150, DOI 10.1016/j.jtos.2014.12.003
   Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235
   Bianco B, 2006, J PEDIATR ENDOCR MET, V19, P1113
   Castro Therezita M Peixoto Patury Galvao, 2009, Braz J Otorhinolaryngol, V75, P167
   Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5
   Fernandes IR, 2016, CYTOTECHNOLOGY, V68, P223, DOI 10.1007/s10616-014-9771-7
   Klingbeil MFG, 2012, CELL TISSUE BANK, V13, P27, DOI 10.1007/s10561-010-9217-1
   Hashemi Hassan, 2009, IRANIAN BIOMEDICAL JOURNAL, V13, P109
   Higa K, 2008, CORNEA, V27, pS41, DOI 10.1097/ICO.0b013e31817f358e
   Hirayama M, 2012, INVEST OPHTH VIS SCI, V53, P1602, DOI 10.1167/iovs.11-7847
   Janardhanam SB, 2012, ARCH ORAL BIOL, V57, P495, DOI 10.1016/j.archoralbio.2011.10.013
   Jung JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028068
   Kanayama S, 2009, BRIT J OPHTHALMOL, V93, P263, DOI 10.1136/bjo.2008.141580
   Khatri M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029567
   Kolltveit KM, 2010, EUR J ORAL SCI, V118, P159, DOI 10.1111/j.1600-0722.2010.00719.x
   Kullaa AM, 2014, ULTRASTRUCT PATHOL, V38, P382, DOI 10.3109/01913123.2014.944732
   Laffargue F, 2013, EUR J MED GENET, V56, P93, DOI 10.1016/j.ejmg.2012.12.002
   Laheij AMGA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/154532
   Bedran TBL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106766
   Madhira SL, 2008, MOL VIS, V14, P189
   Marchetto MCN, 2004, P NATL ACAD SCI USA, V101, P17759, DOI 10.1073/pnas.0406304101
   Munce T, 2008, GENET TEST, V12, P319, DOI 10.1089/gte.2007.0105
   Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P111, DOI 10.3727/000000008783907125
   Queiroz AB, 2010, ANTICANCER RES, V30, P2799
   Scafetta Gaia, 2015, Methods Mol Biol, V1283, P187, DOI 10.1007/7651_2014_102
   Sen S, 2011, INVEST OPHTH VIS SCI, V52, P9548, DOI 10.1167/iovs.11-7946
   Sheth R, 2015, CURR EYE RES, V40, P1077, DOI 10.3109/02713683.2014.978477
   Shiomi A, 2015, J ORAL REHABIL, V42, P192, DOI 10.1111/joor.12254
   Souto Luís Ricardo Martinhão, 2006, Sao Paulo Med. J., V124, P71, DOI 10.1590/S1516-31802006000200005
   Squier C A, 2001, J Natl Cancer Inst Monogr, P7
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Ye P, 2011, BIOCHEM BIOPH RES CO, V412, P165, DOI 10.1016/j.bbrc.2011.07.067
   Yohannes E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027816
NR 38
TC 1
Z9 1
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-9069
EI 1573-0778
J9 CYTOTECHNOLOGY
JI Cytotechnology
PD OCT
PY 2016
VL 68
IS 5
BP 2105
EP 2114
DI 10.1007/s10616-016-9950-9
PG 10
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA DW2TP
UT WOS:000383495000035
PM 26825681
OA Green Published
DA 2020-12-01
ER

PT J
AU Cugola, FR
   Fernandes, IR
   Russo, FB
   Freitas, BC
   Dias, JLM
   Guimaraes, KP
   Benazzato, C
   Almeida, N
   Pignatari, GC
   Romero, S
   Polonio, CM
   Cunha, I
   Freitas, CL
   Brandao, WN
   Rossato, C
   Andrade, DG
   Faria, DD
   Garcez, AT
   Buchpigel, CA
   Braconi, CT
   Mendes, E
   Sall, AA
   Zanotto, PMD
   Peron, JPS
   Muotri, AR
   Beltrao-Braga, PCB
AF Cugola, Fernanda R.
   Fernandes, Isabella R.
   Russo, Fabiele B.
   Freitas, Beatriz C.
   Dias, Joao L. M.
   Guimaraes, Katia P.
   Benazzato, Cecilia
   Almeida, Nathalia
   Pignatari, Graciela C.
   Romero, Sarah
   Polonio, Carolina M.
   Cunha, Isabela
   Freitas, Carla L.
   Brandao, Wesley N.
   Rossato, Cristiano
   Andrade, David G.
   Faria, Daniele de P.
   Garcez, Alexandre T.
   Buchpigel, Carlos A.
   Braconi, Carla T.
   Mendes, Erica
   Sall, Amadou A.
   Zanotto, Paolo M. de A.
   Peron, Jean Pierre S.
   Muotri, Alysson R.
   Beltrao-Braga, Patricia C. B.
TI The Brazilian Zika virus strain causes birth defects in experimental
   models
SO NATURE
LA English
DT Article
ID INFECTION; BRAIN; GROWTH
AB Zika virus (ZIKV) is an arbovirus belonging to the genus Flavivirus (family Flaviviridae) and was first described in 1947 in Uganda following blood analyses of sentinel rhesus monkeys(1). Until the twentieth century, the African and Asian lineages of the virus did not cause meaningful infections in humans. However, in 2007, vectored by Aedes aegypti mosquitoes, ZIKV caused the first noteworthy epidemic on Yap Island in Micronesia(2). Patients experienced fever, skin rash, arthralgia and conjunctivitis(2). From 2013 to 2015, the Asian lineage of the virus caused further massive outbreaks in New Caledonia and French Polynesia. In 2013, ZIKV reached Brazil, later spreading to other countries in South and Central America3. In Brazil, the virus has been linked to congenital malformations, including microcephaly and other severe neurological diseases, such as Guillain-Barre syndrome(4,5). Despite clinical evidence, direct experimental evidence showing that the Brazilian ZIKV (ZIKVBR) strain causes birth defects remains absent(6). Here we demonstrate that ZIKVBR infects fetuses, causing intrauterine growth restriction, including signs of microcephaly, in mice. Moreover, the virus infects human cortical progenitor cells in vitro, leading to an increase in cell death. We also report that the infection of human brain organoids results in a reduction of proliferative zones and disrupted cortical layers. These results indicate that ZIKVBR crosses the placenta and causes microcephaly by targeting cortical progenitor cells, inducing cell death by apoptosis and autophagy, and impairing neurodevelopment. Our data reinforce the growing body of evidence linking the ZIKVBR outbreak to the alarming number of cases of congenital brain malformations. Our model can be used to determine the efficiency of therapeutic approaches to counteracting the harmful impact of ZIKVBR in human neurodevelopment.
C1 [Cugola, Fernanda R.; Fernandes, Isabella R.; Russo, Fabiele B.; Dias, Joao L. M.; Guimaraes, Katia P.; Benazzato, Cecilia; Almeida, Nathalia; Pignatari, Graciela C.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, Brazil.
   [Fernandes, Isabella R.; Freitas, Beatriz C.; Romero, Sarah; Muotri, Alysson R.] Univ Calif San Diego, Dept Cellular & Mol Med, Rady Childrens Hosp San Diego, Sch Med,Dept Pediat,Stem Cell Program, La Jolla, CA 92037 USA.
   [Russo, Fabiele B.; Pignatari, Graciela C.] Tismoo, BR-01401000 Sao Paulo, Brazil.
   [Polonio, Carolina M.; Cunha, Isabela; Freitas, Carla L.; Brandao, Wesley N.; Rossato, Cristiano; Andrade, David G.; Peron, Jean Pierre S.] Univ Sao Paulo, Dept Immunol, Neuroimmune Interact Lab, BR-05508000 Sao Paulo, Brazil.
   [Faria, Daniele de P.; Garcez, Alexandre T.; Buchpigel, Carlos A.] Univ Sao Paulo, USP Sch Med, Dept Radiol & Oncol, BR-05403010 Sao Paulo, Brazil.
   [Braconi, Carla T.; Mendes, Erica; Zanotto, Paolo M. de A.] Univ Sao Paulo, Inst Microbiol Sci, Dept Microbiol, Lab Mol Evolut & Bioinformat, BR-05508000 Sao Paulo, Brazil.
   [Sall, Amadou A.] Inst Pasteur, Dakar 220, Senegal.
   [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, Brazil.
RP Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, Brazil.; Muotri, AR (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Rady Childrens Hosp San Diego, Sch Med,Dept Pediat,Stem Cell Program, La Jolla, CA 92037 USA.; Peron, JPS (corresponding author), Univ Sao Paulo, Dept Immunol, Neuroimmune Interact Lab, BR-05508000 Sao Paulo, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, Brazil.
EM jeanpierre@usp.br; muotri@ucsd.edu; patriciacbbbraga@usp.br
RI Russo, Fabiele/N-4340-2017; Mendes, Erica/L-7333-2018; Peron, Jean
   Pierre S/F-9248-2012; Benazzato, Cecilia/U-5873-2017; Benazzato,
   Cecilia/AAB-8869-2019; de Paula Faria, Daniele/D-7858-2015;
   Beltrao-Braga, Patricia C B/D-6450-2013; de A. Zanotto, Paolo
   M./B-9286-2019; de Paula Faria, Daniele/U-1731-2019; Buchpiguel,
   Carlos/AAC-6237-2020; Brandao, Wesley N/K-5919-2017; Buchpiguel, Carlos
   A/C-3774-2012; Braconi, Carla T./B-3320-2014; Cugola,
   Fernanda/I-9556-2016
OI Russo, Fabiele/0000-0002-4076-1846; Mendes, Erica/0000-0001-9007-1053;
   Benazzato, Cecilia/0000-0002-8656-0871; de Paula Faria,
   Daniele/0000-0002-1766-2786; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; de A. Zanotto, Paolo M./0000-0002-8167-0625;
   Buchpiguel, Carlos/0000-0003-0956-2790; Brandao, Wesley
   N/0000-0001-9306-3251; Buchpiguel, Carlos A/0000-0003-0956-2790;
   Braconi, Carla T./0000-0002-5370-8980; Cugola,
   Fernanda/0000-0002-6677-2404; Peron, Jean Pierre/0000-0003-1638-8866;
   Almeida dos Santos, Nathalia/0000-0003-3145-186X; Rossato,
   Cristiano/0000-0003-1124-0520
FU Zika Network FAPESP [2011/18703-2, 2014/17766-9]; NGO 'The Tooth Fairy
   Project'; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [U19MH107367, R01MH094753]; NARSAD Independent Investigator GrantNARSAD;
   NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) [U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, R01MH094753, U19MH107367,
   R01MH094753, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, R01MH094753, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, R01MH094753, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, R01MH094753, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367, U19MH107367, U19MH107367,
   U19MH107367, U19MH107367, U19MH107367] Funding Source: NIH RePORTER
FX This work was supported by grants from the Zika Network FAPESP projects
   2011/18703-2 and 2014/17766-9, the NGO 'The Tooth Fairy Project', the
   National Institutes of Health through the U19MH107367, R01MH094753 and
   an NARSAD Independent Investigator Grant to A.R.M. We would like to
   thank M. Goncalves and M. A. Miglino for scientific discussions, G.
   Amarante-Mendes for the FITC-Annexin V reagent, M. Zatz for the SJL
   mice, E. Durigon and his group for the ZIKV<SUP>BR</SUP> aliquots, P.
   Vasconcelos for providing a lyophilized ZIKV<SUP>BR</SUP> seed, N. Olsen
   for reagent and equipment support, D. Candido for analysis support, F.
   Mastrantonio for drawings and R. E. Grassi for electron and confocal
   microscopy support.
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Freire C. C. d. M., 2015, PREPRINT
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Jang EA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00176
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Qian X., 2016, CELL, V165, P1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Stock NK, 2013, J VIROL, V87, P2895, DOI 10.1128/JVI.01116-12
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 36
TC 630
Z9 647
U1 5
U2 282
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 9
PY 2016
VL 534
IS 7606
BP 267
EP +
DI 10.1038/nature18296
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO0NH
UT WOS:000377475100045
PM 27279226
OA Green Accepted, Bronze
DA 2020-12-01
ER

PT J
AU Fernandes, IR
   Russo, FB
   Pignatari, GC
   Evangelinellis, MM
   Tavolari, S
   Muotri, AR
   Beltrao-Braga, PCB
AF Fernandes, I. R.
   Russo, F. B.
   Pignatari, G. C.
   Evangelinellis, M. M.
   Tavolari, S.
   Muotri, A. R.
   Beltrao-Braga, P. C. B.
TI Fibroblast sources: Where can we get them?
SO CYTOTECHNOLOGY
LA English
DT Article
DE Skin biopsy; Fibroblast; Primary cell culture; Scar; Eyelid; Ear; Groin
ID PLURIPOTENT STEM-CELLS; INTERSTITIAL FIBROSIS; MOUSE; DISEASE; GROWTH
AB Fibroblasts are cells widely used in cell culture, both for transient primary cell culture or permanent as transformed cell lines. Lately, fibroblasts become cell sources for use in disease modeling after cell reprogramming because it is easily accessible in the body. Fibroblasts in patients will maintain all genetic background during reprogramming into induced pluripotent stem cells. In spite of their large use, fibroblasts are obtained after an invasive procedure, a superficial punch skin biopsy, collected under patient's local anesthesia. Taking into consideration the minimum patient's discomfort during and after the biopsy procedure, as well as the aesthetics aspect, it is essential to reflect on the best site of the body for the biopsy procedure combined with the success of getting robust fibroblast cultures in the lab. For this purpose, we compared the efficiency of four biopsy sites of the body (skin from eyelid, back of the ear, abdominal cesarean scar and groin). Cell proliferation assays and viability after cryopreservation were measured. Our results revealed that scar tissue provided fibroblasts with higher proliferative rates. Also, fibroblasts from scar tissues presented a higher viability after the thawing process.
C1 [Fernandes, I. R.; Russo, F. B.; Pignatari, G. C.; Evangelinellis, M. M.; Tavolari, S.; Beltrao-Braga, P. C. B.] Univ Sao Paulo, Sch Vet Med, Dept Surg, Stem Cell Lab, 87 Prof Dr Orlando Marques de Paiva Av, BR-05508270 Sao Paulo, Brazil.
   [Fernandes, I. R.; Russo, F. B.; Pignatari, G. C.; Evangelinellis, M. M.; Beltrao-Braga, P. C. B.] Univ Sao Paulo, Ctr Cellular & Mol Therapy NETCEM, Sch Med, 455 Dr Arnaldo Av, BR-01246903 Sao Paulo, Brazil.
   [Muotri, A. R.] Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego, Stem Cell Program,Dept Pediat,Dept Cellular & Mol, MC 0695, La Jolla, CA 92093 USA.
   [Beltrao-Braga, P. C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, 100 Arlindo Betio Av, BR-03828100 Sao Paulo, Brazil.
RP Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Surg, Stem Cell Lab, 87 Prof Dr Orlando Marques de Paiva Av, BR-05508270 Sao Paulo, Brazil.
EM patriciacbbbraga@usp.br
RI Russo, Fabiele/N-4340-2017; Beltrao-Braga, Patricia C B/D-6450-2013
OI Russo, Fabiele/0000-0002-4076-1846; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091
FU USP; UCSD; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX We are thankful for USP, UCSD and FAPESP for the financial support
   provided for this research.
CR Acrani GO, 2010, VIRUS RES, V149, P56, DOI 10.1016/j.virusres.2009.12.013
   CARMICHAEL J, 1987, CANCER RES, V47, P936
   Carrel A, 1912, J EXP MED, V15, P516, DOI 10.1084/jem.15.5.516
   Castor CW, 1979, AM REV RESPIR DIS, V120, P21
   Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599
   Chang T, 2011, STEM CELLS, V29, P2090, DOI 10.1002/stem.749
   Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799
   Duvall M., 1879, ATLAS DEMBRYOLOGIE
   Freitas BCG, 2014, EXP NEUROL, V260, P33, DOI 10.1016/j.expneurol.2012.09.017
   Harrison RG, 1907, P SOC EXP BIOL MED, V4, P140
   JONES HW, 1971, OBSTET GYNECOL, V38, P945
   Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Martinez-Santamaria L, 2012, ACTAS DERMO-SIFILOGR, V103, P5, DOI [10.1016/j.ad.2011.03.006, 10.1016/j.adengl.2011.03.016]
   MULLER GA, 1991, AM J KIDNEY DIS, V17, P680
   Odell A, 2010, AGING-US, V2, P160, DOI 10.18632/aging.100129
   Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034
   Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041
   Parsonage G, 2005, TRENDS IMMUNOL, V26, P150, DOI 10.1016/j.it.2004.11.014
   Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   TARIN D, 1969, J ANAT, V105, P189
   TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   VILLEGAS J, 2005, CURR PROTOC MOL BIOL, pCH28, DOI DOI 10.1002/0471142727.MB2803S71
   Virchow RLK, 1858, CELLULARPATHOLOGIE I
   vom Brocke J, 2006, CARCINOGENESIS, V27, P2141, DOI 10.1093/carcin/bg1101
   Zeisberg M, 2000, J NEPHROL, V13, pS111
NR 28
TC 8
Z9 8
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-9069
EI 1573-0778
J9 CYTOTECHNOLOGY
JI Cytotechnology
PD MAR
PY 2016
VL 68
IS 2
BP 223
EP 228
DI 10.1007/s10616-014-9771-7
PG 6
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA DE1AW
UT WOS:000370359200005
PM 25060709
OA Green Published
DA 2020-12-01
ER

PT J
AU Esper, GVZ
   Pignatari, GC
   Rodrigues, MN
   Bertagnon, HG
   Fernandes, IR
   Nascimento, N
   Tabosa, AMF
   Beltrao-Braga, PCB
   Miglino, MA
AF Zanatta Esper, Greyson Vitor
   Pignatari, Graciela Conceicao
   Rodrigues, Marcio Nogueira
   Bertagnon, Heloisa Godoi
   Fernandes, Isabella Rodrigues
   Nascimento, Nanci
   Florencio Tabosa, Angela Maria
   Baleeiro Beltrao-Braga, Patricia Cristina
   Miglino, Maria Angelica
TI Aquapuncture Using Stem Cell Therapy to Treat Mdx Mice
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID DUCHENNE MUSCULAR-DYSTROPHY; BONE-MARROW; MUSCLE FUNCTION; MOUSE MODEL;
   ACUPUNCTURE; EFFICACY; PATHOPHYSIOLOGY; TRANSPLANTATION; RESPONSES; EXON
AB Duchenne muscular dystrophy (DMD) occurs due to genetic mutations that lead to absence or decrease of dystrophin protein generating progressive muscle degeneration. Cell therapy using mesenchymal stem cell (MSC) has been described as a treatment to DMD. In this work, MSC derived from deciduous teeth, called stem cells from human exfoliated deciduous teeth (SHED), were injected in acupoint as an alternative therapy to minimize muscle degeneration in twenty-two mdx mice. The treatment occurred three times with intervals of 21 days, and animals were analyzed four times: seven days prior treatment (T-7); 10 days after first treatment (T10); 10 days after second treatment (T31); and 10 days after third treatment (T52). Animals were evaluated by wire test for estimate strength and blood was collected to perform a creatinine phosphokinase analysis. After euthanasia, cranial tibial muscles were collected and submitted to histological and immunohistochemistry analyses. Treated groups presented improvement of strength and reduced creatinine phosphokinase levels. Also, a slight dystrophin increase was observed in tibial cranial muscle when aquapuncture was associated SHED. All therapies have minimized muscle degeneration, but the association of aquapuncture with SHED appears to have better effect, reducing muscle damage, suggesting a therapeutic value.
C1 [Zanatta Esper, Greyson Vitor; Pignatari, Graciela Conceicao; Rodrigues, Marcio Nogueira; Fernandes, Isabella Rodrigues; Baleeiro Beltrao-Braga, Patricia Cristina; Miglino, Maria Angelica] Univ Sao Paulo, Sch Vet Med, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, SP, Brazil.
   [Pignatari, Graciela Conceicao; Fernandes, Isabella Rodrigues; Baleeiro Beltrao-Braga, Patricia Cristina; Miglino, Maria Angelica] Ctr Cellular & Mol Studies & Therapy NETCEM, Sao Paulo, SP, Brazil.
   [Bertagnon, Heloisa Godoi] Univ Sao Paulo, Sch Vet Med, Clin Dept, BR-05508270 Sao Paulo, SP, Brazil.
   [Nascimento, Nanci] Ctr Biotechnol, Nucl & Energy Res Inst, BR-05508270 Sao Paulo, SP, Brazil.
   [Florencio Tabosa, Angela Maria] Univ Fed Sao Paulo, Div Chinese Med & Acupuncture, BR-04023900 Sao Paulo, SP, Brazil.
   [Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Obstet, Sch Arts Sci & Humanities, BR-03828000 Sao Paulo, SP, Brazil.
RP Pignatari, GC (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Surg, Stem Cell Lab, 87 Prof Dr Orlando Marques de Paiva Ave, BR-05508270 Sao Paulo, SP, Brazil.
EM grapignatari@yahoo.com.br
RI Miglino, Maria Angelica/B-9519-2012; Beltrao-Braga, Patricia C
   B/D-6450-2013
OI Miglino, Maria Angelica/0000-0003-4979-115X; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091
FU Department of Surgery, Anatomy of Wild and Domestic Animals Service;
   National Council of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP)
FX The authors are thankful to the Institute for Energy and Nuclear
   Research for the support regarding the obtaining of animals specially
   Maria Neide F. Mascarenhas, Cecilia S. Ferreira, and Ismaria S. Reis.
   They are also thankful to the Department of Surgery, Anatomy of Wild and
   Domestic Animals Service and National Council of Technological and
   Scientific Development (CNPq), and Sao Paulo Research Foundation
   (FAPESP) for the financial support.
CR Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235
   Burdi R, 2009, J APPL PHYSIOL, V106, P1311, DOI 10.1152/japplphysiol.90985.2008
   Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Chakkalakal JV, 2005, FASEB J, V19, P880, DOI 10.1096/fj.04-1956rev
   Chen CY, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/627342
   Choi DC, 2010, NEUROBIOL DIS, V39, P272, DOI 10.1016/j.nbd.2010.04.003
   Pinheiro CHD, 2012, STEM CELL REV REP, V8, P363, DOI 10.1007/s12015-011-9304-0
   De Luca A, 2008, NEUROBIOL DIS, V32, P243, DOI 10.1016/j.nbd.2008.07.009
   Flanigan KM, 2013, HUM GENE THER, V24, P797, DOI 10.1089/hum.2013.092
   Fujita R, 2015, STEM CELLS, V33, P962, DOI 10.1002/stem.1900
   Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870
   Hoffmann W. E., 1989, CLIN BIOCH DOMESTIC, P351
   Hubscher M, 2010, EUR J APPL PHYSIOL, V110, P353, DOI 10.1007/s00421-010-1510-y
   Ichim TE, 2010, CELL IMMUNOL, V260, P75, DOI 10.1016/j.cellimm.2009.10.006
   Ishkitiev N, 2012, J ENDODONT, V38, P475, DOI 10.1016/j.joen.2011.12.011
   Ishkitiev N, 2010, J ENDODONT, V36, P469, DOI 10.1016/j.joen.2009.12.022
   Jiang Y., 2009, N AM J MED SCI, V2, P32
   Kayali R, 2012, HUM MOL GENET, V21, P4007, DOI 10.1093/hmg/dds223
   Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35
   Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085
   Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013
   Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445
   Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985
   Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897
   Marx C, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/391274
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Noviello M, 2014, MOL THER, V22, P1342, DOI 10.1038/mt.2014.62
   Partridge TA, 2013, FEBS J, V280, P4177, DOI 10.1111/febs.12267
   PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355
   Phillips MF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004571.pub2
   Roemeling-van Rhijn Marieke, 2013, J Stem Cell Res Ther, VSuppl 6, P20780
   Sakai VT, 2010, J DENT RES, V89, P791, DOI 10.1177/0022034510368647
   Sharma A, 2014, AM J CASE REP, V15, P128, DOI 10.12659/AJCR.890078
   Sharma A, 2013, CELL TRANSPLANT, V22, pS127, DOI 10.3727/096368913X672136
   Sych N, 2014, J NEURORESTORATOLOGY, V2, P37, DOI 10.2147/JN.S57276
   TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043
   Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006
   Urtizberea JA, 2003, NEUROMUSCULAR DISORD, V13, P705, DOI 10.1016/S0960-8966(03)00116-0
   Vainzof M., 2005, NEUROSCIENCE, V13, P18
   van Putten M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031937
   Verhaert D, 2011, CIRC-CARDIOVASC IMAG, V4, P67, DOI 10.1161/CIRCIMAGING.110.960740
   Wang HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019790
   Whitehead NP, 2008, J PHYSIOL-LONDON, V586, P2003, DOI 10.1113/jphysiol.2007.148338
   Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015
   Yamaza T, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt5
   Yang JL, 2011, BRAIN BEHAV IMMUN, V25, P1452, DOI 10.1016/j.bbi.2011.05.012
   Zhang Cheng, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P399
NR 49
TC 0
Z9 0
U1 0
U2 9
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2015
VL 2015
AR 132706
DI 10.1155/2015/132706
PG 7
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA CJ9BY
UT WOS:000355798600001
PM 26074983
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Borbely, AU
   Sandri, S
   Fernandes, IR
   Prado, KM
   Cardoso, EC
   Correa-Silva, S
   Albuquerque, R
   Knofler, M
   Beltrao-Braga, P
   Campa, A
   Bevilacqua, E
AF Borbely, Alexandre U.
   Sandri, Silvana
   Fernandes, Isabella R.
   Prado, Karen M.
   Cardoso, Elaine C.
   Correa-Silva, Simone
   Albuquerque, Renata
   Knoefler, Martin
   Beltrao-Braga, Patricia
   Campa, Ana
   Bevilacqua, Estela
TI The term basal plate of the human placenta as a source of functional
   extravillous trophoblast cells
SO REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
LA English
DT Article
DE Basal plate; Cell isolation; Extravillous trophoblast cells;
   Invasiveness; Term placenta
ID IN-VITRO; HLA-G; EXTRACELLULAR-MATRIX; FLOW-CYTOMETRY; INVASION;
   DIFFERENTIATION; EXPRESSION; CYTOTROPHOBLAST; 1ST-TRIMESTER; PREGNANCY
AB Background: Extravillous trophoblast (EVT) cells are of pivotal importance in human embryo implantation and homeostasis of the maternal fetal interface. Invasion of the endometrium by EVT contributes to placental anchorage, spiral artery remodeling, immunological defense, tolerogenic responses, and several collaborative cross talks involved in establishing and maintaining a successful pregnancy. We report here an improved protocol for the isolation of fully differentiated EVT cells from the basal plate of the human term placenta.
   Methods: The basal plate was carefully dissected from the villous tissue and the amniochorion membrane prior to enzymatic digestion. Term basal EVT cells were isolated using a 30 and 60% Percoll gradient. A panel of markers and characteristics of the isolated cells were used to confirm the specificity and efficiency of the method so that their potential as an investigative tool for placental research could be ascertained.
   Results: Isolated cells were immunoreactive for cytokeratin-7 (CK-7), placental growth factor, placental alkaline phosphatase, human leukocyte antigen G1 (HLA-G1), and alpha 1 and alpha 5 integrins, similarly to the EVT markers from first trimester placental villi. Around 95% of the isolated cells labeled positively for CK-7 and 82% for HLA-G1. No significant change in viability was observed during 48 h of EVT culture as indicated by propidium iodide incorporation and trypan blue test exclusion. Genes for metalloproteinases MMP-2 and MMP9 (positive regulators of trophoblast invasiveness) were expressed up to 48 h of culturing, as also the gelatinolytic activity of the isolated cells. Transforming growth factor (TGF)-beta, which inhibits proliferation, migration, and invasiveness of first-trimester EVT cells, also reduced invasion of isolated term EVT cells in transwell assays, whereas epidermal growth factor was a positive modulator.
   Conclusions: Term basal plate may be a viable source of functional EVT cells that is an alternative to villous explant-derived EVT cells and cell lines. Isolated term EVT cells may be particularly useful in investigation of the role of trophoblast cells in pathological gestations, in which the precise regulation and interactive ability of extravillous trophoblast has been impaired.
C1 [Borbely, Alexandre U.; Prado, Karen M.; Cardoso, Elaine C.; Correa-Silva, Simone; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508000 Sao Paulo, Brazil.
   [Sandri, Silvana; Albuquerque, Renata; Campa, Ana] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin Chem, BR-05508000 Sao Paulo, Brazil.
   [Fernandes, Isabella R.; Beltrao-Braga, Patricia] Univ Sao Paulo, Vet Med & Zootechnol Sch, Dept Surg, BR-05508000 Sao Paulo, Brazil.
   [Knoefler, Martin] Med Univ Vienna, Dept Obstet & Fetal Maternal Med, Reprod Biol Unit, A-1090 Vienna, Austria.
   [Beltrao-Braga, Patricia] Univ Sao Paulo, Sch Arts Sci & Humanities, BR-03828000 Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508000 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Beltrao-Braga, Patricia C B/D-6450-2013; Borbely, Alexandre
   U/A-6649-2013; Campa, Ana/D-4669-2012; Sandri, Silvana/A-1650-2015;
   Borbely, Alexandre Urban/Q-2884-2019; Bevilacqua, Estela/H-3354-2011
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Campa,
   Ana/0000-0002-6183-3378; Borbely, Alexandre Urban/0000-0001-6737-0901;
   Bevilacqua, Estela/0000-0003-4178-4625
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2009/05354-0, 2013/12243-5];
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [140088/2010-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [4178-11-4]; Austrian Science FundsAustrian Science Fund
   (FWF) [P-22687-B13]
FX This study was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo [grant no. 2009/05354-0; 2013/12243-5]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [grant no. 140088/2010-5];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [grant no.
   4178-11-4] and the Austrian Science Funds [grant number P-22687-B13]. We
   thank Rosangela Augusto de Oliveira Farias and Katarzyna Biadasiewicz
   for essential assistance with in vitro preparations in Brazil and
   Austria, respectively; to Karen Steponavicius Cruz for assistance with
   invasion assays and flow cytometry analysis; and to Renato Massaro and
   professor Silvya Stuchi Maria-Engler for support with zymography assays.
   We also thank professors Sergio Ferreira de Oliveira and Ruy Gastaldoni
   Jaeger for donating some antibodies and for the use of their
   laboratories.
CR Altieri A, 2003, LANCET ONCOL, V4, P670, DOI 10.1016/S1470-2045(03)01245-2
   Aplin JD, 1999, BIOL REPROD, V60, P828, DOI 10.1095/biolreprod60.4.828
   APLIN JD, 1993, PLACENTA, V14, P203, DOI 10.1016/S0143-4004(05)80261-9
   BEHAM A, 1988, PLACENTA, V9, P479, DOI 10.1016/0143-4004(88)90020-3
   Biadasiewicz K, 2011, ENDOCRINOLOGY, V152, P1458, DOI 10.1210/en.2010-0936
   Bischof P, 2001, ANN NY ACAD SCI, V943, P157, DOI 10.1111/j.1749-6632.2001.tb03799.x
   Borbely A, 2013, HISTOPATHOLOGY, DOI [10.1111/his.12304, DOI 10.1111/HIS.12304.[]
   Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380
   Caniggia I, 1997, ENDOCRINOLOGY, V138, P4977, DOI 10.1210/en.138.11.4977
   Choy MY, 1998, HUM REPROD, V13, P2941, DOI 10.1093/humrep/13.10.2941
   Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318
   DAMSKY CH, 1994, DEVELOPMENT, V120, P3657
   ELLIS SA, 1986, IMMUNOLOGY, V59, P595
   FISHER SJ, 1989, J CELL BIOL, V109, P891, DOI 10.1083/jcb.109.2.891
   Frank HG, 2001, PLACENTA, V22, pS107, DOI 10.1053/plac.2001.0644
   Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546
   Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038
   Harris LK, 2009, PLACENTA, V30, P299, DOI 10.1016/j.placenta.2008.12.003
   Kemp B, 2002, HISTOCHEM CELL BIOL, V117, P401, DOI 10.1007/s00418-002-0396-0
   Khaliq A, 1996, GROWTH FACTORS, V13, P579
   KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567
   KLIMAN HJ, 1990, P NATL ACAD SCI USA, V87, P3057, DOI 10.1073/pnas.87.8.3057
   KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636
   Kumpel BM, 2012, VOX SANG, V102, P2, DOI 10.1111/j.1423-0410.2011.01533.x
   Le Bouteiller P, 1999, IMMUNOL REV, V167, P233
   Leitner K, 2001, J HISTOCHEM CYTOCHEM, V49, P1155, DOI 10.1177/002215540104900909
   LOKE YW, 1988, PLACENTA, V9, P173, DOI 10.1016/0143-4004(88)90015-X
   Loregger T, 2003, PLACENTA, V24, pS104, DOI 10.1053/plac.2002.0929
   Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109
   MCMASTER MT, 1995, J IMMUNOL, V154, P3771
   Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002
   MUHLHAUSER J, 1995, J HISTOCHEM CYTOCHEM, V43, P579, DOI 10.1177/43.6.7539466
   Oki N, 2004, J CLIN ENDOCR METAB, V89, P5213, DOI 10.1210/jc.2004-0352
   Orendi K, 2011, PLACENTA, V32, pS49, DOI 10.1016/j.placenta.2010.11.023
   Pollheimer J, 2011, ENDOCRINOLOGY, V152, P4431, DOI 10.1210/en.2011-1196
   Potgens AJG, 2001, PLACENTA, V22, P251, DOI 10.1053/plac.2000.0597
   Quenby S, 2005, FERTIL STERIL, V83, P691, DOI 10.1016/j.fertnstert.2004.07.978
   SHORTER SC, 1990, PLACENTA, V11, P505, DOI 10.1016/S0143-4004(05)80196-1
   Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5
   Stenqvist AC, 2008, AM J REPROD IMMUNOL, V60, P33, DOI 10.1111/j.1600-0897.2008.00588.x
   Talaulikar VS, 2014, J OBSTET GYNAECOL RE, V40, P80, DOI 10.1111/jog.12127
   Tarrade A, 2001, LAB INVEST, V81, P1199, DOI 10.1038/labinvest.3780334
   von Rango U, 2003, PLACENTA, V24, P929, DOI 10.1016/S0143-4004(03)00168-1
   Vuorela P, 1997, BIOL REPROD, V56, P489, DOI 10.1095/biolreprod56.2.489
   Wu HX, 2010, HUM REPROD, V25, P1146, DOI 10.1093/humrep/deq051
NR 45
TC 17
Z9 21
U1 0
U2 15
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-7827
J9 REPROD BIOL ENDOCRIN
JI Reprod. Biol. Endocrinol.
PD JAN 28
PY 2014
VL 12
AR 7
DI 10.1186/1477-7827-12-7
PG 12
WC Endocrinology & Metabolism; Reproductive Biology
SC Endocrinology & Metabolism; Reproductive Biology
GA AB2QN
UT WOS:000331637300001
PM 24467708
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Beltrao-Braga, PCB
   Pignatari, GC
   Russo, FB
   Fernandes, IR
   Muotri, AR
AF Beltrao-Braga, P. C. B.
   Pignatari, G. C.
   Russo, F. B.
   Fernandes, I. R.
   Muotri, A. R.
TI In-a-Dish: Induced Pluripotent Stem Cells as a Novel Model for Human
   Diseases
SO CYTOMETRY PART A
LA English
DT Review
DE induced pluripotent stem cell; disease modeling; reprogramming;
   neurological diseases
ID HUMAN FIBROBLASTS; GENE-EXPRESSION; IPS CELLS; GENERATION; LINES; OCT4;
   NANOG; MOUSE; DIFFERENTIATION; DERIVATION
AB Human pluripotent stem cells bring promise in regenerative medicine due to their self-renewing ability and the potential to become any cell type in the body. Moreover, pluripotent stem cells can produce specialized cell types that are affected in certain diseases, generating a new way to study cellular and molecular mechanisms involved in the disease pathology under the controlled conditions of a scientific laboratory. Thus, induced pluripotent stem cells (iPSC) are already being used to gain insights into the biological mechanisms of several human disorders. Here we review the use of iPSC as a novel tool for disease modeling in the lab. (C) 2012 International Society for Advancement of Cytometry
C1 [Beltrao-Braga, P. C. B.; Pignatari, G. C.; Russo, F. B.; Fernandes, I. R.; Muotri, A. R.] Univ Sao Paulo, Surg Dept, Stem Cell Lab, Sch Vet Med, Sao Paulo, Brazil.
   [Beltrao-Braga, P. C. B.] Univ Sao Paulo, Obstet Dept, Sch Arts Sci & Humanities, Sao Paulo, Brazil.
   [Muotri, A. R.] Univ Calif San Diego, Dept Pediat, Rady Childrens Hosp San Diego, Sch Med,Stem Cell Program, La Jolla, CA 92093 USA.
   [Muotri, A. R.] Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, Stem Cell Program, La Jolla, CA 92093 USA.
RP Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Surg Dept, Stem Cell Lab, Sch Vet Med, Sao Paulo, Brazil.
EM patriciacbbbraga@usp.br
RI Beltrao-Braga, Patricia C B/D-6450-2013; Russo, Fabiele/N-4340-2017
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Russo,
   Fabiele/0000-0002-4076-1846
CR Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503
   Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318
   Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792
   Amenduni M, 2011, EUR J HUM GENET, V19, P1246, DOI 10.1038/ejhg.2011.131
   Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503
   Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235
   Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073
   Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020
   Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915
   Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0
   Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005
   Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107
   Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580
   Chang T, 2011, STEM CELLS, V29, P2090, DOI 10.1002/stem.749
   Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019
   Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008
   Colman A, 2009, EMBO REP, V10, P714, DOI 10.1038/embor.2009.142
   Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502
   DeRosa BA, 2012, NEUROSCI LETT, V516, P9, DOI 10.1016/j.neulet.2012.02.086
   Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799
   Donnenberg AD, 2007, CLIN LAB MED, V27, P627, DOI 10.1016/j.cll.2007.05.013
   Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677
   Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003
   Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975
   Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937
   Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080
   GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622
   Heins N, 2006, J BIOTECHNOL, V122, P511, DOI 10.1016/j.jbiotec.2005.10.010
   Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329
   Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38
   Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747
   Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698
   Jin ZB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017084
   Kang NY, 2011, NAT PROTOC, V6, P1044, DOI 10.1038/nprot.2011.350
   Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014
   Lahti AL, 2012, DIS MODEL MECH, V5, P220, DOI 10.1242/dmm.008409
   Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320
   Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211
   Looijenga LHJ, 2003, CANCER RES, V63, P2244
   Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105
   Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106
   Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014
   Manos P.D, 2011, CURR PROTOC STEM CEL
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076
   Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056
   Montserrat N, 2012, J BIOL CHEM, V287, P24131, DOI 10.1074/jbc.M112.350413
   Mou XN, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt105
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003
   Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041
   Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576
   Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S
   Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271
   Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]
   Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122
   Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129
   Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399
   Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018
   Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200
   ROGERS MB, 1991, DEVELOPMENT, V113, P815
   Schopperle WM, 2007, STEM CELLS, V25, P723, DOI 10.1634/stemcells.2005-0597
   Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013
   Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001
   Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005
   Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108
   Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016
   Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944
   Yahata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025788
   Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034
   Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252
NR 77
TC 14
Z9 15
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4922
EI 1552-4930
J9 CYTOM PART A
JI Cytom. Part A
PD JAN
PY 2013
VL 83A
IS 1
SI SI
BP 11
EP 17
DI 10.1002/cyto.a.22231
PG 7
WC Biochemical Research Methods; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 079KF
UT WOS:000314168300004
PM 23281003
OA Green Published
DA 2020-12-01
ER

PT J
AU Franciolli, AL
   Pignatari, G
   Fratini, P
   Alcantara, D
   Fernandes, I
   Russo, F
   Rodrigues, M
   Beltrao-Braga, P
   Miglino, MA
AF Franciolli, Andre Luis
   Pignatari, Graciela
   Fratini, Paula
   Alcantara, Dayane
   Fernandes, Isabella
   Russo, Fabiele
   Rodrigues, Marcio
   Beltrao-Braga, Patricia
   Miglino, Maria Angelica
TI ISOLATION AND CHARACTERIZATION OF CELLS OF THE YOLK SAC AND EQUINE
   AMNIOTIC MEMBRANE AS A SOURCE FOR CELLULAR THERAPY
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 18-21, 2012
CL Hiroshima, JAPAN
SP Int Federat Placenta Assoc (IFPA)
C1 [Franciolli, Andre Luis; Pignatari, Graciela; Fratini, Paula; Alcantara, Dayane; Fernandes, Isabella; Russo, Fabiele; Rodrigues, Marcio; Beltrao-Braga, Patricia; Miglino, Maria Angelica] Univ Sao Paulo FMVZ, Sao Paulo, Brazil.
RI Fratini, Paula/C-4084-2014; Beltrao-Braga, Patricia C B/D-6450-2013;
   ALCANTARA, DAYANE/B-4138-2016; Franciolli, Andre Luis/K-6739-2012;
   Miglino, Maria Angelica/B-9519-2012
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; ALCANTARA,
   DAYANE/0000-0003-4932-8245; Franciolli, Andre Luis/0000-0002-1127-9129;
   Miglino, Maria Angelica/0000-0003-4979-115X
NR 0
TC 0
Z9 0
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2012
VL 33
IS 9
BP A57
EP A57
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 007NV
UT WOS:000308896300126
DA 2020-12-01
ER

PT J
AU Lima, SAF
   Wodewotzky, TI
   Lima-Neto, JF
   Beltrao-Braga, PCB
   Alvarenga, FCL
AF Lima, Silvia A. F.
   Wodewotzky, Thaila I.
   Lima-Neto, Joao F.
   Beltrao-Braga, Patricia C. B.
   Alvarenga, Fernanda C. L.
TI In vitro differentiation of mesenchimal stem cells of dogs into
   osteogenic precursors
SO PESQUISA VETERINARIA BRASILEIRA
LA Portuguese
DT Article
DE Mesenchymal stem cell; osteogenic differentiation; dog
ID BONE-MARROW; ASCORBIC-ACID; STROMAL CELLS; OSTEOBLAST; SUBSETS
AB Lima S.A.F., Wodewotzky T.I., Lima-Neto J.F., Beltrao-Braga P.C.B. & Alvarenga F.C.L. 2012. [In vitro differentiation of mesenchimal stem cells of dogs into osteogenic precursors.] Diferenciacao in vitro de celulas-tronco mesenquimais da medula ossea de caes em precursores osteogenicos. Pesquisa Veterinaria Brasileira 32(5):463-469. Departamento de Reproducao Animal e Radiologia Veterinaria, Faculdade de Medicina Veterinaria e Zootecnia, Universidade Estadual Paulista, Campus de Botucatu, Distrito de Rubiao Junior s/n, Botucatu, SP 18618-970, Brazil. E-mail: silviavet@usp.br
   The aim of our research was to evaluate the potential for osteogenic differentiation of mesenchimal stem cells (MSC) obtained from dog bone marrow. The MSC were separated using the Ficoll method and cultured under two different conditions: DMEM low glucose or DMEM/F12, both containing L-glutamine, 20% of FBS and antibiotics. MSC markers were tested, confirming CD44+ and CD34- cells with flow cytometry. For osteogenic differentiation, cells were submitted to four different conditions: Group 1, same conditions used for primary cell culture with DMEM supplemented media; Group 2, same conditions of Group 1 plus differentiation inductors Dexametazone, ascorbic acid and beta-glicerolphosphate. Group 3, Cells cultured with supplemented DMEM/F12 media, and Group 4, same conditions as in Group 3 plus differentiation inductors Dexametazone, ascorbic acid and beta-glicerolphosphate. The cellular differentiation was confirmed using alizarin red and imunostaining with SP7/Osterix antibody. We observed by alizarin staining that calcium deposit was more evident in cells cultivated in DMEM/F12. Furthermore, by SP/7Osterix antibody immunostaining we obtained 1:6 positive cells when using DMEM/F12 compared with 1:12 for low-glucose DMEM. Based on our results, we conclude that the medium DMEM/F12 is more efficient for induction of differentiation of mesenchymal stem cells in canine osteogenic progenitors. This effect is probably due to the greater amount of glucose in the medium and the presence of various amino acids.
C1 [Lima, Silvia A. F.; Wodewotzky, Thaila I.; Lima-Neto, Joao F.; Alvarenga, Fernanda C. L.] Univ Estadual Paulista Unesp, Fac Med Vet & Zootecnia, Dept Reprod Anim & Radiol Vet, BR-18618970 Botucatu, SP, Brazil.
   [Lima, Silvia A. F.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Setor Anat Anim Domest & Silvestres, Dept Cirurgia, BR-05508270 Sao Paulo, Brazil.
RP Lima, SAF (corresponding author), Univ Estadual Paulista Unesp, Fac Med Vet & Zootecnia, Dept Reprod Anim & Radiol Vet, Campus Botucatu,Dist Rubiao Jr S-N, BR-18618970 Botucatu, SP, Brazil.
EM safl_001@hotmail.com
RI Wodewotzky, Thaila/K-4303-2013; Beltrao-Braga, Patricia C B/D-6450-2013
OI Wodewotzky, Thaila/0000-0003-1736-8365; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091
CR ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   Beloti Márcio Mateus, 2005, Braz. Dent. J., V16, P156, DOI 10.1590/S0103-64402005000200013
   Boo JS, 2002, J CRANIOFAC SURG, V13, P231, DOI 10.1097/00001665-200203000-00009
   Brolio MP, 2012, MICROSC RES TECHNIQ, V75, P766, DOI 10.1002/jemt.21123
   Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68
   Bruno B, 1999, TRANSPLANTATION, V68, P338, DOI 10.1097/00007890-199908150-00004
   Bruno B, 2001, BIOL BLOOD MARROW TR, V7, P543, DOI 10.1016/S1083-8791(01)70020-1
   CHUNG CH, 1992, CALCIFIED TISSUE INT, V51, P305, DOI 10.1007/BF00334492
   Conrad C, 2005, J SURG RES, V124, P201, DOI 10.1016/j.jss.2004.09.015
   Cooper MS, 1999, J ENDOCRINOL, V163, P159, DOI 10.1677/joe.0.1630159
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Ducy P, 1998, CURR OPIN CELL BIOL, V10, P614, DOI 10.1016/S0955-0674(98)80037-9
   Faldyna M, 2001, VET IMMUNOL IMMUNOP, V82, P23, DOI 10.1016/S0165-2427(01)00337-3
   Hartnett BJ, 2002, BIOL BLOOD MARROW TR, V8, P188, DOI 10.1053/bbmt.2002.v8.pm12014808
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   McSweeney PA, 1998, BLOOD, V91, P1977, DOI 10.1182/blood.V91.6.1977.1977_1977_1986
   Nakage Ana Paula Massae, 2005, Cienc. Rural, V35, P377, DOI 10.1590/S0103-84782005000200020
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Otsuka E, 2000, ENDOCRINOLOGY, V141, P3006, DOI 10.1210/en.141.8.3006
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Ramoshebi Lentsha N, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004969
   Sutherland DR, 1996, EXP HEMATOL, V24, P795
   Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030
   Wenceslau CV, 2011, TISSUE ENG PT A, V17, P2165, DOI [10.1089/ten.tea.2010.0678, 10.1089/ten.TEA.2010.0678]
   Wu X., 2009, INT J CELL CULTURE B, DOI DOI 10.1007/S10616-009-9200-5
   Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103
   Zucconi E, 2010, STEM CELLS DEV, V19, P395, DOI 10.1089/scd.2008.0314
NR 31
TC 3
Z9 3
U1 0
U2 9
PU REVISTA PESQUISA VETERINARIA BRASILEIRA
PI RIO JANEIRO
PA EMBRAPA-SAUDE ANIMAL, KM47 SEROPEDICA, 23851-970 RIO JANEIRO, BRAZIL
SN 0100-736X
EI 1678-5150
J9 PESQUI VET BRASIL
JI Pesqui. Vet. Bras.
PD MAY
PY 2012
VL 32
IS 5
BP 463
EP 469
DI 10.1590/S0100-736X2012000500016
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA 959CH
UT WOS:000305287600016
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Fernandes, I
   Russo, F
   Pignatari, G
   Borbely, A
   Sandri, S
   Miglino, M
   Bevilacqua, E
   Beltrao-Braga, P
AF Fernandes, Isabella
   Russo, Fabiele
   Pignatari, Graciela
   Borbely, Alexandre
   Sandri, Silvana
   Miglino, Maria
   Bevilacqua, Estela
   Beltrao-Braga, Patricia
TI EXTRAVILLOUS TROPHOBLAST (EVT) FROM HUMAN TERM PLACENTA MAY NOT BE GOOD
   CANDIDATES FOR USING IN CELL THERAPY PROTOCOLS
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 14-17, 2011
CL Geilo, NORWAY
SP Int Federat Placenta Assoc
C1 [Fernandes, Isabella; Russo, Fabiele; Pignatari, Graciela; Miglino, Maria; Beltrao-Braga, Patricia] Univ Sao Paulo, Dept Surg FMVZ, Stem Cell Lab, BR-09500900 Sao Paulo, Brazil.
   [Fernandes, Isabella; Russo, Fabiele; Pignatari, Graciela; Miglino, Maria; Beltrao-Braga, Patricia] Natl Inst Stem Cell INCT, Ribeirao Preto, Sao Paulo, Brazil.
   [Borbely, Alexandre; Sandri, Silvana; Bevilacqua, Estela] Univ Sao Paulo, Dept Cell & Dev Biol ICBI, Trophoblast Res Lab, BR-09500900 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-09500900 Sao Paulo, Brazil.
RI Miglino, Maria Angelica/B-9519-2012; Beltrao-Braga, Patricia C
   B/D-6450-2013; Sandri, Silvana/A-1650-2015; Borbely,
   Alexandre/G-4859-2012
OI Miglino, Maria Angelica/0000-0003-4979-115X; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; 
NR 0
TC 0
Z9 0
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2011
VL 32
IS 9
BP A65
EP A65
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 822TJ
UT WOS:000295072200155
DA 2020-12-01
ER

PT J
AU Beltrao-Braga, PCB
   Pignatari, GC
   Maiorka, PC
   Oliveira, NAJ
   Lizier, NF
   Wenceslau, CV
   Miglino, MA
   Muotri, AR
   Kerkis, I
AF Beltrao-Braga, Patricia C. B.
   Pignatari, Graciela C.
   Maiorka, Paulo C.
   Oliveira, Nelio A. J.
   Lizier, Nelson F.
   Wenceslau, Cristiane V.
   Miglino, Maria A.
   Muotri, Alysson R.
   Kerkis, Irina
TI Feeder-Free Derivation of Induced Pluripotent Stem Cells From Human
   Immature Dental Pulp Stem Cells
SO CELL TRANSPLANTATION
LA English
DT Article
DE Induced pluripotent stem cells (iPSCs); Pediatric diseases; Human
   immature dental pulp stem cells (hIDPSCs); Reprogramming
ID HUMAN FIBROBLASTS; IN-VITRO; GENERATION; TRANSPLANTATION; INDUCTION;
   TERATOMAS
AB Induced pluripotent stem cells (iPSCs) can be created by forcing expression of certain genes in fibroblasts or other somatic cell types, reversing them to a pluripotent state similar to that of embryonic stem cells (ESC). Here, we used human immature dental pulp stem cells (hIDPSCs) as an alternative source for creating iPSC. hIDPSCs can be easily isolated from accessible tissue of young and adult patients. hIDPSCs possess a fibroblast-like morphology, retaining characteristics of adult multipotent stem cells. Reprogramming of hIDPSCs was fast, producing primary hIDPSC-iPSC colonies even under feeder-free conditions. hIDPSCs acquired ESC-like morphology, expressed pluripotent markers, possessed stable, normal karyotypes, and demonstrated the ability to differentiated in vitro and in vivo. Our data demonstrate that hIDPSCs-iPSCs offer an advantageous cell system for future cell therapy and basic studies, particularly as a model for pediatric developmental disorders.
C1 [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, Brazil.
   [Beltrao-Braga, Patricia C. B.; Pignatari, Graciela C.; Maiorka, Paulo C.; Wenceslau, Cristiane V.; Miglino, Maria A.] Univ Sao Paulo, Fac Vet Med, Dept Surg, BR-03828000 Sao Paulo, Brazil.
   [Beltrao-Braga, Patricia C. B.; Pignatari, Graciela C.; Maiorka, Paulo C.; Wenceslau, Cristiane V.; Miglino, Maria A.] Univ Sao Paulo, Dept Pathol, BR-03828000 Sao Paulo, Brazil.
   [Beltrao-Braga, Patricia C. B.; Pignatari, Graciela C.; Lizier, Nelson F.; Wenceslau, Cristiane V.; Miglino, Maria A.; Kerkis, Irina] Natl Inst Sci & Technol Stem Cell & Cell Therapy, Ribeirao Preto, Brazil.
   [Oliveira, Nelio A. J.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Pediat,Stem Cell Program, Rady Childrens Hosp San Diego,Dept Cell & Mol Med, La Jolla, CA 92093 USA.
   [Lizier, Nelson F.; Kerkis, Irina] Butantan Inst, Genet Lab, Sao Paulo, Brazil.
RP Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, 1000 Arlindo Bettio Av, BR-03828000 Sao Paulo, Brazil.
EM patriciacbbbraga@usp.br; muotri@ucsd.edu
RI Miglino, Maria Angelica/B-9519-2012; Oliveira, Nelio/D-8838-2012;
   Kerkis, Irina/AAD-1006-2019; Beltrao-Braga, Patricia C B/D-6450-2013
OI Miglino, Maria Angelica/0000-0003-4979-115X; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [09/51180-3]; CNPqNational Council for Scientific and Technological
   Development (CNPq); National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [1-DP2-OD006495-01]
FX We would like to thank Isabella R. Fernandes, Fabiele B. Russo, Flavia
   G. Gomes, Caroline P. Winck, Janaina M. Monteiro, Cicera M. Gomes,
   Enrico J. C. Santos for technical support, Dr. Alexandre Kerkis for
   discussion, Alexsander Seixas de Souza for his technical assistance with
   confocal microscopy, and Kristin Rauscher for editorial comments. This
   work was supported by FAPESP personal grant (09/51180-3), CNPq, and by
   the National Institutes of Health through the NIH Director's New
   Innovator Award Program, 1-DP2-OD006495-01 (A.R.M.). The hiPSC
   derivation and characterization was performed in Brazil, after a
   training period of Brazilian researches with Dr. Muotri's laboratory in
   San Diego. The authors declare no conflict of interest.
CR Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503
   Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884
   Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844
   Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005
   Cooke MJ, 2006, STEM CELLS DEV, V15, P254, DOI 10.1089/scd.2006.15.254
   Costa AD, 2008, J CRANIOFAC SURG, V19, P204, DOI 10.1097/scs.0b013e31815c8a54
   Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502
   Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317
   Gomes J., 2009, INVEST OPHTH VIS SCI, V51, P1408
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028
   Huang AHC, 2008, J ORAL PATHOL MED, V37, P571, DOI 10.1111/j.1600-0714.2008.00654.x
   Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617
   Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35
   Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061
   Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023
   Kishi Y, 2008, CELL TRANSPLANT, V17, P1095, DOI 10.3727/096368908786991560
   Li H., 2009, NATURE, V460, P1085
   Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800
   Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Muotri AR, 2002, CARCINOGENESIS, V23, P1039, DOI 10.1093/carcin/23.6.1039
   Nam H, 2009, BIOCHEM BIOPH RES CO, V386, P135, DOI 10.1016/j.bbrc.2009.05.141
   Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P111, DOI 10.3727/000000008783907125
   Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]
   da Fonseca SAS, 2009, CELL PROLIFERAT, V42, P132, DOI 10.1111/j.1365-2184.2008.00578.x
   Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takenaka C, 2010, EXP HEMATOL, V38, P154, DOI 10.1016/j.exphem.2009.11.003
   Torrente Y, 2008, CELL TRANSPLANT, V17, P1103, DOI 10.3727/096368908787236576
   Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034
   Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314
   Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406
NR 37
TC 60
Z9 63
U1 0
U2 19
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2011
VL 20
IS 11-12
BP 1707
EP 1719
DI 10.3727/096368911X566235
PG 13
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 901JE
UT WOS:000300962400004
PM 21457612
OA Green Published
DA 2020-12-01
ER

PT J
AU Feitosa, MLT
   Fadel, L
   Beltrao-Braga, PCB
   Wenceslau, CV
   Kerkis, I
   Kerkis, A
   Birgel, EH
   Martins, JFP
   Martins, DD
   Miglino, MA
   Ambrosio, CE
AF Tajra Feitosa, Matheus Levi
   Fadel, Leandro
   Beltrao-Braga, Patricia Cristina Baleeiro
   Wenceslau, Cristiane Valverde
   Kerkis, Irina
   Kerkis, Alexandre
   Birgel Junior, Eduardo Harry
   Panattoni Martins, Joao Flavio
   Martins, Daniele dos Santos
   Miglino, Maria Angelica
   Ambrosio, Carlos Eduardo
TI Successful transplant of mesenchymal stem cells in induced osteonecrosis
   of the ovine femoral head. Preliminary results
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE Hip Joint; Stem Cells; Femur Head; Sheep
ID BONE-MARROW-CELLS; CORE DECOMPRESSION; MENINGOMYELOCELE; IMPLANTATION;
   NECROSIS; THERAPY; TISSUES; DEFECT; FETUS; MODEL
AB Purpose: Evaluate the bone tissue recovery following transplantation of ovine mesenchymal stem cells (MSC) from bone marrow and human immature dental-pulp stem cells (hIDPSC) in ovine model of induced osteonecrosis of femoral head (ONFH). Methods: Eight sheep were divided in three experimental groups. First group was composed by four animals with ONFH induced by ethanol through central decompression (CD), for control group without any treatment. The second and third group were compose by two animals, six weeks after ONFH induction received transplantation of heterologous ovine MSC (CD + oMSC), and hIDPSC (CD + hIDPSC), respectively. In both experiments the cells were transplanted without application of any type of immunosupression protocol. Results: Our data indicate that both cell types used in experiments were able to proliferate within injured site providing bone tissue recovery. The histological results obtained from CD+hIDPSC suggested that the bone regeneration in such animals was better than that observed in CD animals. Conclusion: Mesenchymal stem cell transplant in induced ovine osteonecrosis of femoral head by central decompression technique is safe, and apparently favors bone regeneration of damaged tissues.
C1 Univ Sao Paulo, Postgrad Program Anat Domest & Wild Anim, Dept Vet Surg, Fac Vet Med & Anim Sci, BR-05508 Sao Paulo, Brazil.
RP Feitosa, MLT (corresponding author), Cid Univ Armando de Salles Oliveira, Setor Anat, Av Prof Dr Orlando Marques de Paiva 87, BR-05508000 Sao Paulo, Brazil.
EM mtajra@gmail.com
RI Miglino, Maria Angelica/B-9519-2012; Beltrao-Braga, Patricia C
   B/D-6450-2013; Kerkis, Irina/AAD-1006-2019; Junior, Eduardo Harry
   Birgel/F-2765-2012; Ambrosio, Carlos Eduardo/F-3402-2010; Feitosa,
   Matheus/J-5528-2014; Junior, Eduardo Harry Birgel/N-9298-2016; dos
   Santos Martins, Daniele/C-9004-2013
OI Miglino, Maria Angelica/0000-0003-4979-115X; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; Junior, Eduardo Harry Birgel/0000-0002-9079-0549;
   Ambrosio, Carlos Eduardo/0000-0002-8224-5022; Feitosa,
   Matheus/0000-0002-9247-8532; Junior, Eduardo Harry
   Birgel/0000-0002-9079-0549; dos Santos Martins,
   Daniele/0000-0002-6277-4664
FU FAPESP/CNPqNational Council for Scientific and Technological Development
   (CNPq)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX Financial source: FAPESP/CNPq
CR Abou-Jamra RC, 2009, ACTA CIR BRAS, V24, P239, DOI 10.1590/S0102-86502009000300014
   Boss JH, 2003, VET PATHOL, V40, P345, DOI 10.1354/vp.40-4-345
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Cerqueira A, 2007, ACTA CIR BRAS, V22, P92, DOI 10.1590/S0102-86502007000200003
   d'Aquino R, 2008, STEM CELL REV, V4, P21, DOI 10.1007/s12015-008-9013-5
   Daltro Gildásio Cerqueira, 2008, Acta ortop. bras., V16, P23, DOI 10.1590/S1413-78522008000100004
   FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3
   Gangji V, 2007, BONE, V40, pS46, DOI 10.1016/j.bone.2007.04.050
   Gangji V, 2005, EXPERT OPIN BIOL TH, V5, P437, DOI 10.1517/14712598.5.4.437
   Gangji V, 2004, J BONE JOINT SURG AM, V86A, P1153, DOI 10.2106/00004623-200406000-00006
   Gomes J., 2009, INVEST OPHTH VIS SCI, V51, P1408
   Hannouche D, 2007, J HISTOCHEM CYTOCHEM, V55, P255, DOI 10.1369/jhc.6A7063.2006
   Hassan HT, 2004, J ROY SOC MED, V97, P465, DOI 10.1258/jrsm.97.10.465
   Hernigou P, 1999, J BONE JOINT SURG BR, V81B, P349, DOI 10.1302/0301-620X.81B2.8818
   Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617
   Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35
   Kim Seok-Jung, 2008, J Med Case Rep, V2, P58, DOI 10.1186/1752-1947-2-58
   Kirker-Head CA, 1998, CLIN ORTHOP RELAT R, P205, DOI 10.1097/00003086-199804000-00026
   Pedreiral DAL, 2007, ACTA CIR BRAS, V22, P168, DOI 10.1590/S0102-86502007000300003
   Magnussen RA, 2005, J BONE JOINT SURG AM, V87A, P1272, DOI 10.2106/JBJS.D.01936
   Manggold J, 2002, LAB ANIM-UK, V36, P173, DOI 10.1258/0023677021912460
   Marciniak D, 2005, J BONE JOINT SURG AM, V87A, P742, DOI 10.2106/JBJS.D.02004
   Monteiro BG, 2009, CELL PROLIFERAT, V42, P587, DOI 10.1111/j.1365-2184.2009.00623.x
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Oliveira RDSE, 2007, ACTA CIR BRAS, V22, P174, DOI 10.1590/S0102-86502007000300004
   da Fonseca SAS, 2009, CELL PROLIFERAT, V42, P132, DOI 10.1111/j.1365-2184.2008.00578.x
   Wang CJ, 2005, J BONE JOINT SURG AM, V87A, P2380, DOI 10.2106/JBJS.E.00174
   Yoon TR, 2001, INT ORTHOP, V24, P316, DOI 10.1007/s002640000186
NR 28
TC 30
Z9 39
U1 2
U2 14
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD OCT 10
PY 2010
VL 25
IS 5
BP 416
EP 422
DI 10.1590/S0102-86502010000500006
PG 7
WC Surgery
SC Surgery
GA 655CF
UT WOS:000282219500006
PM 20877951
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Fadel, L
   Feitosa, MLT
   Wenceslau, CV
   Beltrao-Braga, PCB
   Birgel, EH
   Panattoni, JF
   Miglino, MA
   Ambrosio, CE
AF Fadel, L.
   Feitosa, M. L. Tajra
   Wenceslau, C. V.
   Beltrao-Braga, P. C. B.
   Birgel Junior, E. H.
   Panattoni, J. F.
   Miglino, M. A.
   Ambrosio, C. E.
TI Ex Vivo Ovine Umbilical Cord Blood Isolation of Mesenchymal Stem Cells
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 3rd Congress on Regenerative Biology and Medicine/3rd Congress of the
   German-Society-for-Stem-Cell-Research
CY OCT 09-11, 2008
CL Stuttgart, GERMANY
SP German Soc Stem Cell Res
C1 [Fadel, L.; Feitosa, M. L. Tajra; Wenceslau, C. V.; Birgel Junior, E. H.; Miglino, M. A.; Ambrosio, C. E.] Univ Sao Paulo, Fac Vet Med & Anim Sci, BR-05508 Sao Paulo, Brazil.
   [Beltrao-Braga, P. C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, BR-05508 Sao Paulo, Brazil.
RI Feitosa, Matheus/J-5528-2014; Beltrao-Braga, Patricia C B/D-6450-2013;
   Junior, Eduardo Harry Birgel/F-2765-2012; Junior, Eduardo Harry
   Birgel/N-9298-2016; Ambrosio, Carlos Eduardo/F-3402-2010; Miglino, Maria
   Angelica/B-9519-2012
OI Feitosa, Matheus/0000-0002-9247-8532; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; Junior, Eduardo Harry Birgel/0000-0002-9079-0549;
   Junior, Eduardo Harry Birgel/0000-0002-9079-0549; Ambrosio, Carlos
   Eduardo/0000-0002-8224-5022; Miglino, Maria Angelica/0000-0003-4979-115X
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR
PY 2009
VL 15
IS 3
BP 696
EP 696
PG 1
WC Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical;
   Materials Science, Biomaterials
SC Cell Biology; Engineering; Materials Science
GA 415DG
UT WOS:000263913900084
DA 2020-12-01
ER

PT J
AU Fadel, L
   Feitosa, MLT
   Beltrao-Braga, PCB
   Wenceslau, CV
   Birgel, EH
   Panattoni, JF
   Miglino, MA
   Ambrosio, CE
AF Fadel, L.
   Feitosa, M. L. Tajra
   Beltrao-Braga, P. C. B.
   Wenceslau, C. V.
   Birgel Junior, E. H.
   Panattoni, J. F.
   Miglino, M. A.
   Ambrosio, C. E.
TI Retroviral Gene Transfer to Ovine Bone Marrow Mesenchymal Cell
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 3rd Congress on Regenerative Biology and Medicine/3rd Congress of the
   German-Society-for-Stem-Cell-Research
CY OCT 09-11, 2008
CL Stuttgart, GERMANY
SP German Soc Stem Cell Res
C1 [Fadel, L.; Feitosa, M. L. Tajra; Wenceslau, C. V.; Birgel Junior, E. H.; Miglino, M. A.; Ambrosio, C. E.] Univ Sao Paulo, Fac Med Vet & Anim Sci, BR-05508 Sao Paulo, Brazil.
   [Beltrao-Braga, P. C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, BR-05508 Sao Paulo, Brazil.
RI Junior, Eduardo Harry Birgel/F-2765-2012; Miglino, Maria
   Angelica/B-9519-2012; Beltrao-Braga, Patricia C B/D-6450-2013; Feitosa,
   Matheus/J-5528-2014; Ambrosio, Carlos Eduardo/F-3402-2010; Junior,
   Eduardo Harry Birgel/N-9298-2016
OI Junior, Eduardo Harry Birgel/0000-0002-9079-0549; Miglino, Maria
   Angelica/0000-0003-4979-115X; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; Feitosa, Matheus/0000-0002-9247-8532; Ambrosio,
   Carlos Eduardo/0000-0002-8224-5022; Junior, Eduardo Harry
   Birgel/0000-0002-9079-0549
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR
PY 2009
VL 15
IS 3
BP 700
EP 700
PG 1
WC Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical;
   Materials Science, Biomaterials
SC Cell Biology; Engineering; Materials Science
GA 415DG
UT WOS:000263913900098
DA 2020-12-01
ER

PT J
AU Beltrao-Braga, PCB
   Wenceslau, CV
   Winck, CP
   Lima, EB
   Goncalves, LG
   Fernandes, SWH
   Ambrosio, CE
   Miglino, MA
AF Beltrao-Braga, P. C. B.
   Wenceslau, C. V.
   Winck, C. P.
   Lima, E. B.
   Goncalves, L. G.
   Fernandes, S. W. Han
   Ambrosio, C. E.
   Miglino, M. A.
TI Retroviral Gene Transfer to Cells from Amniotic Membrane of Normal
   Embryos of Golden Retriever Muscular Dystrophy Dogs (GRMD)
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 3rd Congress on Regenerative Biology and Medicine/3rd Congress of the
   German-Society-for-Stem-Cell-Research
CY OCT 09-11, 2008
CL Stuttgart, GERMANY
SP German Soc Stem Cell Res
C1 [Beltrao-Braga, P. C. B.; Wenceslau, C. V.; Winck, C. P.; Lima, E. B.; Goncalves, L. G.; Fernandes, S. W. Han; Ambrosio, C. E.; Miglino, M. A.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Chirurg, BR-05580270 Sao Paulo, Brazil.
RI Miglino, Maria Angelica/B-9519-2012; Ambrosio, Carlos
   Eduardo/F-3402-2010; Beltrao-Braga, Patricia C B/D-6450-2013
OI Miglino, Maria Angelica/0000-0003-4979-115X; Ambrosio, Carlos
   Eduardo/0000-0002-8224-5022; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091
NR 0
TC 0
Z9 0
U1 0
U2 3
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR
PY 2009
VL 15
IS 3
BP 723
EP 723
PG 1
WC Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical;
   Materials Science, Biomaterials
SC Cell Biology; Engineering; Materials Science
GA 415DG
UT WOS:000263913900169
DA 2020-12-01
ER

PT J
AU Ambrosio, CE
   Fadel, L
   Gaiad, TP
   Martins, DS
   Araujo, KPC
   Zucconi, E
   Brolio, MP
   Giglio, RF
   Morini, AC
   Jazedje, T
   Froes, TR
   Feitosa, MLT
   Valadares, MC
   Beltrao-Braga, PCB
   Meirelles, FV
   Miglino, MA
AF Ambrosio, C. E.
   Fadel, L.
   Gaiad, T. P.
   Martins, D. S.
   Araujo, K. P. C.
   Zucconi, E.
   Brolio, M. P.
   Giglio, R. F.
   Morini, A. C.
   Jazedje, T.
   Froes, T. R.
   Feitosa, M. L. T.
   Valadares, M. C.
   Beltrao-Braga, P. C. B.
   Meirelles, F. V.
   Miglino, M. A.
TI Identification of three distinguishable phenotypes in golden retriever
   muscular dystrophy
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Duchenne muscular dystrophy; Animal disease; Model; Phenotype
ID NEUROMUSCULAR DISEASES; ANIMAL-MODELS; DOGS; GRMD; TRANSPLANTATION;
   EXPRESSION; CARRIERS; LESIONS; MUSCLE
AB Duchenne muscular dystrophy (DMD) is a human disease characterized by progressive and irreversible skeletal muscle degeneration caused by mutations in genes coding for important muscle proteins. Unfortunately, there is no efficient treatment for this disease; it causes progressive loss of motor and muscular ability until death. The canine model (golden retriever muscular dystrophy) is similar to DMD, showing similar clinical signs. Fifteen dogs were followed from birth and closely observed for clinical signs. Dogs had their disease status confirmed by polymerase chain reaction analysis and genotyping. Clinical observations of musculoskeletal, morphological, gastrointestinal, respiratory, cardiovascular, and renal features allowed us to identify three distinguishable phenotypes in dystrophic dogs: mild (grade I), moderate (grade II) and severe (grade III). These three groups showed no difference in dystrophic alterations of muscle morphology and creatine kinase levels. This information will be useful for therapeutic trials, because DMD also shows significant, inter- and intra-familiar clinical variability. Additionally, being aware of phenotypic differences in this animal model is essential for correct interpretation and understanding of results obtained in pre-clinical trials.
C1 [Ambrosio, C. E.; Meirelles, F. V.] Univ Sao Paulo, Dept Ciencias Basicas, Fac Zootecnia & Engn Alimentos, Sao Paulo, Brazil.
   [Fadel, L.; Gaiad, T. P.; Martins, D. S.; Araujo, K. P. C.; Brolio, M. P.; Morini, A. C.; Feitosa, M. L. T.; Beltrao-Braga, P. C. B.; Miglino, M. A.] Univ Sao Paulo, Dept Cirugia, Fac Med Vet & Zootecnia, Sao Paulo, Brazil.
   [Zucconi, E.; Jazedje, T.; Valadares, M. C.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Ctr Estudos Genoma Humano, Sao Paulo, Brazil.
   [Froes, T. R.] Univ Fed Parana, Fac Med Vet, BR-80060000 Curitiba, Parana, Brazil.
   [Giglio, R. F.] Univ Florida, Gainesville, FL USA.
RP Ambrosio, CE (corresponding author), Univ Sao Paulo, Dept Ciencias Basicas, Fac Zootecnia & Engn Alimentos, Sao Paulo, Brazil.
EM ceambrosio@usp.br
RI Miglino, Maria Angelica/B-9519-2012; Tazedje, Tatiana/A-5631-2013;
   Rodrigues Froes, Tilde/I-7956-2016; Zucconi, Eder/AAJ-9548-2020;
   Valadares, Marcos/B-1155-2013; Feitosa, Matheus/J-5528-2014; Morini,
   Adriana/K-2028-2012; Meirelles, Flavio V/B-5048-2010; Beltrao-Braga,
   Patricia C B/D-6450-2013; Ambrosio, Carlos Eduardo/F-3402-2010;
   Valadares, Marcos/AAB-8953-2019; dos Santos Martins, Daniele/C-9004-2013
OI Miglino, Maria Angelica/0000-0003-4979-115X; Rodrigues Froes,
   Tilde/0000-0002-7802-2598; Zucconi, Eder/0000-0002-5904-4564; Feitosa,
   Matheus/0000-0002-9247-8532; Morini, Adriana/0000-0001-8731-9935;
   Meirelles, Flavio V/0000-0003-0372-4920; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; Ambrosio, Carlos Eduardo/0000-0002-8224-5022; dos
   Santos Martins, Daniele/0000-0002-6277-4664
CR Alves FR, 2009, PESQUI VET BRASIL, V29, P99, DOI 10.1590/S0100-736X2009000200002
   Ambrosio C, 2007, NEUROMUSCULAR DISORD, V17, P776, DOI 10.1016/j.nmd.2007.06.056
   Ambrosio CE, 2008, NEUROMUSCULAR DISORD, V18, P892, DOI 10.1016/j.nmd.2008.06.385
   Bergman RL, 2002, J AM ANIM HOSP ASSOC, V38, P255, DOI 10.5326/0380255
   BRAZEAU GA, 1992, RES COMMUN CHEM PATH, V77, P179
   Childers MK, 2002, ARCH PHYS MED REHAB, V83, P1572, DOI 10.1053/apmr.2002.35109
   Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x
   Dell'Agnola C, 2004, BLOOD, V104, P4311, DOI 10.1182/blood-2004-06-2247
   Dubowitz V, 2006, NEUROMUSCULAR DISORD, V16, P865, DOI 10.1016/j.nmd.2006.09.003
   Grando AP, 2009, CIENC RURAL, V39, P123, DOI 10.1590/S0103-84782008005000037
   Hoffman EP, 2001, TRENDS PHARMACOL SCI, V22, P465, DOI 10.1016/S0165-6147(00)01770-3
   Honeyman K, 1999, AM J VET RES, V60, P734
   Howell JM, 1997, NEUROMUSCULAR DISORD, V7, P325
   Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35
   KORNEGAY JN, 1988, MUSCLE NERVE, V11, P1056, DOI 10.1002/mus.880111008
   Liu JMK, 2004, MUSCLE NERVE, V30, P767, DOI 10.1002/mus.20154
   Manzur AY, 2002, CURRENT PAEDIAT, V12, P261
   McClorey G, 2006, GENE THER, V13, P1373, DOI 10.1038/sj.gt.3302800
   MCKERRELL RE, 2001, TRATADO MED PEQUENOS, P699
   Nguyen F, 2002, J COMP PATHOL, V126, P100, DOI 10.1053/jcpa.2001.0526
   NICHOLS PL, 1994, GENE THERAPY DUCHENN
   PASSOSBUENO MR, 1995, MIOPATIAS HEREDITARI, P70
   Pellegrino Arine, 2007, Cienc. Rural, V37, P1039, DOI 10.1590/S0103-84782007000400019
   SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J
   Shelton GD, 2002, VET CLIN N AM-SMALL, V32, P103, DOI 10.1016/S0195-5616(03)00081-0
   Sifringer M, 2004, HUM GENET, V114, P149, DOI 10.1007/s00439-003-1041-2
   Vainzof M, 2003, BRAZ J MED BIOL RES, V36, P543, DOI 10.1590/S0100-879X2003000500001
   Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9
   Valentine B A, 1991, Neuromuscul Disord, V1, P31, DOI 10.1016/0960-8966(91)90040-Y
   VALENTINE BA, 1990, J NEUROL SCI, V97, P1, DOI 10.1016/0022-510X(90)90095-5
   VALENTINE BA, 1988, J NEUROL SCI, V88, P69, DOI 10.1016/0022-510X(88)90206-7
   ZATZ M, 2004, GENOMICA, P345
NR 32
TC 29
Z9 29
U1 0
U2 8
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA HUDSON 655, JARDIM CANADA, RIBEIRAO PRETO, SP, BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2009
VL 8
IS 2
BP 389
EP 396
DI 10.4238/vol8-2gmr581
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 469YQ
UT WOS:000267938300001
PM 19440974
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Beltrao-Braga, PCB
   Koh, IHJ
   Silva, MRR
   Gutierrez, PS
   Han, SW
AF Beltrao-Braga, PCB
   Koh, IHJ
   Silva, MRR
   Gutierrez, PS
   Han, SW
TI Vascular adventitia is a suitable compartment to transplant transduced
   vascular smooth muscle cells for ex vivo gene expression
SO CELL TRANSPLANTATION
LA English
DT Article
DE smooth muscle cells; adventitia; retroviral vector; gene therapy; hGH
ID HUMAN ADENOSINE-DEAMINASE; RETROVIRAL VECTORS; IN-VIVO; ARTERIES;
   THERAPY; MODEL; RATS; DELIVERY; LINES
AB Vascular smooth muscle cells (VSMC) are ideal for systemic gene therapy because of their proximity to blood vessels and they have demonstrated long-term exogenous gene expression in vivo. However, the procedure generally followed to seed the transduced VSMC onto arteries denuded of endothelial cells usually induces stenosis and thrombosis, with a consequent high risk for use in humans. We demonstrate here that the vascular adventitia is a suitable place to introduce transduced VSMC and to secrete therapeutic proteins into the blood stream by a simple procedure, avoiding postoperative vascular complications. Transduced VSMC, with the retroviral vectors carrying the human growth hormone gene (hGH), were seeded into the adventitia of the rat abdominal aorta by single injection of a cell suspension. Based on the hGH and anti-hGH production in serum and on histological analysis of the removed aortas, we demonstrated hGH production over the 2-month experimental period. None of the animals used in the experiment showed stenosis, thrombosis, or other vascular or visible physiological abnormalities.
C1 UNIFESP, EPM, Dept Biophys, BR-04023062 Sao Paulo, Brazil.
   UNIFESP, EPM, Dept Pediat, BR-04023062 Sao Paulo, Brazil.
   UNIFESP, EPM, Dept Pathol, BR-04023062 Sao Paulo, Brazil.
   USP, INCOR, Pathol Lab, BR-05403000 Sao Paulo, Brazil.
RP Han, SW (corresponding author), UNIFESP, EPM, Dept Biophys, Rua Botucatu 862, BR-04023062 Sao Paulo, Brazil.
RI Gutierrez, Paulo S/E-6783-2012; Beltrao-Braga, Patricia C B/D-6450-2013
OI Gutierrez, Paulo S/0000-0002-9544-2359; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091
CR BARTOLINI P, 1992, DEV RADIOIMMUNOASSAY, P197
   Chen AFY, 1997, P NATL ACAD SCI USA, V94, P12568, DOI 10.1073/pnas.94.23.12568
   CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016
   FRAZIER JM, 1980, J TOXICOL ENV HEALTH, V6, P503, DOI 10.1080/15287398009529869
   GEARY RL, 1994, HUM GENE THER, V5, P1211, DOI 10.1089/hum.1994.5.10-1211
   HANTZOPOULOS PA, 1989, P NATL ACAD SCI USA, V86, P3519, DOI 10.1073/pnas.86.10.3519
   HOCK RA, 1989, BLOOD, V74, P876
   House WA, 1997, AM J PHYSIOL-REG I, V273, pR1117
   KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0
   Koshino T, 1998, SURG TODAY, V28, P1295
   Lejnieks DV, 1998, BLOOD, V92, P888
   Lejnieks DV, 1996, HUM GENE THER, V7, P1431, DOI 10.1089/hum.1996.7.12-1431
   Lynch CM, 1997, CIRC RES, V80, P497
   LYNCH CM, 1992, P NATL ACAD SCI USA, V89, P1138, DOI 10.1073/pnas.89.3.1138
   MATHOR MB, 1994, THESIS
   MILLER AD, 1993, METHOD ENZYMOL, V217, P581
   MILLER AD, 1989, BIOTECHNIQUES, V7, P980
   MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895
   OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883
   Ooboshi H, 1997, MOL CELL BIOCHEM, V172, P37, DOI 10.1023/A:1006803202179
   PEETERS S, 1977, ENDOCRINOLOGY, V101, P1164, DOI 10.1210/endo-101-4-1164
   Rolling F, 1997, GENE THER, V4, P757, DOI 10.1038/sj.gt.3300465
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
   Schneider DB, 1999, J VASC SURG, V29, P543, DOI 10.1016/S0741-5214(99)70283-1
   SCHWARTZ RS, 1990, CIRCULATION, V82, P2190, DOI 10.1161/01.CIR.82.6.2190
   White RA, 1997, J ENDOVASC SURG, V4, P88, DOI 10.1583/1074-6218(1997)004<0088:EGEOAP>2.0.CO;2
   WOLINSKY H, 1967, CIRC RES, V20, P409, DOI 10.1161/01.RES.20.4.409
NR 27
TC 4
Z9 4
U1 0
U2 2
PU COGNIZANT COMMUNICATION CORP
PI ELMSFORD
PA 3 HARTSDALE ROAD, ELMSFORD, NY 10523-3701 USA
SN 0963-6897
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2002
VL 11
IS 6
BP 583
EP 592
PG 10
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 608FF
UT WOS:000178834200012
PM 12428748
DA 2020-12-01
ER

EF